id	sid	tid	token	lemma	pos
ijpds-4638	1	1	dyade	dyade	VERB
ijpds-4638	1	2	et	et	PROPN
ijpds-4638	1	3	al	al	PROPN
ijpds-4638	1	4	.	.	PROPN
ijpds-4638	1	5	qbd	qbd	PROPN
ijpds-4638	1	6	and	and	CCONJ
ijpds-4638	1	7	chemometric	chemometric	ADJ
ijpds-4638	1	8	method	method	NOUN
ijpds-4638	1	9	for	for	ADP
ijpds-4638	1	10	estimation	estimation	NOUN
ijpds-4638	1	11	of	of	ADP
ijpds-4638	1	12	metoprolol	metoprolol	NOUN
ijpds-4638	1	13	and	and	CCONJ
ijpds-4638	1	14	cilnidipine	cilnidipine	ADJ
ijpds-4638	1	15	online	online	ADJ
ijpds-4638	1	16	first	first	PROPN
ijpds-4638	1	17	indian	indian	PROPN
ijpds-4638	1	18	j	j	PROPN
ijpds-4638	1	19	pharm	pharm	PROPN
ijpds-4638	1	20	drug	drug	PROPN
ijpds-4638	1	21	studies	study	NOUN
ijpds-4638	1	22	|	|	ADV
ijpds-4638	1	23	1	1	NUM
ijpds-4638	1	24	original	original	ADJ
ijpds-4638	1	25	article	article	NOUN
ijpds-4638	1	26	qbd	qbd	NOUN
ijpds-4638	1	27	approach	approach	NOUN
ijpds-4638	1	28	and	and	CCONJ
ijpds-4638	1	29	chemo	chemo	VERB
ijpds-4638	1	30	metric	metric	ADJ
ijpds-4638	1	31	method	method	NOUN
ijpds-4638	1	32	development	development	NOUN
ijpds-4638	1	33	for	for	ADP
ijpds-4638	1	34	the	the	DET
ijpds-4638	1	35	estimation	estimation	NOUN
ijpds-4638	1	36	of	of	ADP
ijpds-4638	1	37	metoprolol	metoprolol	PROPN
ijpds-4638	1	38	succinate	succinate	NOUN
ijpds-4638	1	39	and	and	CCONJ
ijpds-4638	1	40	cilnidipine	cilnidipine	NOUN
ijpds-4638	1	41	in	in	ADP
ijpds-4638	1	42	combined	combine	VERB
ijpds-4638	1	43	solid	solid	ADJ
ijpds-4638	1	44	dosage	dosage	NOUN
ijpds-4638	1	45	form	form	NOUN
ijpds-4638	1	46	g.	g.	PROPN
ijpds-4638	1	47	k.	k.	PROPN
ijpds-4638	2	1	dyade1	dyade1	PROPN
ijpds-4638	2	2	,	,	PUNCT
ijpds-4638	2	3	r.	r.	PROPN
ijpds-4638	2	4	b.	b.	PROPN
ijpds-4638	2	5	jadhav2	jadhav2	PROPN
ijpds-4638	2	6	,	,	PUNCT
ijpds-4638	2	7	sanket	sanket	NOUN
ijpds-4638	2	8	repal3	repal3	NOUN
ijpds-4638	2	9	,	,	PUNCT
ijpds-4638	2	10	shital	shital	PROPN
ijpds-4638	2	11	uparwad3	uparwad3	PROPN
ijpds-4638	2	12	,	,	PUNCT
ijpds-4638	2	13	prashant	prashant	PROPN
ijpds-4638	2	14	suryawanshi3	suryawanshi3	PROPN
ijpds-4638	2	15	,	,	PUNCT
ijpds-4638	2	16	aashish	aashish	ADJ
ijpds-4638	2	17	taware3	taware3	PROPN
ijpds-4638	2	18	,	,	PUNCT
ijpds-4638	2	19	sonali	sonali	PROPN
ijpds-4638	2	20	khapne3	khapne3	PROPN
ijpds-4638	2	21	,	,	PUNCT
ijpds-4638	2	22	shweta	shweta	PROPN
ijpds-4638	2	23	kokare3	kokare3	PROPN
ijpds-4638	2	24	,	,	PUNCT
ijpds-4638	2	25	anuse	anuse	NOUN
ijpds-4638	2	26	dnyaneshwar3	dnyaneshwar3	NOUN
ijpds-4638	2	27	from	from	ADP
ijpds-4638	2	28	,	,	PUNCT
ijpds-4638	2	29	1asso	1asso	NUM
ijpds-4638	2	30	.	.	PUNCT
ijpds-4638	2	31	professor	professor	NOUN
ijpds-4638	2	32	,	,	PUNCT
ijpds-4638	2	33	2principal	2principal	NUM
ijpds-4638	2	34	,	,	PUNCT
ijpds-4638	2	35	3	3	NUM
ijpds-4638	2	36	m.	m.	NOUN
ijpds-4638	2	37	pharma	pharma	PROPN
ijpds-4638	2	38	students	student	NOUN
ijpds-4638	2	39	,	,	PUNCT
ijpds-4638	2	40	dept	dept	NOUN
ijpds-4638	2	41	of	of	ADP
ijpds-4638	2	42	post	post	PROPN
ijpds-4638	2	43	graduate	graduate	NOUN
ijpds-4638	2	44	studies	study	NOUN
ijpds-4638	2	45	in	in	ADP
ijpds-4638	2	46	pharmaceutical	pharmaceutical	ADJ
ijpds-4638	2	47	quality	quality	NOUN
ijpds-4638	2	48	assurance	assurance	NOUN
ijpds-4638	2	49	,	,	PUNCT
ijpds-4638	2	50	svpm	svpm	NOUN
ijpds-4638	2	51	’s	’s	PART
ijpds-4638	2	52	college	college	PROPN
ijpds-4638	2	53	of	of	ADP
ijpds-4638	2	54	pharmacy	pharmacy	NOUN
ijpds-4638	2	55	,	,	PUNCT
ijpds-4638	2	56	malegaon	malegaon	PROPN
ijpds-4638	2	57	(	(	PUNCT
ijpds-4638	2	58	bkii)-413115	bkii)-413115	PROPN
ijpds-4638	2	59	baramati	baramati	PROPN
ijpds-4638	2	60	dist	dist	PROPN
ijpds-4638	2	61	pune	pune	PROPN
ijpds-4638	2	62	,	,	PUNCT
ijpds-4638	2	63	maharashtra	maharashtra	PROPN
ijpds-4638	2	64	,	,	PUNCT
ijpds-4638	2	65	india	india	PROPN
ijpds-4638	2	66	.	.	PUNCT
ijpds-4638	3	1	abstract	abstract	ADJ
ijpds-4638	3	2	background	background	NOUN
ijpds-4638	3	3	:	:	PUNCT
ijpds-4638	3	4	development	development	NOUN
ijpds-4638	3	5	of	of	ADP
ijpds-4638	3	6	several	several	ADJ
ijpds-4638	3	7	pharmaceutical	pharmaceutical	NOUN
ijpds-4638	3	8	processes	process	NOUN
ijpds-4638	3	9	including	include	VERB
ijpds-4638	3	10	analytical	analytical	ADJ
ijpds-4638	3	11	methods	method	NOUN
ijpds-4638	3	12	by	by	ADP
ijpds-4638	3	13	applying	apply	VERB
ijpds-4638	3	14	quality	quality	NOUN
ijpds-4638	3	15	by	by	ADP
ijpds-4638	3	16	design	design	NOUN
ijpds-4638	3	17	assists	assist	NOUN
ijpds-4638	3	18	in	in	ADP
ijpds-4638	3	19	ensuring	ensure	VERB
ijpds-4638	3	20	the	the	DET
ijpds-4638	3	21	robustness	robustness	NOUN
ijpds-4638	3	22	of	of	ADP
ijpds-4638	3	23	the	the	DET
ijpds-4638	3	24	method	method	NOUN
ijpds-4638	3	25	.	.	PUNCT
ijpds-4638	4	1	usfda	usfda	PROPN
ijpds-4638	4	2	and	and	CCONJ
ijpds-4638	4	3	other	other	ADJ
ijpds-4638	4	4	regulatory	regulatory	ADJ
ijpds-4638	4	5	agencies	agency	NOUN
ijpds-4638	4	6	have	have	AUX
ijpds-4638	4	7	recommended	recommend	VERB
ijpds-4638	4	8	implementation	implementation	NOUN
ijpds-4638	4	9	of	of	ADP
ijpds-4638	4	10	quality	quality	NOUN
ijpds-4638	4	11	by	by	ADP
ijpds-4638	4	12	design	design	NOUN
ijpds-4638	4	13	(	(	PUNCT
ijpds-4638	4	14	qbd	qbd	PROPN
ijpds-4638	4	15	)	)	PUNCT
ijpds-4638	4	16	a	a	DET
ijpds-4638	4	17	systematic	systematic	ADJ
ijpds-4638	4	18	process	process	NOUN
ijpds-4638	4	19	for	for	ADP
ijpds-4638	4	20	pharmaceutical	pharmaceutical	ADJ
ijpds-4638	4	21	development	development	NOUN
ijpds-4638	4	22	along	along	ADP
ijpds-4638	4	23	with	with	ADP
ijpds-4638	4	24	its	its	PRON
ijpds-4638	4	25	significance	significance	NOUN
ijpds-4638	4	26	.	.	PUNCT
ijpds-4638	5	1	objective	objective	NOUN
ijpds-4638	5	2	:	:	PUNCT
ijpds-4638	5	3	chemo	chemo	VERB
ijpds-4638	5	4	metric	metric	ADJ
ijpds-4638	5	5	assisted	assist	VERB
ijpds-4638	5	6	uv	uv	NOUN
ijpds-4638	5	7	-	-	PUNCT
ijpds-4638	5	8	vis	vis	X
ijpds-4638	5	9	spectrophotometric	spectrophotometric	ADJ
ijpds-4638	5	10	analytical	analytical	ADJ
ijpds-4638	5	11	method	method	NOUN
ijpds-4638	5	12	based	base	VERB
ijpds-4638	5	13	on	on	ADP
ijpds-4638	5	14	qbd	qbd	PROPN
ijpds-4638	5	15	was	be	AUX
ijpds-4638	5	16	developed	develop	VERB
ijpds-4638	5	17	for	for	ADP
ijpds-4638	5	18	the	the	DET
ijpds-4638	5	19	estimation	estimation	NOUN
ijpds-4638	5	20	of	of	ADP
ijpds-4638	5	21	metoprolol	metoprolol	PROPN
ijpds-4638	5	22	succinate	succinate	NOUN
ijpds-4638	5	23	(	(	PUNCT
ijpds-4638	5	24	met	meet	VERB
ijpds-4638	5	25	)	)	PUNCT
ijpds-4638	5	26	and	and	CCONJ
ijpds-4638	5	27	cilnidipine	cilnidipine	NOUN
ijpds-4638	5	28	(	(	PUNCT
ijpds-4638	5	29	cil	cil	PROPN
ijpds-4638	5	30	)	)	PUNCT
ijpds-4638	5	31	from	from	ADP
ijpds-4638	5	32	the	the	DET
ijpds-4638	5	33	combined	combine	VERB
ijpds-4638	5	34	dosage	dosage	NOUN
ijpds-4638	5	35	forms	form	NOUN
ijpds-4638	5	36	.	.	PUNCT
ijpds-4638	6	1	method	method	NOUN
ijpds-4638	6	2	:	:	PUNCT
ijpds-4638	6	3	nature	nature	NOUN
ijpds-4638	6	4	of	of	ADP
ijpds-4638	6	5	spectra	spectra	PROPN
ijpds-4638	6	6	focused	focus	VERB
ijpds-4638	6	7	applicability	applicability	NOUN
ijpds-4638	6	8	of	of	ADP
ijpds-4638	6	9	absorbance	absorbance	NOUN
ijpds-4638	6	10	correction	correction	NOUN
ijpds-4638	6	11	and	and	CCONJ
ijpds-4638	6	12	amplitude	amplitude	NOUN
ijpds-4638	6	13	modulation	modulation	NOUN
ijpds-4638	6	14	methods	method	NOUN
ijpds-4638	6	15	for	for	ADP
ijpds-4638	6	16	estimation	estimation	NOUN
ijpds-4638	6	17	of	of	ADP
ijpds-4638	6	18	both	both	DET
ijpds-4638	6	19	drugs	drug	NOUN
ijpds-4638	6	20	from	from	ADP
ijpds-4638	6	21	the	the	DET
ijpds-4638	6	22	formulations	formulation	NOUN
ijpds-4638	6	23	;	;	PUNCT
ijpds-4638	6	24	and	and	CCONJ
ijpds-4638	6	25	50	50	NUM
ijpds-4638	6	26	%	%	NOUN
ijpds-4638	6	27	alcohol	alcohol	NOUN
ijpds-4638	6	28	was	be	AUX
ijpds-4638	6	29	being	be	AUX
ijpds-4638	6	30	the	the	DET
ijpds-4638	6	31	common	common	ADJ
ijpds-4638	6	32	solvent	solvent	NOUN
ijpds-4638	6	33	.	.	PUNCT
ijpds-4638	7	1	for	for	ADP
ijpds-4638	7	2	both	both	DET
ijpds-4638	7	3	this	this	DET
ijpds-4638	7	4	method	method	NOUN
ijpds-4638	7	5	221	221	NUM
ijpds-4638	7	6	nm	nm	NOUN
ijpds-4638	7	7	and	and	CCONJ
ijpds-4638	7	8	242	242	NUM
ijpds-4638	7	9	nm	nm	NOUN
ijpds-4638	7	10	was	be	AUX
ijpds-4638	7	11	the	the	DET
ijpds-4638	7	12	wavelength	wavelength	NOUN
ijpds-4638	7	13	for	for	ADP
ijpds-4638	7	14	measurement	measurement	NOUN
ijpds-4638	7	15	of	of	ADP
ijpds-4638	7	16	absorbance	absorbance	NOUN
ijpds-4638	7	17	of	of	ADP
ijpds-4638	7	18	metoprolol	metoprolol	NOUN
ijpds-4638	7	19	and	and	CCONJ
ijpds-4638	7	20	cilnidipine	cilnidipine	NOUN
ijpds-4638	7	21	respectively	respectively	ADV
ijpds-4638	7	22	.	.	PUNCT
ijpds-4638	8	1	effect	effect	NOUN
ijpds-4638	8	2	of	of	ADP
ijpds-4638	8	3	input	input	NOUN
ijpds-4638	8	4	variables	variable	NOUN
ijpds-4638	8	5	on	on	ADP
ijpds-4638	8	6	spectrum	spectrum	NOUN
ijpds-4638	8	7	characteristics	characteristic	NOUN
ijpds-4638	8	8	were	be	AUX
ijpds-4638	8	9	studied	study	VERB
ijpds-4638	8	10	for	for	ADP
ijpds-4638	8	11	selection	selection	NOUN
ijpds-4638	8	12	of	of	ADP
ijpds-4638	8	13	critical	critical	ADJ
ijpds-4638	8	14	parameters	parameter	NOUN
ijpds-4638	8	15	and	and	CCONJ
ijpds-4638	8	16	developed	develop	VERB
ijpds-4638	8	17	method	method	NOUN
ijpds-4638	8	18	was	be	AUX
ijpds-4638	8	19	validated	validate	VERB
ijpds-4638	8	20	as	as	ADP
ijpds-4638	8	21	per	per	ADP
ijpds-4638	8	22	ich	ich	NOUN
ijpds-4638	8	23	q	q	PROPN
ijpds-4638	8	24	2	2	NUM
ijpds-4638	8	25	r1	r1	NOUN
ijpds-4638	8	26	regulatory	regulatory	ADJ
ijpds-4638	8	27	guidelines	guideline	NOUN
ijpds-4638	8	28	.	.	PUNCT
ijpds-4638	9	1	result	result	NOUN
ijpds-4638	9	2	and	and	CCONJ
ijpds-4638	9	3	conclusion	conclusion	NOUN
ijpds-4638	9	4	:	:	PUNCT
ijpds-4638	9	5	linearity	linearity	NOUN
ijpds-4638	9	6	of	of	ADP
ijpds-4638	9	7	the	the	DET
ijpds-4638	9	8	drugs	drug	NOUN
ijpds-4638	9	9	was	be	AUX
ijpds-4638	9	10	ascertained	ascertain	VERB
ijpds-4638	9	11	over	over	ADP
ijpds-4638	9	12	the	the	DET
ijpds-4638	9	13	conc	conc	ADJ
ijpds-4638	9	14	range	range	NOUN
ijpds-4638	9	15	1	1	NUM
ijpds-4638	9	16	-	-	SYM
ijpds-4638	9	17	36	36	NUM
ijpds-4638	9	18	μg	μg	PROPN
ijpds-4638	9	19	/	/	SYM
ijpds-4638	9	20	ml	ml	PROPN
ijpds-4638	9	21	(	(	PUNCT
ijpds-4638	9	22	microgram	microgram	NOUN
ijpds-4638	9	23	/	/	SYM
ijpds-4638	9	24	ml	ml	NOUN
ijpds-4638	9	25	)	)	PUNCT
ijpds-4638	9	26	for	for	AUX
ijpds-4638	9	27	met	meet	VERB
ijpds-4638	9	28	and	and	CCONJ
ijpds-4638	9	29	1	1	NUM
ijpds-4638	9	30	-	-	SYM
ijpds-4638	9	31	16	16	NUM
ijpds-4638	9	32	μg	μg	NOUN
ijpds-4638	9	33	/	/	SYM
ijpds-4638	9	34	ml	ml	PROPN
ijpds-4638	9	35	for	for	ADP
ijpds-4638	9	36	cil	cil	PROPN
ijpds-4638	9	37	.	.	PUNCT
ijpds-4638	10	1	the	the	DET
ijpds-4638	10	2	percentage	percentage	NOUN
ijpds-4638	10	3	purity	purity	NOUN
ijpds-4638	10	4	of	of	ADP
ijpds-4638	10	5	assay	assay	NOUN
ijpds-4638	10	6	in	in	ADP
ijpds-4638	10	7	method	method	PROPN
ijpds-4638	10	8	ii	ii	PROPN
ijpds-4638	10	9	was	be	AUX
ijpds-4638	10	10	found	find	VERB
ijpds-4638	10	11	103.773	103.773	NUM
ijpds-4638	10	12	%	%	NOUN
ijpds-4638	10	13	for	for	ADP
ijpds-4638	10	14	met	meet	VERB
ijpds-4638	10	15	and	and	CCONJ
ijpds-4638	10	16	96.825	96.825	NUM
ijpds-4638	10	17	%	%	NOUN
ijpds-4638	10	18	for	for	ADP
ijpds-4638	10	19	cil	cil	NOUN
ijpds-4638	10	20	;	;	PUNCT
ijpds-4638	10	21	and	and	CCONJ
ijpds-4638	10	22	the	the	DET
ijpds-4638	10	23	accuracy	accuracy	NOUN
ijpds-4638	10	24	study	study	NOUN
ijpds-4638	10	25	data	datum	NOUN
ijpds-4638	10	26	of	of	ADP
ijpds-4638	10	27	method	method	NOUN
ijpds-4638	10	28	i	i	PRON
ijpds-4638	10	29	were	be	AUX
ijpds-4638	10	30	varied	varied	ADJ
ijpds-4638	10	31	2.04859	2.04859	NUM
ijpds-4638	10	32	for	for	ADP
ijpds-4638	10	33	met	meet	VERB
ijpds-4638	10	34	and	and	CCONJ
ijpds-4638	10	35	1.26321	1.26321	NUM
ijpds-4638	10	36	for	for	ADP
ijpds-4638	10	37	cil	cil	PROPN
ijpds-4638	10	38	.	.	PUNCT
ijpds-4638	11	1	precision	precision	NOUN
ijpds-4638	11	2	study	study	NOUN
ijpds-4638	11	3	was	be	AUX
ijpds-4638	11	4	shown	show	VERB
ijpds-4638	11	5	acceptable	acceptable	ADJ
ijpds-4638	11	6	data	datum	NOUN
ijpds-4638	11	7	as	as	ADP
ijpds-4638	11	8	%	%	NOUN
ijpds-4638	11	9	rsd	rsd	NOUN
ijpds-4638	11	10	in	in	ADP
ijpds-4638	11	11	method	method	NOUN
ijpds-4638	11	12	i	i	PRON
ijpds-4638	11	13	data	data	VERB
ijpds-4638	11	14	varied	vary	VERB
ijpds-4638	11	15	0.58894	0.58894	NUM
ijpds-4638	11	16	for	for	ADP
ijpds-4638	11	17	met	meet	VERB
ijpds-4638	11	18	and	and	CCONJ
ijpds-4638	11	19	1.15116	1.15116	NUM
ijpds-4638	11	20	for	for	ADP
ijpds-4638	11	21	cil	cil	PROPN
ijpds-4638	11	22	.	.	PUNCT
ijpds-4638	12	1	the	the	DET
ijpds-4638	12	2	developed	develop	VERB
ijpds-4638	12	3	method	method	NOUN
ijpds-4638	12	4	is	be	AUX
ijpds-4638	12	5	rigid	rigid	ADJ
ijpds-4638	12	6	,	,	PUNCT
ijpds-4638	12	7	robust	robust	ADJ
ijpds-4638	12	8	and	and	CCONJ
ijpds-4638	12	9	efficient	efficient	ADJ
ijpds-4638	12	10	for	for	ADP
ijpds-4638	12	11	the	the	DET
ijpds-4638	12	12	estimation	estimation	NOUN
ijpds-4638	12	13	of	of	ADP
ijpds-4638	12	14	met	meet	VERB
ijpds-4638	12	15	and	and	CCONJ
ijpds-4638	12	16	cil	cil	NOUN
ijpds-4638	12	17	from	from	ADP
ijpds-4638	12	18	the	the	DET
ijpds-4638	12	19	composition	composition	NOUN
ijpds-4638	12	20	of	of	ADP
ijpds-4638	12	21	dosage	dosage	NOUN
ijpds-4638	12	22	form	form	NOUN
ijpds-4638	12	23	.	.	PUNCT
ijpds-4638	13	1	keywords	keyword	NOUN
ijpds-4638	13	2	:	:	PUNCT
ijpds-4638	13	3	metoprolol	metoprolol	NOUN
ijpds-4638	13	4	succinate	succinate	NOUN
ijpds-4638	13	5	,	,	PUNCT
ijpds-4638	13	6	cilnidipine	cilnidipine	NOUN
ijpds-4638	13	7	,	,	PUNCT
ijpds-4638	13	8	qbd	qbd	PROPN
ijpds-4638	13	9	,	,	PUNCT
ijpds-4638	13	10	ich	ich	NOUN
ijpds-4638	13	11	,	,	PUNCT
ijpds-4638	13	12	absorbance	absorbance	NOUN
ijpds-4638	13	13	correction	correction	NOUN
ijpds-4638	13	14	method	method	NOUN
ijpds-4638	13	15	,	,	PUNCT
ijpds-4638	13	16	amplitude	amplitude	NOUN
ijpds-4638	13	17	modulation	modulation	NOUN
ijpds-4638	13	18	method	method	NOUN
ijpds-4638	13	19	ilnidipine	ilnidipine	PROPN
ijpds-4638	13	20	(	(	PUNCT
ijpds-4638	13	21	cil	cil	PROPN
ijpds-4638	13	22	)	)	PUNCT
ijpds-4638	13	23	chemically	chemically	ADV
ijpds-4638	13	24	1	1	NUM
ijpds-4638	13	25	,	,	PUNCT
ijpds-4638	13	26	4	4	NUM
ijpds-4638	13	27	-	-	PUNCT
ijpds-4638	13	28	dihydro-2,6dimethyl-4-(3	dihydro-2,6dimethyl-4-(3	NOUN
ijpds-4638	13	29	-	-	PUNCT
ijpds-4638	13	30	nitrophenyl)-3,5	nitrophenyl)-3,5	NOUN
ijpds-4638	13	31	-	-	PUNCT
ijpds-4638	13	32	pyridine	pyridine	ADJ
ijpds-4638	13	33	dicarboxylic	dicarboxylic	ADJ
ijpds-4638	13	34	acid	acid	NOUN
ijpds-4638	13	35	2	2	NUM
ijpds-4638	13	36	-	-	PUNCT
ijpds-4638	13	37	methyloxyethyl	methyloxyethyl	NOUN
ijpds-4638	13	38	(	(	PUNCT
ijpds-4638	13	39	2e)-3	2e)-3	PROPN
ijpds-4638	13	40	-	-	PUNCT
ijpds-4638	13	41	phenyl-2	phenyl-2	NUM
ijpds-4638	13	42	-	-	PUNCT
ijpds-4638	13	43	propenyl	propenyl	NOUN
ijpds-4638	13	44	ester	ester	NOUN
ijpds-4638	13	45	[	[	X
ijpds-4638	13	46	1	1	X
ijpds-4638	13	47	]	]	PUNCT
ijpds-4638	13	48	is	be	AUX
ijpds-4638	13	49	a	a	DET
ijpds-4638	13	50	dihydropyridine	dihydropyridine	NOUN
ijpds-4638	13	51	calcium	calcium	NOUN
ijpds-4638	13	52	channel	channel	NOUN
ijpds-4638	13	53	blocker	blocker	NOUN
ijpds-4638	13	54	given	give	VERB
ijpds-4638	13	55	orally	orally	ADV
ijpds-4638	13	56	in	in	ADP
ijpds-4638	13	57	the	the	DET
ijpds-4638	13	58	management	management	NOUN
ijpds-4638	13	59	of	of	ADP
ijpds-4638	13	60	hypertension	hypertension	NOUN
ijpds-4638	13	61	[	[	X
ijpds-4638	13	62	2	2	X
ijpds-4638	13	63	]	]	PUNCT
ijpds-4638	13	64	reported	report	VERB
ijpds-4638	13	65	analytical	analytical	ADJ
ijpds-4638	13	66	methods	method	NOUN
ijpds-4638	13	67	for	for	ADP
ijpds-4638	13	68	estimation	estimation	NOUN
ijpds-4638	13	69	of	of	ADP
ijpds-4638	13	70	cilnidipine	cilnidipine	NOUN
ijpds-4638	13	71	were	be	AUX
ijpds-4638	13	72	includes	include	NOUN
ijpds-4638	13	73	alone	alone	ADV
ijpds-4638	13	74	by	by	ADP
ijpds-4638	13	75	uv	uv	NOUN
ijpds-4638	13	76	spectrophotometric	spectrophotometric	ADJ
ijpds-4638	13	77	method	method	NOUN
ijpds-4638	13	78	[	[	X
ijpds-4638	13	79	3	3	NUM
ijpds-4638	13	80	]	]	PUNCT
ijpds-4638	13	81	,	,	PUNCT
ijpds-4638	13	82	uv	uv	NOUN
ijpds-4638	13	83	spectrometric	spectrometric	ADJ
ijpds-4638	13	84	methods	method	NOUN
ijpds-4638	13	85	with	with	ADP
ijpds-4638	13	86	metoprolol	metoprolol	PROPN
ijpds-4638	14	1	[	[	X
ijpds-4638	14	2	4	4	NUM
ijpds-4638	14	3	,	,	PUNCT
ijpds-4638	14	4	5	5	NUM
ijpds-4638	14	5	]	]	PUNCT
ijpds-4638	14	6	alone	alone	ADJ
ijpds-4638	14	7	uv	uv	NOUN
ijpds-4638	14	8	-	-	PUNCT
ijpds-4638	14	9	hplc	hplc	NOUN
ijpds-4638	14	10	method	method	NOUN
ijpds-4638	14	11	[	[	X
ijpds-4638	14	12	6	6	NUM
ijpds-4638	14	13	]	]	PUNCT
ijpds-4638	14	14	,	,	PUNCT
ijpds-4638	14	15	stability	stability	NOUN
ijpds-4638	14	16	indicating	indicate	VERB
ijpds-4638	14	17	hplc	hplc	NOUN
ijpds-4638	14	18	[	[	X
ijpds-4638	14	19	7	7	NUM
ijpds-4638	14	20	]	]	X
ijpds-4638	14	21	qbd	qbd	X
ijpds-4638	14	22	based	base	VERB
ijpds-4638	14	23	hplc	hplc	PROPN
ijpds-4638	14	24	[	[	X
ijpds-4638	14	25	8	8	NUM
ijpds-4638	14	26	]	]	X
ijpds-4638	14	27	chromatographic	chromatographic	ADJ
ijpds-4638	14	28	methods	method	NOUN
ijpds-4638	14	29	[	[	PUNCT
ijpds-4638	14	30	9	9	NUM
ijpds-4638	14	31	-	-	SYM
ijpds-4638	14	32	12	12	NUM
ijpds-4638	14	33	]	]	PUNCT
ijpds-4638	14	34	and	and	CCONJ
ijpds-4638	14	35	have	have	AUX
ijpds-4638	14	36	been	be	AUX
ijpds-4638	14	37	found	find	VERB
ijpds-4638	14	38	in	in	ADP
ijpds-4638	14	39	the	the	DET
ijpds-4638	14	40	literature	literature	NOUN
ijpds-4638	14	41	.	.	PUNCT
ijpds-4638	15	1	metoprolol	metoprolol	PROPN
ijpds-4638	15	2	succinate	succinate	NOUN
ijpds-4638	15	3	(	(	PUNCT
ijpds-4638	15	4	met	meet	VERB
ijpds-4638	15	5	)	)	PUNCT
ijpds-4638	15	6	is	be	AUX
ijpds-4638	15	7	a	a	DET
ijpds-4638	15	8	beta	beta	NOUN
ijpds-4638	15	9	blocker	blocker	NOUN
ijpds-4638	15	10	;	;	PUNCT
ijpds-4638	15	11	used	use	VERB
ijpds-4638	15	12	in	in	ADP
ijpds-4638	15	13	the	the	DET
ijpds-4638	15	14	treatment	treatment	NOUN
ijpds-4638	15	15	of	of	ADP
ijpds-4638	15	16	hypertension	hypertension	NOUN
ijpds-4638	15	17	,	,	PUNCT
ijpds-4638	15	18	angina	angina	NOUN
ijpds-4638	15	19	and	and	CCONJ
ijpds-4638	15	20	to	to	PART
ijpds-4638	15	21	reduce	reduce	VERB
ijpds-4638	15	22	myocardial	myocardial	ADJ
ijpds-4638	15	23	infarction	infarction	NOUN
ijpds-4638	15	24	[	[	X
ijpds-4638	15	25	2	2	NUM
ijpds-4638	15	26	]	]	PUNCT
ijpds-4638	15	27	.	.	PUNCT
ijpds-4638	16	1	chemically	chemically	ADV
ijpds-4638	16	2	it	it	PRON
ijpds-4638	16	3	is	be	AUX
ijpds-4638	16	4	(	(	PUNCT
ijpds-4638	16	5	rs)-1-(isopropy	rs)-1-(isopropy	VERB
ijpds-4638	16	6	access	access	NOUN
ijpds-4638	16	7	this	this	DET
ijpds-4638	16	8	article	article	NOUN
ijpds-4638	16	9	online	online	ADV
ijpds-4638	16	10	received	receive	VERB
ijpds-4638	16	11	–	–	PUNCT
ijpds-4638	16	12	20th	20th	ADJ
ijpds-4638	16	13	may	may	AUX
ijpds-4638	16	14	2024	2024	NUM
ijpds-4638	16	15	initial	initial	ADJ
ijpds-4638	16	16	review	review	NOUN
ijpds-4638	16	17	–	–	PUNCT
ijpds-4638	16	18	13th	13th	NOUN
ijpds-4638	16	19	june	june	PROPN
ijpds-4638	16	20	2024	2024	NUM
ijpds-4638	16	21	accepted	accept	VERB
ijpds-4638	16	22	–	–	PUNCT
ijpds-4638	16	23	15th	15th	ADJ
ijpds-4638	16	24	july	july	PROPN
ijpds-4638	16	25	2024	2024	NUM
ijpds-4638	16	26	quick	quick	ADJ
ijpds-4638	16	27	response	response	NOUN
ijpds-4638	16	28	code	code	PROPN
ijpds-4638	16	29	lamino)-3-[p-(2methoxyethyl	lamino)-3-[p-(2methoxyethyl	PROPN
ijpds-4638	16	30	)	)	PUNCT
ijpds-4638	16	31	phenoxy]-2	phenoxy]-2	PROPN
ijpds-4638	16	32	-	-	PUNCT
ijpds-4638	16	33	propan-2	propan-2	NOUN
ijpds-4638	16	34	-	-	ADJ
ijpds-4638	16	35	ol	ol	ADJ
ijpds-4638	16	36	succinate	succinate	NOUN
ijpds-4638	17	1	[	[	X
ijpds-4638	17	2	1	1	NUM
ijpds-4638	17	3	]	]	PUNCT
ijpds-4638	17	4	.	.	PUNCT
ijpds-4638	18	1	literature	literature	NOUN
ijpds-4638	18	2	survey	survey	NOUN
ijpds-4638	18	3	revealed	reveal	VERB
ijpds-4638	18	4	that	that	SCONJ
ijpds-4638	18	5	various	various	ADJ
ijpds-4638	18	6	analytical	analytical	ADJ
ijpds-4638	18	7	methods	method	NOUN
ijpds-4638	18	8	have	have	AUX
ijpds-4638	18	9	been	be	AUX
ijpds-4638	18	10	reported	report	VERB
ijpds-4638	18	11	for	for	ADP
ijpds-4638	18	12	estimation	estimation	NOUN
ijpds-4638	18	13	of	of	ADP
ijpds-4638	18	14	met	meet	VERB
ijpds-4638	18	15	such	such	ADJ
ijpds-4638	18	16	as	as	ADP
ijpds-4638	18	17	alone	alone	ADJ
ijpds-4638	18	18	uv	uv	NOUN
ijpds-4638	18	19	spectrophotometric	spectrophotometric	ADJ
ijpds-4638	18	20	method	method	NOUN
ijpds-4638	18	21	[	[	X
ijpds-4638	18	22	13	13	NUM
ijpds-4638	18	23	-	-	SYM
ijpds-4638	18	24	16	16	NUM
ijpds-4638	18	25	]	]	PUNCT
ijpds-4638	18	26	,	,	PUNCT
ijpds-4638	18	27	with	with	ADP
ijpds-4638	18	28	other	other	ADJ
ijpds-4638	18	29	drugs	drug	NOUN
ijpds-4638	18	30	uv	uv	NOUN
ijpds-4638	18	31	spectrophotometric	spectrophotometric	ADJ
ijpds-4638	18	32	method	method	NOUN
ijpds-4638	18	33	[	[	X
ijpds-4638	18	34	17	17	NUM
ijpds-4638	18	35	-	-	SYM
ijpds-4638	18	36	22	22	NUM
ijpds-4638	18	37	]	]	PUNCT
ijpds-4638	18	38	,	,	PUNCT
ijpds-4638	18	39	bio	bio	PROPN
ijpds-4638	18	40	analytical	analytical	ADJ
ijpds-4638	18	41	method	method	NOUN
ijpds-4638	18	42	[	[	X
ijpds-4638	18	43	23	23	NUM
ijpds-4638	18	44	]	]	PUNCT
ijpds-4638	18	45	,	,	PUNCT
ijpds-4638	18	46	met	meet	VERB
ijpds-4638	18	47	alone	alone	ADV
ijpds-4638	18	48	by	by	ADP
ijpds-4638	18	49	rp	rp	NOUN
ijpds-4638	18	50	-	-	PUNCT
ijpds-4638	18	51	hplc	hplc	NOUN
ijpds-4638	18	52	[	[	X
ijpds-4638	18	53	24	24	NUM
ijpds-4638	18	54	]	]	PUNCT
ijpds-4638	18	55	,	,	PUNCT
ijpds-4638	18	56	with	with	ADP
ijpds-4638	18	57	other	other	ADJ
ijpds-4638	18	58	drug	drug	NOUN
ijpds-4638	18	59	by	by	ADP
ijpds-4638	18	60	rphplc	rphplc	NOUN
ijpds-4638	18	61	[	[	X
ijpds-4638	18	62	25	25	NUM
ijpds-4638	18	63	-	-	SYM
ijpds-4638	18	64	30	30	NUM
ijpds-4638	18	65	]	]	PUNCT
ijpds-4638	18	66	,	,	PUNCT
ijpds-4638	18	67	stability	stability	NOUN
ijpds-4638	18	68	indicating	indicate	VERB
ijpds-4638	18	69	hplc	hplc	NOUN
ijpds-4638	18	70	[	[	X
ijpds-4638	18	71	31	31	NUM
ijpds-4638	18	72	,	,	PUNCT
ijpds-4638	18	73	32	32	NUM
ijpds-4638	18	74	]	]	PUNCT
ijpds-4638	18	75	,	,	PUNCT
ijpds-4638	18	76	designed	design	VERB
ijpds-4638	18	77	and	and	CCONJ
ijpds-4638	18	78	eco	eco	NOUN
ijpds-4638	18	79	-	-	PUNCT
ijpds-4638	18	80	friendly	friendly	ADJ
ijpds-4638	18	81	tlc	tlc	NOUN
ijpds-4638	18	82	densitometry	densitometry	NOUN
ijpds-4638	18	83	[	[	X
ijpds-4638	18	84	33	33	NUM
ijpds-4638	18	85	]	]	PUNCT
ijpds-4638	18	86	and	and	CCONJ
ijpds-4638	18	87	hptlc	hptlc	NOUN
ijpds-4638	19	1	[	[	X
ijpds-4638	19	2	34	34	NUM
ijpds-4638	19	3	]	]	PUNCT
ijpds-4638	19	4	in	in	ADP
ijpds-4638	19	5	combination	combination	NOUN
ijpds-4638	19	6	with	with	ADP
ijpds-4638	19	7	other	other	ADJ
ijpds-4638	19	8	drug	drug	NOUN
ijpds-4638	19	9	.	.	PUNCT
ijpds-4638	20	1	cilnidipine	cilnidipine	NOUN
ijpds-4638	20	2	and	and	CCONJ
ijpds-4638	20	3	metoprolol	metoprolol	PROPN
ijpds-4638	20	4	succinate	succinate	NOUN
ijpds-4638	20	5	are	be	AUX
ijpds-4638	20	6	official	official	ADJ
ijpds-4638	20	7	in	in	ADP
ijpds-4638	20	8	indian	indian	ADJ
ijpds-4638	20	9	pharmacopoeia	pharmacopoeia	NOUN
ijpds-4638	20	10	[	[	X
ijpds-4638	20	11	35	35	NUM
ijpds-4638	20	12	]	]	PUNCT
ijpds-4638	20	13	,	,	PUNCT
ijpds-4638	20	14	whereas	whereas	SCONJ
ijpds-4638	20	15	metoprolol	metoprolol	PROPN
ijpds-4638	20	16	is	be	AUX
ijpds-4638	20	17	official	official	ADJ
ijpds-4638	20	18	in	in	ADP
ijpds-4638	20	19	bp	bp	PROPN
ijpds-4638	21	1	[	[	X
ijpds-4638	21	2	36	36	NUM
ijpds-4638	21	3	]	]	PUNCT
ijpds-4638	21	4	.	.	PUNCT
ijpds-4638	22	1	chemical	chemical	NOUN
ijpds-4638	22	2	structures	structure	NOUN
ijpds-4638	22	3	of	of	ADP
ijpds-4638	22	4	both	both	DET
ijpds-4638	22	5	drugs	drug	NOUN
ijpds-4638	22	6	are	be	AUX
ijpds-4638	22	7	shown	show	VERB
ijpds-4638	22	8	in	in	ADP
ijpds-4638	22	9	(	(	PUNCT
ijpds-4638	22	10	fig	fig	NOUN
ijpds-4638	22	11	1	1	NUM
ijpds-4638	22	12	)	)	PUNCT
ijpds-4638	22	13	.	.	PUNCT
ijpds-4638	23	1	quality	quality	NOUN
ijpds-4638	23	2	by	by	ADP
ijpds-4638	23	3	design	design	NOUN
ijpds-4638	23	4	concept	concept	NOUN
ijpds-4638	23	5	is	be	AUX
ijpds-4638	23	6	applied	apply	VERB
ijpds-4638	23	7	for	for	ADP
ijpds-4638	23	8	the	the	DET
ijpds-4638	23	9	development	development	NOUN
ijpds-4638	23	10	of	of	ADP
ijpds-4638	23	11	pharmaceutical	pharmaceutical	NOUN
ijpds-4638	23	12	processes	process	NOUN
ijpds-4638	23	13	to	to	PART
ijpds-4638	23	14	assure	assure	VERB
ijpds-4638	23	15	a	a	DET
ijpds-4638	23	16	predefined	predefine	VERB
ijpds-4638	23	17	product	product	NOUN
ijpds-4638	23	18	quality	quality	NOUN
ijpds-4638	23	19	.	.	PUNCT
ijpds-4638	24	1	_	_	PUNCT
ijpds-4638	25	1	_	_	PUNCT
ijpds-4638	26	1	_	_	PUNCT
ijpds-4638	27	1	_	_	PUNCT
ijpds-4638	28	1	_	_	PUNCT
ijpds-4638	29	1	_	_	PUNCT
ijpds-4638	30	1	_	_	PUNCT
ijpds-4638	31	1	_	_	PUNCT
ijpds-4638	32	1	_	_	PUNCT
ijpds-4638	33	1	_	_	PUNCT
ijpds-4638	34	1	_	_	PUNCT
ijpds-4638	35	1	_	_	PUNCT
ijpds-4638	36	1	_	_	PUNCT
ijpds-4638	37	1	_	_	PUNCT
ijpds-4638	38	1	_	_	PUNCT
ijpds-4638	39	1	_	_	PUNCT
ijpds-4638	40	1	_	_	PUNCT
ijpds-4638	41	1	_	_	PUNCT
ijpds-4638	42	1	_	_	PUNCT
ijpds-4638	43	1	_	_	PUNCT
ijpds-4638	44	1	_	_	PUNCT
ijpds-4638	45	1	_	_	PUNCT
ijpds-4638	46	1	_	_	PUNCT
ijpds-4638	47	1	_	_	PUNCT
ijpds-4638	48	1	_	_	PUNCT
ijpds-4638	49	1	_	_	PUNCT
ijpds-4638	50	1	_	_	PUNCT
ijpds-4638	51	1	_	_	PUNCT
ijpds-4638	52	1	_	_	PUNCT
ijpds-4638	53	1	_	_	PUNCT
ijpds-4638	54	1	_	_	PUNCT
ijpds-4638	55	1	_	_	PUNCT
ijpds-4638	56	1	_	_	PUNCT
ijpds-4638	57	1	_	_	PUNCT
ijpds-4638	58	1	_	_	PUNCT
ijpds-4638	59	1	_	_	PUNCT
ijpds-4638	60	1	_	_	PUNCT
ijpds-4638	61	1	_	_	PUNCT
ijpds-4638	62	1	_	_	PUNCT
ijpds-4638	63	1	_	_	PUNCT
ijpds-4638	64	1	_	_	PUNCT
ijpds-4638	65	1	_	_	PUNCT
ijpds-4638	66	1	_	_	PUNCT
ijpds-4638	67	1	_	_	PUNCT
ijpds-4638	68	1	_	_	PUNCT
ijpds-4638	69	1	_	_	PUNCT
ijpds-4638	70	1	_	_	PUNCT
ijpds-4638	71	1	_	_	PUNCT
ijpds-4638	72	1	_	_	PUNCT
ijpds-4638	73	1	_	_	PUNCT
ijpds-4638	73	2	correspondence	correspondence	NOUN
ijpds-4638	73	3	to	to	ADP
ijpds-4638	73	4	:	:	PUNCT
ijpds-4638	73	5	g.	g.	PROPN
ijpds-4638	73	6	k.	k.	PROPN
ijpds-4638	73	7	dyade	dyade	PROPN
ijpds-4638	73	8	,	,	PUNCT
ijpds-4638	73	9	dept	dept	NOUN
ijpds-4638	73	10	of	of	ADP
ijpds-4638	73	11	post	post	PROPN
ijpds-4638	73	12	graduate	graduate	NOUN
ijpds-4638	73	13	studies	study	NOUN
ijpds-4638	73	14	in	in	ADP
ijpds-4638	73	15	pharmaceutical	pharmaceutical	ADJ
ijpds-4638	73	16	quality	quality	NOUN
ijpds-4638	73	17	assurance	assurance	NOUN
ijpds-4638	73	18	,	,	PUNCT
ijpds-4638	73	19	svpm	svpm	NOUN
ijpds-4638	73	20	’s	’s	PART
ijpds-4638	73	21	college	college	PROPN
ijpds-4638	73	22	of	of	ADP
ijpds-4638	73	23	pharmacy	pharmacy	NOUN
ijpds-4638	73	24	,	,	PUNCT
ijpds-4638	73	25	malegaon	malegaon	PROPN
ijpds-4638	73	26	(	(	PUNCT
ijpds-4638	73	27	bkii)-413115	bkii)-413115	PROPN
ijpds-4638	73	28	baramati	baramati	PROPN
ijpds-4638	73	29	dist	dist	PROPN
ijpds-4638	73	30	pune	pune	PROPN
ijpds-4638	73	31	,	,	PUNCT
ijpds-4638	73	32	maharashtra	maharashtra	PROPN
ijpds-4638	73	33	,	,	PUNCT
ijpds-4638	73	34	india	india	PROPN
ijpds-4638	73	35	.	.	PUNCT
ijpds-4638	74	1	email	email	NOUN
ijpds-4638	74	2	:	:	PUNCT
ijpds-4638	75	1	pharmacyresearchsvpmcop@gmail.com	pharmacyresearchsvpmcop@gmail.com	X
ijpds-4638	75	2	c	c	NOUN
ijpds-4638	75	3	pharmacyresearchsvpmcop@gmail.com	pharmacyresearchsvpmcop@gmail.com	X
ijpds-4638	76	1	dyade	dyade	VERB
ijpds-4638	76	2	et	et	PROPN
ijpds-4638	76	3	al	al	PROPN
ijpds-4638	76	4	.	.	PROPN
ijpds-4638	76	5	qbd	qbd	PROPN
ijpds-4638	76	6	and	and	CCONJ
ijpds-4638	76	7	chemometric	chemometric	ADJ
ijpds-4638	76	8	method	method	NOUN
ijpds-4638	76	9	for	for	ADP
ijpds-4638	76	10	estimation	estimation	NOUN
ijpds-4638	76	11	of	of	ADP
ijpds-4638	76	12	metoprolol	metoprolol	NOUN
ijpds-4638	76	13	and	and	CCONJ
ijpds-4638	76	14	cilnidipine	cilnidipine	ADJ
ijpds-4638	76	15	online	online	ADJ
ijpds-4638	76	16	first	first	PROPN
ijpds-4638	76	17	indian	indian	PROPN
ijpds-4638	76	18	j	j	PROPN
ijpds-4638	76	19	pharm	pharm	PROPN
ijpds-4638	76	20	drug	drug	PROPN
ijpds-4638	76	21	studies	study	NOUN
ijpds-4638	76	22	|	|	ADV
ijpds-4638	76	23	2	2	NUM
ijpds-4638	76	24	fig	fig	NOUN
ijpds-4638	76	25	1	1	NUM
ijpds-4638	76	26	:	:	PUNCT
ijpds-4638	76	27	chemical	chemical	ADJ
ijpds-4638	76	28	structure	structure	NOUN
ijpds-4638	76	29	of	of	ADP
ijpds-4638	76	30	drug	drug	NOUN
ijpds-4638	76	31	molecule	molecule	NOUN
ijpds-4638	76	32	qbd	qbd	NOUN
ijpds-4638	76	33	concepts	concept	NOUN
ijpds-4638	76	34	are	be	AUX
ijpds-4638	76	35	mentioned	mention	VERB
ijpds-4638	76	36	in	in	ADP
ijpds-4638	76	37	ich	ich	NOUN
ijpds-4638	76	38	guidelines	guideline	NOUN
ijpds-4638	76	39	q	q	NOUN
ijpds-4638	76	40	8(r2	8(r2	NOUN
ijpds-4638	76	41	)	)	PUNCT
ijpds-4638	76	42	(	(	PUNCT
ijpds-4638	76	43	pharmaceutical	pharmaceutical	NOUN
ijpds-4638	76	44	development	development	NOUN
ijpds-4638	76	45	)	)	PUNCT
ijpds-4638	76	46	,	,	PUNCT
ijpds-4638	76	47	q9	q9	PROPN
ijpds-4638	76	48	(	(	PUNCT
ijpds-4638	76	49	quality	quality	NOUN
ijpds-4638	76	50	risk	risk	NOUN
ijpds-4638	76	51	management	management	NOUN
ijpds-4638	76	52	)	)	PUNCT
ijpds-4638	76	53	,	,	PUNCT
ijpds-4638	76	54	and	and	CCONJ
ijpds-4638	76	55	q10	q10	PROPN
ijpds-4638	76	56	(	(	PUNCT
ijpds-4638	76	57	pharmaceutical	pharmaceutical	ADJ
ijpds-4638	76	58	quality	quality	NOUN
ijpds-4638	76	59	system	system	NOUN
ijpds-4638	76	60	)	)	PUNCT
ijpds-4638	77	1	[	[	X
ijpds-4638	77	2	3739	3739	NUM
ijpds-4638	77	3	]	]	PUNCT
ijpds-4638	77	4	shown	show	VERB
ijpds-4638	77	5	in	in	ADP
ijpds-4638	77	6	fig	fig	NOUN
ijpds-4638	77	7	2	2	NUM
ijpds-4638	77	8	.	.	PUNCT
ijpds-4638	77	9	ich	ich	NOUN
ijpds-4638	77	10	guidelines	guideline	VERB
ijpds-4638	77	11	q8	q8	PROPN
ijpds-4638	77	12	(	(	PUNCT
ijpds-4638	77	13	r2	r2	PROPN
ijpds-4638	77	14	)	)	PUNCT
ijpds-4638	78	1	[	[	X
ijpds-4638	78	2	40	40	NUM
ijpds-4638	78	3	]	]	PUNCT
ijpds-4638	78	4	defines	define	VERB
ijpds-4638	78	5	qbd	qbd	NOUN
ijpds-4638	78	6	as	as	ADP
ijpds-4638	78	7	a	a	DET
ijpds-4638	78	8	“	"	PUNCT
ijpds-4638	78	9	a	a	DET
ijpds-4638	78	10	systematic	systematic	ADJ
ijpds-4638	78	11	approach	approach	NOUN
ijpds-4638	78	12	to	to	ADP
ijpds-4638	78	13	development	development	NOUN
ijpds-4638	78	14	that	that	PRON
ijpds-4638	78	15	begins	begin	VERB
ijpds-4638	78	16	with	with	ADP
ijpds-4638	78	17	predefined	predefine	VERB
ijpds-4638	78	18	objectives	objective	NOUN
ijpds-4638	78	19	and	and	CCONJ
ijpds-4638	78	20	emphasizes	emphasize	VERB
ijpds-4638	78	21	product	product	NOUN
ijpds-4638	78	22	and	and	CCONJ
ijpds-4638	78	23	process	process	NOUN
ijpds-4638	78	24	understanding	understanding	NOUN
ijpds-4638	78	25	and	and	CCONJ
ijpds-4638	78	26	process	process	NOUN
ijpds-4638	78	27	control	control	NOUN
ijpds-4638	78	28	,	,	PUNCT
ijpds-4638	78	29	based	base	VERB
ijpds-4638	78	30	on	on	ADP
ijpds-4638	78	31	sound	sound	ADJ
ijpds-4638	78	32	science	science	NOUN
ijpds-4638	78	33	and	and	CCONJ
ijpds-4638	78	34	quality	quality	NOUN
ijpds-4638	78	35	risk	risk	NOUN
ijpds-4638	78	36	management	management	NOUN
ijpds-4638	78	37	”	"	PUNCT
ijpds-4638	78	38	.	.	PUNCT
ijpds-4638	79	1	qbd	qbd	PROPN
ijpds-4638	79	2	approach	approach	NOUN
ijpds-4638	79	3	in	in	ADP
ijpds-4638	79	4	analytical	analytical	ADJ
ijpds-4638	79	5	method	method	NOUN
ijpds-4638	79	6	summarizes	summarize	VERB
ijpds-4638	79	7	a	a	DET
ijpds-4638	79	8	complete	complete	ADJ
ijpds-4638	79	9	understanding	understanding	NOUN
ijpds-4638	79	10	of	of	ADP
ijpds-4638	79	11	how	how	SCONJ
ijpds-4638	79	12	the	the	DET
ijpds-4638	79	13	analytical	analytical	ADJ
ijpds-4638	79	14	technique	technique	NOUN
ijpds-4638	79	15	attributes	attribute	NOUN
ijpds-4638	79	16	and	and	CCONJ
ijpds-4638	79	17	operating	operating	NOUN
ijpds-4638	79	18	conditions	condition	NOUN
ijpds-4638	79	19	affect	affect	VERB
ijpds-4638	79	20	the	the	DET
ijpds-4638	79	21	analytical	analytical	ADJ
ijpds-4638	79	22	performance	performance	NOUN
ijpds-4638	79	23	.	.	PUNCT
ijpds-4638	80	1	factors	factor	NOUN
ijpds-4638	80	2	to	to	PART
ijpds-4638	80	3	study	study	VERB
ijpds-4638	80	4	in	in	ADP
ijpds-4638	80	5	analytical	analytical	ADJ
ijpds-4638	80	6	quality	quality	NOUN
ijpds-4638	80	7	by	by	ADP
ijpds-4638	80	8	design	design	NOUN
ijpds-4638	80	9	(	(	PUNCT
ijpds-4638	80	10	aqbd	aqbd	NOUN
ijpds-4638	80	11	)	)	PUNCT
ijpds-4638	80	12	approach	approach	NOUN
ijpds-4638	80	13	may	may	AUX
ijpds-4638	80	14	include	include	VERB
ijpds-4638	80	15	the	the	DET
ijpds-4638	80	16	type	type	NOUN
ijpds-4638	80	17	of	of	ADP
ijpds-4638	80	18	analytical	analytical	ADJ
ijpds-4638	80	19	technique	technique	NOUN
ijpds-4638	80	20	chosen	choose	VERB
ijpds-4638	80	21	,	,	PUNCT
ijpds-4638	80	22	reagents	reagent	NOUN
ijpds-4638	80	23	used	use	VERB
ijpds-4638	80	24	and	and	CCONJ
ijpds-4638	80	25	instrument	instrument	NOUN
ijpds-4638	80	26	parameters	parameter	NOUN
ijpds-4638	80	27	.	.	PUNCT
ijpds-4638	81	1	qbd	qbd	PROPN
ijpds-4638	81	2	was	be	AUX
ijpds-4638	81	3	applied	apply	VERB
ijpds-4638	81	4	to	to	PART
ijpds-4638	81	5	build	build	VERB
ijpds-4638	81	6	rigid	rigid	ADJ
ijpds-4638	81	7	robust	robust	ADJ
ijpds-4638	81	8	method	method	NOUN
ijpds-4638	81	9	through	through	ADP
ijpds-4638	81	10	risk	risk	NOUN
ijpds-4638	81	11	assessment	assessment	NOUN
ijpds-4638	81	12	at	at	ADP
ijpds-4638	81	13	early	early	ADJ
ijpds-4638	81	14	stage	stage	NOUN
ijpds-4638	81	15	and	and	CCONJ
ijpds-4638	81	16	defining	define	VERB
ijpds-4638	81	17	the	the	DET
ijpds-4638	81	18	design	design	NOUN
ijpds-4638	81	19	space	space	NOUN
ijpds-4638	81	20	at	at	ADP
ijpds-4638	81	21	the	the	DET
ijpds-4638	81	22	later	later	ADJ
ijpds-4638	81	23	stage	stage	NOUN
ijpds-4638	81	24	.	.	PUNCT
ijpds-4638	82	1	fig	fig	NOUN
ijpds-4638	82	2	2	2	NUM
ijpds-4638	82	3	:	:	PUNCT
ijpds-4638	82	4	analytical	analytical	ADJ
ijpds-4638	82	5	qbd	qbd	NOUN
ijpds-4638	82	6	approach	approach	NOUN
ijpds-4638	82	7	there	there	PRON
ijpds-4638	82	8	are	be	VERB
ijpds-4638	82	9	similar	similar	ADJ
ijpds-4638	82	10	advantages	advantage	NOUN
ijpds-4638	82	11	of	of	ADP
ijpds-4638	82	12	applying	apply	VERB
ijpds-4638	82	13	qbd	qbd	NOUN
ijpds-4638	82	14	principles	principle	NOUN
ijpds-4638	82	15	to	to	ADP
ijpds-4638	82	16	analytical	analytical	ADJ
ijpds-4638	82	17	methods	method	NOUN
ijpds-4638	82	18	as	as	ADP
ijpds-4638	82	19	to	to	ADP
ijpds-4638	82	20	manufacturing	manufacturing	NOUN
ijpds-4638	82	21	processes	process	NOUN
ijpds-4638	82	22	and	and	CCONJ
ijpds-4638	82	23	product	product	NOUN
ijpds-4638	82	24	[	[	X
ijpds-4638	82	25	41	41	NUM
ijpds-4638	82	26	]	]	PUNCT
ijpds-4638	82	27	.	.	PUNCT
ijpds-4638	83	1	a	a	DET
ijpds-4638	83	2	qbd	qbd	NOUN
ijpds-4638	83	3	approach	approach	NOUN
ijpds-4638	83	4	can	can	AUX
ijpds-4638	83	5	be	be	AUX
ijpds-4638	83	6	beneficial	beneficial	ADJ
ijpds-4638	83	7	in	in	ADP
ijpds-4638	83	8	the	the	DET
ijpds-4638	83	9	development	development	NOUN
ijpds-4638	83	10	of	of	ADP
ijpds-4638	83	11	suitable	suitable	ADJ
ijpds-4638	83	12	,	,	PUNCT
ijpds-4638	83	13	robust	robust	ADJ
ijpds-4638	83	14	,	,	PUNCT
ijpds-4638	83	15	low	low	ADJ
ijpds-4638	83	16	cost	cost	NOUN
ijpds-4638	83	17	and	and	CCONJ
ijpds-4638	83	18	eco	eco	NOUN
ijpds-4638	83	19	-	-	PUNCT
ijpds-4638	83	20	friendly	friendly	ADJ
ijpds-4638	83	21	(	(	PUNCT
ijpds-4638	83	22	eco	eco	NOUN
ijpds-4638	83	23	-	-	PUNCT
ijpds-4638	83	24	friendly	friendly	ADJ
ijpds-4638	83	25	solvent	solvent	NOUN
ijpds-4638	83	26	,	,	PUNCT
ijpds-4638	83	27	chemicals	chemical	NOUN
ijpds-4638	83	28	)	)	PUNCT
ijpds-4638	83	29	method	method	NOUN
ijpds-4638	83	30	which	which	PRON
ijpds-4638	83	31	is	be	AUX
ijpds-4638	83	32	applicable	applicable	ADJ
ijpds-4638	83	33	at	at	ADP
ijpds-4638	83	34	any	any	DET
ijpds-4638	83	35	stage	stage	NOUN
ijpds-4638	83	36	of	of	ADP
ijpds-4638	83	37	the	the	DET
ijpds-4638	83	38	lifecycle	lifecycle	NOUN
ijpds-4638	83	39	of	of	ADP
ijpds-4638	83	40	the	the	DET
ijpds-4638	83	41	product	product	NOUN
ijpds-4638	83	42	.	.	PUNCT
ijpds-4638	84	1	also	also	ADV
ijpds-4638	84	2	some	some	DET
ijpds-4638	84	3	regulatory	regulatory	ADJ
ijpds-4638	84	4	guidelines	guideline	NOUN
ijpds-4638	84	5	have	have	AUX
ijpds-4638	84	6	mentioned	mention	VERB
ijpds-4638	84	7	flexibility	flexibility	NOUN
ijpds-4638	84	8	of	of	ADP
ijpds-4638	84	9	changing	change	VERB
ijpds-4638	84	10	analytical	analytical	ADJ
ijpds-4638	84	11	method	method	NOUN
ijpds-4638	84	12	without	without	ADP
ijpds-4638	84	13	revalidation	revalidation	NOUN
ijpds-4638	84	14	if	if	SCONJ
ijpds-4638	84	15	the	the	DET
ijpds-4638	84	16	aqbd	aqbd	PROPN
ijpds-4638	84	17	approach	approach	NOUN
ijpds-4638	84	18	has	have	AUX
ijpds-4638	84	19	been	be	AUX
ijpds-4638	84	20	implemented	implement	VERB
ijpds-4638	84	21	during	during	ADP
ijpds-4638	84	22	analytical	analytical	ADJ
ijpds-4638	84	23	method	method	NOUN
ijpds-4638	84	24	development	development	NOUN
ijpds-4638	84	25	.	.	PUNCT
ijpds-4638	85	1	the	the	DET
ijpds-4638	85	2	first	first	ADJ
ijpds-4638	85	3	stage	stage	NOUN
ijpds-4638	85	4	of	of	ADP
ijpds-4638	85	5	aqbd	aqbd	PROPN
ijpds-4638	85	6	approach	approach	NOUN
ijpds-4638	85	7	is	be	AUX
ijpds-4638	85	8	to	to	PART
ijpds-4638	85	9	fix	fix	VERB
ijpds-4638	85	10	an	an	DET
ijpds-4638	85	11	analytical	analytical	ADJ
ijpds-4638	85	12	target	target	NOUN
ijpds-4638	85	13	profile	profile	NOUN
ijpds-4638	85	14	(	(	PUNCT
ijpds-4638	85	15	atp	atp	PROPN
ijpds-4638	85	16	)	)	PUNCT
ijpds-4638	85	17	for	for	ADP
ijpds-4638	85	18	the	the	DET
ijpds-4638	85	19	method	method	NOUN
ijpds-4638	85	20	.	.	PUNCT
ijpds-4638	86	1	atp	atp	PROPN
ijpds-4638	86	2	defines	define	VERB
ijpds-4638	86	3	the	the	DET
ijpds-4638	86	4	goal	goal	NOUN
ijpds-4638	86	5	of	of	ADP
ijpds-4638	86	6	the	the	DET
ijpds-4638	86	7	analytical	analytical	ADJ
ijpds-4638	86	8	method	method	NOUN
ijpds-4638	86	9	development	development	NOUN
ijpds-4638	86	10	process	process	NOUN
ijpds-4638	86	11	and	and	CCONJ
ijpds-4638	86	12	it	it	PRON
ijpds-4638	86	13	is	be	AUX
ijpds-4638	86	14	the	the	DET
ijpds-4638	86	15	sign	sign	NOUN
ijpds-4638	86	16	of	of	ADP
ijpds-4638	86	17	method	method	NOUN
ijpds-4638	86	18	performance	performance	NOUN
ijpds-4638	86	19	[	[	X
ijpds-4638	86	20	42	42	NUM
ijpds-4638	86	21	,	,	PUNCT
ijpds-4638	86	22	43	43	NUM
ijpds-4638	86	23	]	]	PUNCT
ijpds-4638	86	24	.	.	PUNCT
ijpds-4638	87	1	for	for	ADP
ijpds-4638	87	2	analytical	analytical	ADJ
ijpds-4638	87	3	method	method	NOUN
ijpds-4638	87	4	validation	validation	NOUN
ijpds-4638	87	5	ich	ich	PROPN
ijpds-4638	87	6	q2	q2	NOUN
ijpds-4638	87	7	(	(	PUNCT
ijpds-4638	87	8	r1	r1	PROPN
ijpds-4638	87	9	)	)	PUNCT
ijpds-4638	87	10	has	have	AUX
ijpds-4638	87	11	given	give	VERB
ijpds-4638	87	12	various	various	ADJ
ijpds-4638	87	13	method	method	NOUN
ijpds-4638	87	14	performance	performance	NOUN
ijpds-4638	87	15	characteristics	characteristic	NOUN
ijpds-4638	87	16	for	for	ADP
ijpds-4638	87	17	an	an	DET
ijpds-4638	87	18	analytical	analytical	ADJ
ijpds-4638	87	19	method	method	NOUN
ijpds-4638	87	20	.	.	PUNCT
ijpds-4638	88	1	thus	thus	ADV
ijpds-4638	88	2	a	a	DET
ijpds-4638	88	3	qbd	qbd	NOUN
ijpds-4638	88	4	based	base	VERB
ijpds-4638	88	5	uv	uv	NOUN
ijpds-4638	88	6	spectrophotometric	spectrophotometric	NOUN
ijpds-4638	88	7	was	be	AUX
ijpds-4638	88	8	developed	develop	VERB
ijpds-4638	88	9	,	,	PUNCT
ijpds-4638	88	10	qbd	qbd	NOUN
ijpds-4638	88	11	approach	approach	NOUN
ijpds-4638	88	12	was	be	AUX
ijpds-4638	88	13	implemented	implement	VERB
ijpds-4638	88	14	with	with	ADP
ijpds-4638	88	15	the	the	DET
ijpds-4638	88	16	study	study	NOUN
ijpds-4638	88	17	of	of	ADP
ijpds-4638	88	18	the	the	DET
ijpds-4638	88	19	effect	effect	NOUN
ijpds-4638	88	20	of	of	ADP
ijpds-4638	88	21	method	method	ADJ
ijpds-4638	88	22	input	input	NOUN
ijpds-4638	88	23	variables	variable	NOUN
ijpds-4638	88	24	on	on	ADP
ijpds-4638	88	25	spectral	spectral	ADJ
ijpds-4638	88	26	shape	shape	NOUN
ijpds-4638	88	27	,	,	PUNCT
ijpds-4638	88	28	intensity	intensity	NOUN
ijpds-4638	88	29	of	of	ADP
ijpds-4638	88	30	absorbance	absorbance	NOUN
ijpds-4638	88	31	,	,	PUNCT
ijpds-4638	88	32	and	and	CCONJ
ijpds-4638	88	33	absorbance	absorbance	NOUN
ijpds-4638	88	34	maxima	maxima	NOUN
ijpds-4638	88	35	λmax	λmax	NOUN
ijpds-4638	88	36	and	and	CCONJ
ijpds-4638	88	37	critical	critical	ADJ
ijpds-4638	88	38	parameters	parameter	NOUN
ijpds-4638	88	39	were	be	AUX
ijpds-4638	88	40	selected	select	VERB
ijpds-4638	88	41	for	for	ADP
ijpds-4638	88	42	the	the	DET
ijpds-4638	88	43	proposed	propose	VERB
ijpds-4638	88	44	method	method	NOUN
ijpds-4638	88	45	and	and	CCONJ
ijpds-4638	88	46	method	method	NOUN
ijpds-4638	88	47	was	be	AUX
ijpds-4638	88	48	validated	validate	VERB
ijpds-4638	88	49	as	as	ADP
ijpds-4638	88	50	per	per	ADP
ijpds-4638	88	51	ich	ich	NOUN
ijpds-4638	88	52	guidelines	guideline	NOUN
ijpds-4638	88	53	q2	q2	NOUN
ijpds-4638	88	54	(	(	PUNCT
ijpds-4638	88	55	r1	r1	PROPN
ijpds-4638	88	56	)	)	PUNCT
ijpds-4638	88	57	.	.	PUNCT
ijpds-4638	89	1	materials	material	NOUN
ijpds-4638	89	2	and	and	CCONJ
ijpds-4638	89	3	methods	method	NOUN
ijpds-4638	89	4	instrumentation	instrumentation	NOUN
ijpds-4638	89	5	:	:	PUNCT
ijpds-4638	89	6	analysis	analysis	NOUN
ijpds-4638	89	7	was	be	AUX
ijpds-4638	89	8	performed	perform	VERB
ijpds-4638	89	9	with	with	ADP
ijpds-4638	89	10	a	a	DET
ijpds-4638	89	11	shimadzu	shimadzu	ADJ
ijpds-4638	89	12	double	double	ADJ
ijpds-4638	89	13	beam	beam	NOUN
ijpds-4638	89	14	uv	uv	NOUN
ijpds-4638	89	15	-	-	PUNCT
ijpds-4638	89	16	visible	visible	ADJ
ijpds-4638	89	17	spectrophotometer	spectrophotometer	NOUN
ijpds-4638	89	18	1900i	1900i	NUM
ijpds-4638	89	19	and	and	CCONJ
ijpds-4638	89	20	1700	1700	NUM
ijpds-4638	89	21	(	(	PUNCT
ijpds-4638	89	22	shimadzu	shimadzu	PROPN
ijpds-4638	89	23	,	,	PUNCT
ijpds-4638	89	24	kyoto	kyoto	PROPN
ijpds-4638	89	25	,	,	PUNCT
ijpds-4638	89	26	japan	japan	PROPN
ijpds-4638	89	27	)	)	PUNCT
ijpds-4638	89	28	with	with	ADP
ijpds-4638	89	29	spectral	spectral	ADJ
ijpds-4638	89	30	bandwidth	bandwidth	NOUN
ijpds-4638	89	31	of	of	ADP
ijpds-4638	89	32	2	2	NUM
ijpds-4638	89	33	nm	nm	NOUN
ijpds-4638	89	34	and	and	CCONJ
ijpds-4638	89	35	wavelength	wavelength	NOUN
ijpds-4638	89	36	accuracy	accuracy	NOUN
ijpds-4638	89	37	of	of	ADP
ijpds-4638	89	38	±	±	NUM
ijpds-4638	89	39	1	1	NUM
ijpds-4638	89	40	nm	nm	NOUN
ijpds-4638	89	41	with	with	SCONJ
ijpds-4638	89	42	10	10	NUM
ijpds-4638	89	43	mm	mm	NUM
ijpds-4638	89	44	matched	match	VERB
ijpds-4638	89	45	quartz	quartz	NOUN
ijpds-4638	89	46	cells	cell	NOUN
ijpds-4638	89	47	was	be	AUX
ijpds-4638	89	48	used	use	VERB
ijpds-4638	89	49	.	.	PUNCT
ijpds-4638	90	1	electronic	electronic	ADJ
ijpds-4638	90	2	balance	balance	NOUN
ijpds-4638	90	3	afcoset	afcoset	NOUN
ijpds-4638	90	4	balance	balance	NOUN
ijpds-4638	90	5	(	(	PUNCT
ijpds-4638	90	6	the	the	DET
ijpds-4638	90	7	bombay	bombay	PROPN
ijpds-4638	90	8	burmah	burmah	PROPN
ijpds-4638	90	9	trading	trading	PROPN
ijpds-4638	90	10	corpo	corpo	PROPN
ijpds-4638	90	11	ltd	ltd	PROPN
ijpds-4638	90	12	)	)	PUNCT
ijpds-4638	90	13	with	with	ADP
ijpds-4638	90	14	accuracy	accuracy	NOUN
ijpds-4638	90	15	±0.1	±0.1	PROPN
ijpds-4638	90	16	mg	mg	PROPN
ijpds-4638	90	17	model	model	NOUN
ijpds-4638	90	18	no	no	INTJ
ijpds-4638	90	19	.	.	PUNCT
ijpds-4638	91	1	er	er	INTJ
ijpds-4638	91	2	200a	200a	PROPN
ijpds-4638	91	3	was	be	AUX
ijpds-4638	91	4	utilised	utilise	VERB
ijpds-4638	91	5	for	for	ADP
ijpds-4638	91	6	weighing	weigh	VERB
ijpds-4638	91	7	and	and	CCONJ
ijpds-4638	91	8	for	for	ADP
ijpds-4638	91	9	degassing	degas	VERB
ijpds-4638	91	10	the	the	DET
ijpds-4638	91	11	solution	solution	NOUN
ijpds-4638	91	12	digital	digital	ADJ
ijpds-4638	91	13	ultrasonic	ultrasonic	ADJ
ijpds-4638	91	14	cleaner	cleaner	NOUN
ijpds-4638	91	15	1.8	1.8	NUM
ijpds-4638	91	16	ltr	ltr	NOUN
ijpds-4638	91	17	(	(	PUNCT
ijpds-4638	91	18	labman	labman	ADJ
ijpds-4638	91	19	scientific	scientific	ADJ
ijpds-4638	91	20	instruments	instrument	NOUN
ijpds-4638	91	21	chennai	chennai	PROPN
ijpds-4638	91	22	)	)	PUNCT
ijpds-4638	91	23	was	be	AUX
ijpds-4638	91	24	used	use	VERB
ijpds-4638	91	25	.	.	PUNCT
ijpds-4638	92	1	reagents	reagent	NOUN
ijpds-4638	92	2	and	and	CCONJ
ijpds-4638	92	3	chemicals	chemical	NOUN
ijpds-4638	92	4	:	:	PUNCT
ijpds-4638	92	5	pharmaceutically	pharmaceutically	ADJ
ijpds-4638	92	6	pure	pure	ADJ
ijpds-4638	92	7	sample	sample	NOUN
ijpds-4638	92	8	of	of	ADP
ijpds-4638	92	9	met	meet	VERB
ijpds-4638	92	10	was	be	AUX
ijpds-4638	92	11	procured	procure	VERB
ijpds-4638	92	12	from	from	ADP
ijpds-4638	92	13	macleods	macleod	NOUN
ijpds-4638	92	14	pharmaceuticals	pharmaceuticals	PROPN
ijpds-4638	92	15	ltd	ltd	PROPN
ijpds-4638	92	16	.	.	PROPN
ijpds-4638	92	17	mumbai	mumbai	PROPN
ijpds-4638	92	18	and	and	CCONJ
ijpds-4638	92	19	cil	cil	PROPN
ijpds-4638	92	20	from	from	ADP
ijpds-4638	92	21	swapnroop	swapnroop	NOUN
ijpds-4638	92	22	drugs	drug	NOUN
ijpds-4638	92	23	and	and	CCONJ
ijpds-4638	92	24	pharmaceuticals	pharmaceutical	NOUN
ijpds-4638	92	25	,	,	PUNCT
ijpds-4638	92	26	aurangabad	aurangabad	PROPN
ijpds-4638	92	27	,	,	PUNCT
ijpds-4638	92	28	maharashtra	maharashtra	PROPN
ijpds-4638	92	29	,	,	PUNCT
ijpds-4638	92	30	india	india	PROPN
ijpds-4638	92	31	procured	procure	VERB
ijpds-4638	92	32	as	as	ADP
ijpds-4638	92	33	a	a	DET
ijpds-4638	92	34	gift	gift	NOUN
ijpds-4638	92	35	samples	sample	NOUN
ijpds-4638	92	36	and	and	CCONJ
ijpds-4638	92	37	the	the	DET
ijpds-4638	92	38	commercial	commercial	ADJ
ijpds-4638	92	39	formulation	formulation	NOUN
ijpds-4638	92	40	cilacar	cilacar	NOUN
ijpds-4638	92	41	-	-	PUNCT
ijpds-4638	92	42	m	m	AUX
ijpds-4638	92	43	manufactured	manufacture	VERB
ijpds-4638	92	44	by	by	ADP
ijpds-4638	92	45	j	j	PROPN
ijpds-4638	92	46	b	b	PROPN
ijpds-4638	92	47	chemicals	chemical	NOUN
ijpds-4638	92	48	and	and	CCONJ
ijpds-4638	92	49	pharmaceuticals	pharmaceutical	NOUN
ijpds-4638	92	50	containing	contain	VERB
ijpds-4638	92	51	cilnidipine	cilnidipine	NOUN
ijpds-4638	92	52	10	10	NUM
ijpds-4638	92	53	and	and	CCONJ
ijpds-4638	92	54	metoprolol	metoprolol	PROPN
ijpds-4638	92	55	50	50	NUM
ijpds-4638	92	56	mg	mg	NOUN
ijpds-4638	92	57	was	be	AUX
ijpds-4638	92	58	procured	procure	VERB
ijpds-4638	92	59	from	from	ADP
ijpds-4638	92	60	the	the	DET
ijpds-4638	92	61	local	local	ADJ
ijpds-4638	92	62	market	market	NOUN
ijpds-4638	92	63	.	.	PUNCT
ijpds-4638	93	1	aqbd	aqbd	PROPN
ijpds-4638	93	2	approach	approach	NOUN
ijpds-4638	93	3	application	application	NOUN
ijpds-4638	93	4	in	in	ADP
ijpds-4638	93	5	method	method	NOUN
ijpds-4638	93	6	development	development	NOUN
ijpds-4638	93	7	:	:	PUNCT
ijpds-4638	93	8	aqbd	aqbd	PROPN
ijpds-4638	93	9	approach	approach	NOUN
ijpds-4638	93	10	was	be	AUX
ijpds-4638	93	11	applied	apply	VERB
ijpds-4638	93	12	to	to	PART
ijpds-4638	93	13	study	study	VERB
ijpds-4638	93	14	the	the	DET
ijpds-4638	93	15	influence	influence	NOUN
ijpds-4638	93	16	of	of	ADP
ijpds-4638	93	17	input	input	ADJ
ijpds-4638	93	18	variable	variable	ADJ
ijpds-4638	93	19	parameters	parameter	NOUN
ijpds-4638	93	20	on	on	ADP
ijpds-4638	93	21	spectrophotometric	spectrophotometric	ADJ
ijpds-4638	93	22	analytical	analytical	ADJ
ijpds-4638	93	23	method	method	NOUN
ijpds-4638	93	24	performance	performance	NOUN
ijpds-4638	93	25	shown	show	VERB
ijpds-4638	93	26	in	in	ADP
ijpds-4638	93	27	(	(	PUNCT
ijpds-4638	93	28	fig	fig	NOUN
ijpds-4638	93	29	3	3	NUM
ijpds-4638	93	30	)	)	PUNCT
ijpds-4638	93	31	.	.	PUNCT
ijpds-4638	94	1	solvent	solvent	ADJ
ijpds-4638	94	2	selection	selection	NOUN
ijpds-4638	94	3	:	:	PUNCT
ijpds-4638	94	4	cil	cil	PROPN
ijpds-4638	94	5	is	be	AUX
ijpds-4638	94	6	very	very	ADV
ijpds-4638	94	7	soluble	soluble	ADJ
ijpds-4638	94	8	in	in	ADP
ijpds-4638	94	9	n	n	CCONJ
ijpds-4638	94	10	,	,	PUNCT
ijpds-4638	94	11	n	n	CCONJ
ijpds-4638	94	12	-	-	PUNCT
ijpds-4638	94	13	dimethyl	dimethyl	NOUN
ijpds-4638	94	14	acetamide	acetamide	NOUN
ijpds-4638	94	15	,	,	PUNCT
ijpds-4638	94	16	freely	freely	ADV
ijpds-4638	94	17	soluble	soluble	ADJ
ijpds-4638	94	18	in	in	ADP
ijpds-4638	94	19	acetone	acetone	NOUN
ijpds-4638	94	20	,	,	PUNCT
ijpds-4638	94	21	soluble	soluble	ADJ
ijpds-4638	94	22	in	in	ADP
ijpds-4638	94	23	methanol	methanol	NOUN
ijpds-4638	94	24	and	and	CCONJ
ijpds-4638	94	25	practically	practically	ADV
ijpds-4638	94	26	insoluble	insoluble	ADJ
ijpds-4638	94	27	in	in	ADP
ijpds-4638	94	28	water	water	NOUN
ijpds-4638	94	29	,	,	PUNCT
ijpds-4638	94	30	whereas	whereas	SCONJ
ijpds-4638	94	31	met	meet	VERB
ijpds-4638	94	32	is	be	AUX
ijpds-4638	94	33	freely	freely	ADV
ijpds-4638	94	34	soluble	soluble	ADJ
ijpds-4638	94	35	in	in	ADP
ijpds-4638	94	36	water	water	NOUN
ijpds-4638	94	37	,	,	PUNCT
ijpds-4638	94	38	ethanol	ethanol	NOUN
ijpds-4638	94	39	,	,	PUNCT
ijpds-4638	94	40	methanol	methanol	NOUN
ijpds-4638	94	41	and	and	CCONJ
ijpds-4638	94	42	ethyl	ethyl	PROPN
ijpds-4638	94	43	acetate	acetate	NOUN
ijpds-4638	94	44	;	;	PUNCT
ijpds-4638	94	45	.	.	PUNCT
ijpds-4638	95	1	although	although	SCONJ
ijpds-4638	95	2	the	the	DET
ijpds-4638	95	3	solubility	solubility	NOUN
ijpds-4638	95	4	of	of	ADP
ijpds-4638	95	5	the	the	DET
ijpds-4638	95	6	procured	procure	VERB
ijpds-4638	95	7	drugs	drug	NOUN
ijpds-4638	95	8	were	be	AUX
ijpds-4638	95	9	studied	study	VERB
ijpds-4638	95	10	in	in	ADP
ijpds-4638	95	11	alcohol	alcohol	NOUN
ijpds-4638	95	12	90	90	NUM
ijpds-4638	95	13	%	%	NOUN
ijpds-4638	95	14	,	,	PUNCT
ijpds-4638	95	15	0.1	0.1	NUM
ijpds-4638	95	16	n	n	PRON
ijpds-4638	95	17	hcl	hcl	PROPN
ijpds-4638	95	18	and	and	CCONJ
ijpds-4638	95	19	0.1	0.1	NUM
ijpds-4638	95	20	n	n	PRON
ijpds-4638	95	21	naoh	naoh	NOUN
ijpds-4638	95	22	separately	separately	ADV
ijpds-4638	95	23	;	;	PUNCT
ijpds-4638	95	24	and	and	CCONJ
ijpds-4638	95	25	found	find	VERB
ijpds-4638	95	26	that	that	SCONJ
ijpds-4638	95	27	cil	cil	PROPN
ijpds-4638	95	28	is	be	AUX
ijpds-4638	95	29	insoluble	insoluble	ADJ
ijpds-4638	95	30	in	in	ADP
ijpds-4638	95	31	both	both	DET
ijpds-4638	95	32	these	these	DET
ijpds-4638	95	33	solvents	solvent	NOUN
ijpds-4638	95	34	however	however	ADV
ijpds-4638	95	35	met	meet	VERB
ijpds-4638	95	36	is	be	AUX
ijpds-4638	95	37	soluble	soluble	ADJ
ijpds-4638	95	38	in	in	ADP
ijpds-4638	95	39	0.1	0.1	NUM
ijpds-4638	95	40	n	n	DET
ijpds-4638	95	41	naoh	naoh	NOUN
ijpds-4638	95	42	.	.	PUNCT
ijpds-4638	96	1	alcohol	alcohol	NOUN
ijpds-4638	96	2	90	90	NUM
ijpds-4638	96	3	%	%	NOUN
ijpds-4638	96	4	was	be	AUX
ijpds-4638	96	5	selected	select	VERB
ijpds-4638	96	6	as	as	ADP
ijpds-4638	96	7	common	common	ADJ
ijpds-4638	96	8	solvent	solvent	NOUN
ijpds-4638	96	9	as	as	SCONJ
ijpds-4638	96	10	both	both	DET
ijpds-4638	96	11	drugs	drug	NOUN
ijpds-4638	96	12	have	have	VERB
ijpds-4638	96	13	solubility	solubility	NOUN
ijpds-4638	96	14	.	.	PUNCT
ijpds-4638	97	1	each	each	DET
ijpds-4638	97	2	solution	solution	NOUN
ijpds-4638	97	3	with	with	ADP
ijpds-4638	97	4	known	know	VERB
ijpds-4638	97	5	conc	conc	NOUN
ijpds-4638	97	6	of	of	ADP
ijpds-4638	97	7	analyte	analyte	NOUN
ijpds-4638	97	8	was	be	AUX
ijpds-4638	97	9	scanned	scan	VERB
ijpds-4638	97	10	in	in	ADP
ijpds-4638	97	11	uv	uv	NOUN
ijpds-4638	97	12	range	range	NOUN
ijpds-4638	97	13	of	of	ADP
ijpds-4638	97	14	400	400	NUM
ijpds-4638	97	15	nm	nm	NOUN
ijpds-4638	97	16	to	to	ADP
ijpds-4638	97	17	200	200	NUM
ijpds-4638	97	18	nm	nm	NOUN
ijpds-4638	97	19	.	.	PUNCT
ijpds-4638	98	1	it	it	PRON
ijpds-4638	98	2	dyade	dyade	VERB
ijpds-4638	98	3	et	et	PROPN
ijpds-4638	98	4	al	al	PROPN
ijpds-4638	98	5	.	.	PROPN
ijpds-4638	98	6	qbd	qbd	PROPN
ijpds-4638	98	7	and	and	CCONJ
ijpds-4638	98	8	chemometric	chemometric	ADJ
ijpds-4638	98	9	method	method	NOUN
ijpds-4638	98	10	for	for	ADP
ijpds-4638	98	11	estimation	estimation	NOUN
ijpds-4638	98	12	of	of	ADP
ijpds-4638	98	13	metoprolol	metoprolol	NOUN
ijpds-4638	98	14	and	and	CCONJ
ijpds-4638	98	15	cilnidipine	cilnidipine	ADJ
ijpds-4638	98	16	online	online	ADJ
ijpds-4638	98	17	first	first	PROPN
ijpds-4638	98	18	indian	indian	PROPN
ijpds-4638	98	19	j	j	PROPN
ijpds-4638	98	20	pharm	pharm	PROPN
ijpds-4638	98	21	drug	drug	PROPN
ijpds-4638	98	22	studies	study	NOUN
ijpds-4638	98	23	|	|	ADV
ijpds-4638	98	24	3	3	NUM
ijpds-4638	98	25	was	be	AUX
ijpds-4638	98	26	found	find	VERB
ijpds-4638	98	27	that	that	SCONJ
ijpds-4638	98	28	suitable	suitable	ADJ
ijpds-4638	98	29	solvent	solvent	NOUN
ijpds-4638	98	30	is	be	AUX
ijpds-4638	98	31	alcohol	alcohol	NOUN
ijpds-4638	98	32	90	90	NUM
ijpds-4638	98	33	%	%	NOUN
ijpds-4638	98	34	with	with	ADP
ijpds-4638	98	35	respect	respect	NOUN
ijpds-4638	98	36	to	to	ADP
ijpds-4638	98	37	stable	stable	ADJ
ijpds-4638	98	38	,	,	PUNCT
ijpds-4638	98	39	robust	robust	ADJ
ijpds-4638	98	40	and	and	CCONJ
ijpds-4638	98	41	precise	precise	ADJ
ijpds-4638	98	42	in	in	ADP
ijpds-4638	98	43	producing	produce	VERB
ijpds-4638	98	44	result	result	NOUN
ijpds-4638	98	45	.	.	PUNCT
ijpds-4638	99	1	fig	fig	NOUN
ijpds-4638	99	2	3	3	NUM
ijpds-4638	99	3	:	:	PUNCT
ijpds-4638	99	4	diagram	diagram	NOUN
ijpds-4638	99	5	showing	show	VERB
ijpds-4638	99	6	the	the	DET
ijpds-4638	99	7	relationship	relationship	NOUN
ijpds-4638	99	8	between	between	ADP
ijpds-4638	99	9	input	input	NOUN
ijpds-4638	99	10	variable	variable	ADJ
ijpds-4638	99	11	parameters	parameter	NOUN
ijpds-4638	99	12	and	and	CCONJ
ijpds-4638	99	13	the	the	DET
ijpds-4638	99	14	spectrophotometric	spectrophotometric	ADJ
ijpds-4638	99	15	method	method	NOUN
ijpds-4638	99	16	performance	performance	NOUN
ijpds-4638	99	17	characteristics	characteristic	NOUN
ijpds-4638	99	18	preparation	preparation	NOUN
ijpds-4638	99	19	of	of	ADP
ijpds-4638	99	20	stock	stock	NOUN
ijpds-4638	99	21	solutions	solution	NOUN
ijpds-4638	99	22	and	and	CCONJ
ijpds-4638	99	23	standard	standard	ADJ
ijpds-4638	99	24	solutions	solution	NOUN
ijpds-4638	99	25	:	:	PUNCT
ijpds-4638	99	26	10	10	NUM
ijpds-4638	99	27	mg	mg	NOUN
ijpds-4638	99	28	each	each	PRON
ijpds-4638	99	29	of	of	ADP
ijpds-4638	99	30	drug	drug	NOUN
ijpds-4638	99	31	cil	cil	NOUN
ijpds-4638	99	32	and	and	CCONJ
ijpds-4638	99	33	met	meet	VERB
ijpds-4638	99	34	were	be	AUX
ijpds-4638	99	35	separately	separately	ADV
ijpds-4638	99	36	and	and	CCONJ
ijpds-4638	99	37	accurately	accurately	ADV
ijpds-4638	99	38	weighed	weigh	VERB
ijpds-4638	99	39	;	;	PUNCT
ijpds-4638	99	40	and	and	CCONJ
ijpds-4638	99	41	transferred	transfer	VERB
ijpds-4638	99	42	into	into	ADP
ijpds-4638	99	43	separate	separate	ADJ
ijpds-4638	99	44	25	25	NUM
ijpds-4638	99	45	ml	ml	NOUN
ijpds-4638	99	46	volumetric	volumetric	ADJ
ijpds-4638	99	47	flask	flask	NOUN
ijpds-4638	99	48	.	.	PUNCT
ijpds-4638	100	1	dissolved	dissolve	VERB
ijpds-4638	100	2	into	into	ADP
ijpds-4638	100	3	alcohol	alcohol	NOUN
ijpds-4638	100	4	90	90	NUM
ijpds-4638	100	5	%	%	NOUN
ijpds-4638	100	6	solvent	solvent	NOUN
ijpds-4638	100	7	and	and	CCONJ
ijpds-4638	100	8	volume	volume	NOUN
ijpds-4638	100	9	was	be	AUX
ijpds-4638	100	10	made	make	VERB
ijpds-4638	100	11	to	to	ADP
ijpds-4638	100	12	25	25	NUM
ijpds-4638	100	13	ml	ml	NOUN
ijpds-4638	100	14	with	with	ADP
ijpds-4638	100	15	solvent	solvent	NOUN
ijpds-4638	100	16	.	.	PUNCT
ijpds-4638	101	1	subsequent	subsequent	ADJ
ijpds-4638	101	2	standard	standard	ADJ
ijpds-4638	101	3	solution	solution	NOUN
ijpds-4638	101	4	of	of	ADP
ijpds-4638	101	5	drug	drug	NOUN
ijpds-4638	101	6	met	meet	VERB
ijpds-4638	101	7	with	with	ADP
ijpds-4638	101	8	conc	conc	ADJ
ijpds-4638	101	9	16μg	16μg	NOUN
ijpds-4638	101	10	/	/	SYM
ijpds-4638	101	11	ml	ml	NOUN
ijpds-4638	101	12	and	and	CCONJ
ijpds-4638	101	13	cil	cil	VERB
ijpds-4638	101	14	with	with	ADP
ijpds-4638	101	15	conc	conc	ADJ
ijpds-4638	101	16	8μg	8μg	NOUN
ijpds-4638	101	17	/	/	SYM
ijpds-4638	101	18	ml	ml	NOUN
ijpds-4638	101	19	were	be	AUX
ijpds-4638	101	20	prepared	prepare	VERB
ijpds-4638	101	21	by	by	ADP
ijpds-4638	101	22	diluting	dilute	VERB
ijpds-4638	101	23	aliquot	aliquot	NOUN
ijpds-4638	101	24	of	of	ADP
ijpds-4638	101	25	stock	stock	NOUN
ijpds-4638	101	26	solution	solution	NOUN
ijpds-4638	101	27	to	to	ADP
ijpds-4638	101	28	10	10	NUM
ijpds-4638	101	29	ml	ml	NOUN
ijpds-4638	101	30	with	with	ADP
ijpds-4638	101	31	50	50	NUM
ijpds-4638	101	32	%	%	NOUN
ijpds-4638	101	33	alcohol	alcohol	NOUN
ijpds-4638	101	34	into	into	ADP
ijpds-4638	101	35	10	10	NUM
ijpds-4638	101	36	ml	ml	NOUN
ijpds-4638	101	37	capacity	capacity	NOUN
ijpds-4638	101	38	volumetric	volumetric	NOUN
ijpds-4638	101	39	flask	flask	NOUN
ijpds-4638	101	40	.	.	PUNCT
ijpds-4638	102	1	selection	selection	NOUN
ijpds-4638	102	2	of	of	ADP
ijpds-4638	102	3	method	method	NOUN
ijpds-4638	102	4	,	,	PUNCT
ijpds-4638	102	5	wavelength	wavelength	NOUN
ijpds-4638	102	6	and	and	CCONJ
ijpds-4638	102	7	conc	conc	ADJ
ijpds-4638	102	8	range	range	NOUN
ijpds-4638	102	9	:	:	PUNCT
ijpds-4638	102	10	from	from	ADP
ijpds-4638	102	11	uv	uv	NOUN
ijpds-4638	102	12	spectra	spectra	NOUN
ijpds-4638	102	13	it	it	PRON
ijpds-4638	102	14	was	be	AUX
ijpds-4638	102	15	found	find	VERB
ijpds-4638	102	16	that	that	SCONJ
ijpds-4638	102	17	cil	cil	PROPN
ijpds-4638	102	18	has	have	VERB
ijpds-4638	102	19	measurable	measurable	ADJ
ijpds-4638	102	20	absorbance	absorbance	NOUN
ijpds-4638	102	21	at	at	ADP
ijpds-4638	102	22	242	242	NUM
ijpds-4638	102	23	nm	nm	NOUN
ijpds-4638	102	24	(	(	PUNCT
ijpds-4638	102	25	fig	fig	NOUN
ijpds-4638	102	26	4	4	NUM
ijpds-4638	102	27	)	)	PUNCT
ijpds-4638	102	28	and	and	CCONJ
ijpds-4638	102	29	less	less	ADJ
ijpds-4638	102	30	interference	interference	NOUN
ijpds-4638	102	31	was	be	AUX
ijpds-4638	102	32	observed	observe	VERB
ijpds-4638	102	33	by	by	ADP
ijpds-4638	102	34	met	meet	VERB
ijpds-4638	102	35	;	;	PUNCT
ijpds-4638	102	36	similarly	similarly	ADV
ijpds-4638	102	37	met	meet	VERB
ijpds-4638	102	38	has	have	VERB
ijpds-4638	102	39	maximum	maximum	ADJ
ijpds-4638	102	40	absorbance	absorbance	NOUN
ijpds-4638	102	41	at	at	ADP
ijpds-4638	102	42	221	221	NUM
ijpds-4638	102	43	nm	nm	NOUN
ijpds-4638	102	44	(	(	PUNCT
ijpds-4638	102	45	fig	fig	NOUN
ijpds-4638	102	46	4	4	NUM
ijpds-4638	102	47	)	)	PUNCT
ijpds-4638	102	48	and	and	CCONJ
ijpds-4638	102	49	measurable	measurable	ADJ
ijpds-4638	102	50	interference	interference	NOUN
ijpds-4638	102	51	having	have	VERB
ijpds-4638	102	52	constant	constant	ADJ
ijpds-4638	102	53	absorptivity	absorptivity	NOUN
ijpds-4638	102	54	by	by	ADP
ijpds-4638	102	55	cil	cil	PROPN
ijpds-4638	102	56	was	be	AUX
ijpds-4638	102	57	accounted	account	VERB
ijpds-4638	102	58	.	.	PUNCT
ijpds-4638	103	1	chemo	chemo	VERB
ijpds-4638	103	2	metric	metric	ADJ
ijpds-4638	103	3	method	method	NOUN
ijpds-4638	103	4	i.e.	i.e.	X
ijpds-4638	103	5	absorbance	absorbance	NOUN
ijpds-4638	103	6	correction	correction	NOUN
ijpds-4638	103	7	method	method	NOUN
ijpds-4638	103	8	was	be	AUX
ijpds-4638	103	9	applied	apply	VERB
ijpds-4638	103	10	and	and	CCONJ
ijpds-4638	103	11	which	which	PRON
ijpds-4638	103	12	was	be	AUX
ijpds-4638	103	13	reasonable	reasonable	ADJ
ijpds-4638	103	14	remedy	remedy	NOUN
ijpds-4638	103	15	to	to	PART
ijpds-4638	103	16	overcome	overcome	VERB
ijpds-4638	103	17	interference	interference	NOUN
ijpds-4638	103	18	at	at	ADP
ijpds-4638	103	19	each	each	DET
ijpds-4638	103	20	other	other	ADJ
ijpds-4638	103	21	’s	’s	PART
ijpds-4638	103	22	absorbance	absorbance	NOUN
ijpds-4638	103	23	,	,	PUNCT
ijpds-4638	103	24	and	and	CCONJ
ijpds-4638	103	25	other	other	ADJ
ijpds-4638	103	26	method	method	NOUN
ijpds-4638	103	27	was	be	AUX
ijpds-4638	103	28	amplitude	amplitude	NOUN
ijpds-4638	103	29	modulation	modulation	NOUN
ijpds-4638	103	30	method	method	NOUN
ijpds-4638	103	31	.	.	PUNCT
ijpds-4638	104	1	from	from	ADP
ijpds-4638	104	2	the	the	DET
ijpds-4638	104	3	nature	nature	NOUN
ijpds-4638	104	4	of	of	ADP
ijpds-4638	104	5	spectra	spectra	NOUN
ijpds-4638	104	6	to	to	PART
ijpds-4638	104	7	study	study	VERB
ijpds-4638	104	8	linearity	linearity	NOUN
ijpds-4638	104	9	,	,	PUNCT
ijpds-4638	104	10	working	work	VERB
ijpds-4638	104	11	conc	conc	VERB
ijpds-4638	104	12	range	range	NOUN
ijpds-4638	104	13	1	1	NUM
ijpds-4638	104	14	to	to	ADP
ijpds-4638	104	15	16	16	NUM
ijpds-4638	104	16	μg	μg	NOUN
ijpds-4638	104	17	/	/	SYM
ijpds-4638	104	18	ml	ml	PROPN
ijpds-4638	104	19	for	for	ADP
ijpds-4638	104	20	cil	cil	NOUN
ijpds-4638	104	21	and	and	CCONJ
ijpds-4638	104	22	1	1	NUM
ijpds-4638	104	23	to	to	ADP
ijpds-4638	104	24	36μg	36μg	NUM
ijpds-4638	104	25	/	/	SYM
ijpds-4638	104	26	ml	ml	NOUN
ijpds-4638	104	27	for	for	ADP
ijpds-4638	104	28	met	meet	VERB
ijpds-4638	104	29	was	be	AUX
ijpds-4638	104	30	selected	select	VERB
ijpds-4638	104	31	.	.	PUNCT
ijpds-4638	105	1	also	also	ADV
ijpds-4638	105	2	combined	combine	VERB
ijpds-4638	105	3	drug	drug	NOUN
ijpds-4638	105	4	solution	solution	NOUN
ijpds-4638	105	5	was	be	AUX
ijpds-4638	105	6	prepared	prepare	VERB
ijpds-4638	105	7	simulated	simulate	VERB
ijpds-4638	105	8	to	to	PART
ijpds-4638	105	9	marketed	market	VERB
ijpds-4638	105	10	formulation	formulation	NOUN
ijpds-4638	105	11	.	.	PUNCT
ijpds-4638	106	1	selected	select	VERB
ijpds-4638	106	2	critical	critical	ADJ
ijpds-4638	106	3	parameters	parameter	NOUN
ijpds-4638	106	4	based	base	VERB
ijpds-4638	106	5	upon	upon	SCONJ
ijpds-4638	106	6	above	above	ADP
ijpds-4638	106	7	discussion	discussion	NOUN
ijpds-4638	106	8	,	,	PUNCT
ijpds-4638	106	9	observations	observation	NOUN
ijpds-4638	106	10	are	be	AUX
ijpds-4638	106	11	listed	list	VERB
ijpds-4638	106	12	in	in	ADP
ijpds-4638	106	13	and	and	CCONJ
ijpds-4638	106	14	by	by	ADP
ijpds-4638	106	15	using	use	VERB
ijpds-4638	106	16	these	these	PRON
ijpds-4638	106	17	;	;	PUNCT
ijpds-4638	106	18	method	method	NOUN
ijpds-4638	106	19	was	be	AUX
ijpds-4638	106	20	validated	validate	VERB
ijpds-4638	106	21	as	as	ADP
ijpds-4638	106	22	per	per	ADP
ijpds-4638	106	23	ich	ich	NOUN
ijpds-4638	106	24	guidelines	guideline	NOUN
ijpds-4638	106	25	and	and	CCONJ
ijpds-4638	106	26	by	by	ADP
ijpds-4638	106	27	analysing	analyse	VERB
ijpds-4638	106	28	marketed	market	VERB
ijpds-4638	106	29	preparations	preparation	NOUN
ijpds-4638	106	30	.	.	PUNCT
ijpds-4638	107	1	experimental	experimental	ADJ
ijpds-4638	107	2	method	method	NOUN
ijpds-4638	107	3	for	for	ADP
ijpds-4638	107	4	estimation	estimation	NOUN
ijpds-4638	107	5	:	:	PUNCT
ijpds-4638	107	6	from	from	ADP
ijpds-4638	107	7	the	the	DET
ijpds-4638	107	8	overlain	overlain	ADJ
ijpds-4638	107	9	spectra	spectra	ADJ
ijpds-4638	107	10	absorbance	absorbance	NOUN
ijpds-4638	107	11	correction	correction	NOUN
ijpds-4638	107	12	method	method	NOUN
ijpds-4638	107	13	was	be	AUX
ijpds-4638	107	14	applicable	applicable	ADJ
ijpds-4638	107	15	for	for	ADP
ijpds-4638	107	16	estimation	estimation	NOUN
ijpds-4638	107	17	of	of	ADP
ijpds-4638	107	18	both	both	CCONJ
ijpds-4638	107	19	the	the	DET
ijpds-4638	107	20	analytes	analyte	NOUN
ijpds-4638	107	21	from	from	ADP
ijpds-4638	107	22	the	the	DET
ijpds-4638	107	23	combined	combine	VERB
ijpds-4638	107	24	dosage	dosage	NOUN
ijpds-4638	107	25	form	form	NOUN
ijpds-4638	107	26	.	.	PUNCT
ijpds-4638	108	1	method	method	PROPN
ijpds-4638	108	2	-	-	PUNCT
ijpds-4638	108	3	i	i	NOUN
ijpds-4638	108	4	:	:	PUNCT
ijpds-4638	108	5	absorbance	absorbance	NOUN
ijpds-4638	108	6	correction	correction	NOUN
ijpds-4638	108	7	method	method	NOUN
ijpds-4638	108	8	for	for	ADP
ijpds-4638	108	9	estimation	estimation	NOUN
ijpds-4638	108	10	of	of	ADP
ijpds-4638	108	11	met	meet	VERB
ijpds-4638	108	12	and	and	CCONJ
ijpds-4638	108	13	cil	cil	PROPN
ijpds-4638	108	14	:	:	PUNCT
ijpds-4638	108	15	met	meet	VERB
ijpds-4638	108	16	was	be	AUX
ijpds-4638	108	17	shown	show	VERB
ijpds-4638	108	18	maximum	maximum	ADJ
ijpds-4638	108	19	absorbance	absorbance	NOUN
ijpds-4638	108	20	i.e.	i.e.	X
ijpds-4638	108	21	λmax	λmax	NOUN
ijpds-4638	108	22	at	at	ADP
ijpds-4638	108	23	221	221	NUM
ijpds-4638	108	24	nm	nm	NOUN
ijpds-4638	108	25	where	where	SCONJ
ijpds-4638	108	26	measurable	measurable	ADJ
ijpds-4638	108	27	interference	interference	NOUN
ijpds-4638	108	28	with	with	ADP
ijpds-4638	108	29	constant	constant	ADJ
ijpds-4638	108	30	absorptivity	absorptivity	NOUN
ijpds-4638	108	31	by	by	ADP
ijpds-4638	108	32	cil	cil	PROPN
ijpds-4638	108	33	found	find	VERB
ijpds-4638	108	34	and	and	CCONJ
ijpds-4638	108	35	cil	cil	NOUN
ijpds-4638	108	36	has	have	VERB
ijpds-4638	108	37	maximum	maximum	ADJ
ijpds-4638	108	38	absorbance	absorbance	NOUN
ijpds-4638	108	39	i.e.	i.e.	X
ijpds-4638	108	40	λmax	λmax	NOUN
ijpds-4638	108	41	at	at	ADP
ijpds-4638	108	42	242	242	NUM
ijpds-4638	108	43	nm	nm	NOUN
ijpds-4638	108	44	where	where	SCONJ
ijpds-4638	108	45	negligible	negligible	ADJ
ijpds-4638	108	46	interference	interference	NOUN
ijpds-4638	108	47	observed	observe	VERB
ijpds-4638	108	48	by	by	ADP
ijpds-4638	108	49	met	meet	VERB
ijpds-4638	108	50	.	.	PUNCT
ijpds-4638	109	1	at	at	ADP
ijpds-4638	109	2	242	242	NUM
ijpds-4638	109	3	nm	nm	NOUN
ijpds-4638	109	4	the	the	DET
ijpds-4638	109	5	λmax	λmax	NOUN
ijpds-4638	109	6	of	of	ADP
ijpds-4638	109	7	cil	cil	PROPN
ijpds-4638	109	8	,	,	PUNCT
ijpds-4638	109	9	met	meet	VERB
ijpds-4638	109	10	was	be	AUX
ijpds-4638	109	11	shown	show	VERB
ijpds-4638	109	12	consistency	consistency	NOUN
ijpds-4638	109	13	in	in	ADP
ijpds-4638	109	14	the	the	DET
ijpds-4638	109	15	absorptivity	absorptivity	NOUN
ijpds-4638	109	16	;	;	PUNCT
ijpds-4638	109	17	hence	hence	ADV
ijpds-4638	109	18	two	two	NUM
ijpds-4638	109	19	wavelengths	wavelength	NOUN
ijpds-4638	109	20	221	221	NUM
ijpds-4638	109	21	and	and	CCONJ
ijpds-4638	109	22	242	242	NUM
ijpds-4638	109	23	nm	nm	NOUN
ijpds-4638	109	24	were	be	AUX
ijpds-4638	109	25	considered	consider	VERB
ijpds-4638	109	26	as	as	ADP
ijpds-4638	109	27	1	1	NUM
ijpds-4638	109	28	and	and	CCONJ
ijpds-4638	109	29	2	2	NUM
ijpds-4638	109	30	respectively	respectively	ADV
ijpds-4638	109	31	for	for	ADP
ijpds-4638	109	32	the	the	DET
ijpds-4638	109	33	said	say	VERB
ijpds-4638	109	34	method	method	NOUN
ijpds-4638	109	35	to	to	PART
ijpds-4638	109	36	estimate	estimate	VERB
ijpds-4638	109	37	met	meet	VERB
ijpds-4638	109	38	and	and	CCONJ
ijpds-4638	109	39	cil	cil	PROPN
ijpds-4638	109	40	.	.	PUNCT
ijpds-4638	110	1	the	the	DET
ijpds-4638	110	2	equation	equation	NOUN
ijpds-4638	110	3	a=	a=	VERB
ijpds-4638	110	4	abc	abc	PROPN
ijpds-4638	110	5	was	be	AUX
ijpds-4638	110	6	applied	apply	VERB
ijpds-4638	110	7	for	for	ADP
ijpds-4638	110	8	x	x	PRON
ijpds-4638	110	9	(	(	PUNCT
ijpds-4638	110	10	met	meet	VERB
ijpds-4638	110	11	)	)	PUNCT
ijpds-4638	110	12	and	and	CCONJ
ijpds-4638	110	13	y	y	PROPN
ijpds-4638	110	14	(	(	PUNCT
ijpds-4638	110	15	cil	cil	PROPN
ijpds-4638	110	16	)	)	PUNCT
ijpds-4638	110	17	determination	determination	NOUN
ijpds-4638	110	18	.	.	PUNCT
ijpds-4638	111	1	conc	conc	NOUN
ijpds-4638	111	2	of	of	ADP
ijpds-4638	111	3	working	work	VERB
ijpds-4638	111	4	standard	standard	ADJ
ijpds-4638	111	5	solutions	solution	NOUN
ijpds-4638	111	6	of	of	ADP
ijpds-4638	111	7	met	meet	VERB
ijpds-4638	111	8	and	and	CCONJ
ijpds-4638	111	9	cil	cil	NOUN
ijpds-4638	111	10	containing	contain	VERB
ijpds-4638	111	11	28	28	NUM
ijpds-4638	111	12	mcg	mcg	PROPN
ijpds-4638	111	13	/	/	SYM
ijpds-4638	111	14	ml	ml	NOUN
ijpds-4638	111	15	and	and	CCONJ
ijpds-4638	111	16	8	8	NUM
ijpds-4638	111	17	mcg	mcg	NOUN
ijpds-4638	111	18	/	/	SYM
ijpds-4638	111	19	ml	ml	NOUN
ijpds-4638	111	20	conc	conc	VERB
ijpds-4638	111	21	respectively	respectively	ADV
ijpds-4638	111	22	were	be	AUX
ijpds-4638	111	23	separately	separately	ADV
ijpds-4638	111	24	prepared	prepare	VERB
ijpds-4638	111	25	and	and	CCONJ
ijpds-4638	111	26	used	use	VERB
ijpds-4638	111	27	for	for	ADP
ijpds-4638	111	28	the	the	DET
ijpds-4638	111	29	method	method	NOUN
ijpds-4638	111	30	.	.	PUNCT
ijpds-4638	112	1	where	where	SCONJ
ijpds-4638	112	2	cx	cx	NOUN
ijpds-4638	112	3	=	=	SYM
ijpds-4638	112	4	conc	conc	NOUN
ijpds-4638	112	5	of	of	ADP
ijpds-4638	112	6	mps	mp	NOUN
ijpds-4638	112	7	in	in	ADP
ijpds-4638	112	8	sample	sample	NOUN
ijpds-4638	112	9	solution	solution	NOUN
ijpds-4638	112	10	a1	a1	NOUN
ijpds-4638	112	11	and	and	CCONJ
ijpds-4638	112	12	a2	a2	NOUN
ijpds-4638	112	13	=	=	SYM
ijpds-4638	112	14	absorbance	absorbance	NOUN
ijpds-4638	112	15	of	of	ADP
ijpds-4638	112	16	sample	sample	NOUN
ijpds-4638	112	17	solution	solution	NOUN
ijpds-4638	112	18	at	at	ADP
ijpds-4638	112	19	1	1	NUM
ijpds-4638	112	20	and	and	CCONJ
ijpds-4638	112	21	2	2	NUM
ijpds-4638	112	22	wavelength	wavelength	NOUN
ijpds-4638	112	23	ay1	ay1	NOUN
ijpds-4638	112	24	and	and	CCONJ
ijpds-4638	112	25	ay2	ay2	NOUN
ijpds-4638	112	26	=	=	SYM
ijpds-4638	112	27	absorptivity	absorptivity	NOUN
ijpds-4638	112	28	of	of	ADP
ijpds-4638	112	29	cil	cil	NOUN
ijpds-4638	112	30	at	at	ADP
ijpds-4638	112	31	1	1	NUM
ijpds-4638	112	32	and	and	CCONJ
ijpds-4638	112	33	2	2	NUM
ijpds-4638	112	34	wavelength	wavelength	NOUN
ijpds-4638	112	35	of	of	ADP
ijpds-4638	112	36	standard	standard	ADJ
ijpds-4638	112	37	solution	solution	NOUN
ijpds-4638	112	38	ax1	ax1	NOUN
ijpds-4638	112	39	and	and	CCONJ
ijpds-4638	112	40	ax2	ax2	NOUN
ijpds-4638	112	41	=	=	PUNCT
ijpds-4638	112	42	absorptivity	absorptivity	NOUN
ijpds-4638	112	43	of	of	ADP
ijpds-4638	112	44	met	meet	VERB
ijpds-4638	112	45	at	at	ADP
ijpds-4638	112	46	1	1	NUM
ijpds-4638	112	47	and	and	CCONJ
ijpds-4638	112	48	2	2	NUM
ijpds-4638	112	49	wavelength	wavelength	NOUN
ijpds-4638	112	50	of	of	ADP
ijpds-4638	112	51	standard	standard	ADJ
ijpds-4638	112	52	solution	solution	NOUN
ijpds-4638	112	53	cy	cy	NOUN
ijpds-4638	112	54	=	=	PUNCT
ijpds-4638	112	55	conc	conc	NOUN
ijpds-4638	112	56	of	of	ADP
ijpds-4638	112	57	cil	cil	NOUN
ijpds-4638	112	58	in	in	ADP
ijpds-4638	112	59	sample	sample	NOUN
ijpds-4638	112	60	solution	solution	NOUN
ijpds-4638	112	61	as	as	ADP
ijpds-4638	112	62	=	=	SYM
ijpds-4638	112	63	absorbance	absorbance	NOUN
ijpds-4638	112	64	of	of	ADP
ijpds-4638	112	65	sample	sample	NOUN
ijpds-4638	112	66	solution	solution	NOUN
ijpds-4638	112	67	at	at	ADP
ijpds-4638	112	68	2	2	NUM
ijpds-4638	112	69	wavelength	wavelength	NOUN
ijpds-4638	112	70	method	method	NOUN
ijpds-4638	112	71	-	-	PUNCT
ijpds-4638	112	72	ii	ii	NOUN
ijpds-4638	112	73	:	:	PUNCT
ijpds-4638	112	74	amplitude	amplitude	NOUN
ijpds-4638	112	75	modulation	modulation	NOUN
ijpds-4638	112	76	method	method	NOUN
ijpds-4638	112	77	:	:	PUNCT
ijpds-4638	112	78	this	this	DET
ijpds-4638	112	79	method	method	NOUN
ijpds-4638	112	80	comprises	comprise	VERB
ijpds-4638	112	81	the	the	DET
ijpds-4638	112	82	conversion	conversion	NOUN
ijpds-4638	112	83	of	of	ADP
ijpds-4638	112	84	zero	zero	NUM
ijpds-4638	112	85	order	order	NOUN
ijpds-4638	112	86	/	/	SYM
ijpds-4638	112	87	normal	normal	ADJ
ijpds-4638	112	88	spectra	spectra	NOUN
ijpds-4638	112	89	to	to	ADP
ijpds-4638	112	90	its	its	PRON
ijpds-4638	112	91	first	first	ADJ
ijpds-4638	112	92	,	,	PUNCT
ijpds-4638	112	93	second	second	ADJ
ijpds-4638	112	94	or	or	CCONJ
ijpds-4638	112	95	higher	high	ADJ
ijpds-4638	112	96	derivative	derivative	ADJ
ijpds-4638	112	97	spectrum	spectrum	NOUN
ijpds-4638	112	98	.	.	PUNCT
ijpds-4638	113	1	the	the	DET
ijpds-4638	113	2	amplitude	amplitude	NOUN
ijpds-4638	113	3	is	be	AUX
ijpds-4638	113	4	directly	directly	ADV
ijpds-4638	113	5	proportional	proportional	ADJ
ijpds-4638	113	6	to	to	ADP
ijpds-4638	113	7	the	the	DET
ijpds-4638	113	8	conc	conc	NOUN
ijpds-4638	113	9	of	of	ADP
ijpds-4638	113	10	solution	solution	NOUN
ijpds-4638	113	11	provided	provide	VERB
ijpds-4638	113	12	beer	beer	NOUN
ijpds-4638	113	13	’s	’s	PART
ijpds-4638	113	14	law	law	NOUN
ijpds-4638	113	15	is	be	AUX
ijpds-4638	113	16	obeyed	obey	VERB
ijpds-4638	113	17	by	by	ADP
ijpds-4638	113	18	spectrum	spectrum	NOUN
ijpds-4638	113	19	.	.	PUNCT
ijpds-4638	114	1	in	in	ADP
ijpds-4638	114	2	derivative	derivative	ADJ
ijpds-4638	114	3	method	method	NOUN
ijpds-4638	114	4	zero	zero	NUM
ijpds-4638	114	5	crossing	crossing	NOUN
ijpds-4638	114	6	wave	wave	NOUN
ijpds-4638	114	7	length	length	NOUN
ijpds-4638	114	8	for	for	ADP
ijpds-4638	114	9	both	both	DET
ijpds-4638	114	10	drugs	drug	NOUN
ijpds-4638	114	11	is	be	AUX
ijpds-4638	114	12	found	find	VERB
ijpds-4638	114	13	such	such	ADJ
ijpds-4638	114	14	that	that	SCONJ
ijpds-4638	114	15	at	at	ADP
ijpds-4638	114	16	the	the	DET
ijpds-4638	114	17	zero	zero	NUM
ijpds-4638	114	18	crossing	crossing	NOUN
ijpds-4638	114	19	of	of	ADP
ijpds-4638	114	20	one	one	NUM
ijpds-4638	114	21	drug	drug	NOUN
ijpds-4638	114	22	the	the	DET
ijpds-4638	114	23	other	other	ADJ
ijpds-4638	114	24	drug	drug	NOUN
ijpds-4638	114	25	should	should	AUX
ijpds-4638	114	26	show	show	VERB
ijpds-4638	114	27	substantial	substantial	ADJ
ijpds-4638	114	28	absorbance	absorbance	NOUN
ijpds-4638	114	29	.	.	PUNCT
ijpds-4638	115	1	here	here	ADV
ijpds-4638	115	2	standard	standard	ADJ
ijpds-4638	115	3	solutions	solution	NOUN
ijpds-4638	115	4	16	16	NUM
ijpds-4638	115	5	µg	µg	NOUN
ijpds-4638	115	6	/	/	SYM
ijpds-4638	115	7	ml	ml	ADP
ijpds-4638	115	8	each	each	PRON
ijpds-4638	115	9	of	of	ADP
ijpds-4638	115	10	metoprolol	metoprolol	NOUN
ijpds-4638	115	11	and	and	CCONJ
ijpds-4638	115	12	cilnidipine	cilnidipine	NOUN
ijpds-4638	115	13	were	be	AUX
ijpds-4638	115	14	prepared	prepare	VERB
ijpds-4638	115	15	in	in	ADP
ijpds-4638	115	16	10	10	NUM
ijpds-4638	115	17	ml	ml	NOUN
ijpds-4638	115	18	volumetric	volumetric	ADJ
ijpds-4638	115	19	flask	flask	NOUN
ijpds-4638	115	20	and	and	CCONJ
ijpds-4638	115	21	scanned	scan	VERB
ijpds-4638	115	22	from	from	ADP
ijpds-4638	115	23	400	400	NUM
ijpds-4638	115	24	to	to	ADP
ijpds-4638	115	25	200	200	NUM
ijpds-4638	115	26	nm	nm	ADJ
ijpds-4638	115	27	wavelength	wavelength	NOUN
ijpds-4638	115	28	range	range	NOUN
ijpds-4638	115	29	against	against	ADP
ijpds-4638	115	30	ethanol	ethanol	NOUN
ijpds-4638	115	31	50	50	NUM
ijpds-4638	115	32	%	%	NOUN
ijpds-4638	115	33	as	as	ADV
ijpds-4638	115	34	blank	blank	ADJ
ijpds-4638	115	35	.	.	PUNCT
ijpds-4638	116	1	absorption	absorption	NOUN
ijpds-4638	116	2	spectra	spectra	NOUN
ijpds-4638	116	3	of	of	ADP
ijpds-4638	116	4	both	both	DET
ijpds-4638	116	5	drugs	drug	NOUN
ijpds-4638	116	6	were	be	AUX
ijpds-4638	116	7	recorded	record	VERB
ijpds-4638	116	8	and	and	CCONJ
ijpds-4638	116	9	the	the	DET
ijpds-4638	116	10	found	find	VERB
ijpds-4638	116	11	λmax	λmax	NOUN
ijpds-4638	116	12	of	of	ADP
ijpds-4638	116	13	met	meet	VERB
ijpds-4638	116	14	and	and	CCONJ
ijpds-4638	116	15	cil	cil	PROPN
ijpds-4638	116	16	were	be	AUX
ijpds-4638	116	17	stated	state	VERB
ijpds-4638	116	18	in	in	ADP
ijpds-4638	116	19	earlier	early	ADV
ijpds-4638	116	20	discussed	discuss	VERB
ijpds-4638	116	21	method	method	NOUN
ijpds-4638	116	22	.	.	PUNCT
ijpds-4638	117	1	from	from	ADP
ijpds-4638	117	2	overlain	overlain	PROPN
ijpds-4638	117	3	spectra	spectra	PROPN
ijpds-4638	117	4	cil	cil	PROPN
ijpds-4638	117	5	has	have	VERB
ijpds-4638	117	6	substantial	substantial	ADJ
ijpds-4638	117	7	interference	interference	NOUN
ijpds-4638	117	8	due	due	ADP
ijpds-4638	117	9	to	to	ADP
ijpds-4638	117	10	absorption	absorption	NOUN
ijpds-4638	117	11	at	at	ADP
ijpds-4638	117	12	wavelength	wavelength	NOUN
ijpds-4638	117	13	221	221	NUM
ijpds-4638	117	14	nm	nm	NOUN
ijpds-4638	117	15	and	and	CCONJ
ijpds-4638	117	16	met	meet	VERB
ijpds-4638	117	17	shows	show	VERB
ijpds-4638	117	18	negligible	negligible	ADJ
ijpds-4638	117	19	absorption	absorption	NOUN
ijpds-4638	117	20	at	at	ADP
ijpds-4638	117	21	242	242	NUM
ijpds-4638	117	22	nm	nm	NOUN
ijpds-4638	117	23	,	,	PUNCT
ijpds-4638	117	24	hence	hence	ADV
ijpds-4638	117	25	it	it	PRON
ijpds-4638	117	26	was	be	AUX
ijpds-4638	117	27	decided	decide	VERB
ijpds-4638	117	28	to	to	PART
ijpds-4638	117	29	apply	apply	VERB
ijpds-4638	117	30	derivative	derivative	ADJ
ijpds-4638	117	31	method	method	NOUN
ijpds-4638	117	32	.	.	PUNCT
ijpds-4638	118	1	dyade	dyade	VERB
ijpds-4638	118	2	et	et	PROPN
ijpds-4638	118	3	al	al	PROPN
ijpds-4638	118	4	.	.	PROPN
ijpds-4638	118	5	qbd	qbd	PROPN
ijpds-4638	118	6	and	and	CCONJ
ijpds-4638	118	7	chemometric	chemometric	ADJ
ijpds-4638	118	8	method	method	NOUN
ijpds-4638	118	9	for	for	ADP
ijpds-4638	118	10	estimation	estimation	NOUN
ijpds-4638	118	11	of	of	ADP
ijpds-4638	118	12	metoprolol	metoprolol	NOUN
ijpds-4638	118	13	and	and	CCONJ
ijpds-4638	118	14	cilnidipine	cilnidipine	ADJ
ijpds-4638	118	15	online	online	ADJ
ijpds-4638	118	16	first	first	PROPN
ijpds-4638	118	17	indian	indian	PROPN
ijpds-4638	118	18	j	j	PROPN
ijpds-4638	118	19	pharm	pharm	PROPN
ijpds-4638	118	20	drug	drug	PROPN
ijpds-4638	118	21	studies	study	NOUN
ijpds-4638	118	22	|	|	ADV
ijpds-4638	118	23	4	4	NUM
ijpds-4638	118	24	zero	zero	NUM
ijpds-4638	118	25	order	order	NOUN
ijpds-4638	118	26	spectra	spectra	NOUN
ijpds-4638	118	27	of	of	ADP
ijpds-4638	118	28	both	both	DET
ijpds-4638	118	29	drug	drug	NOUN
ijpds-4638	118	30	was	be	AUX
ijpds-4638	118	31	modulated	modulate	VERB
ijpds-4638	118	32	and	and	CCONJ
ijpds-4638	118	33	converted	convert	VERB
ijpds-4638	118	34	to	to	ADP
ijpds-4638	118	35	first	first	ADJ
ijpds-4638	118	36	order	order	VERB
ijpds-4638	118	37	derivative	derivative	ADJ
ijpds-4638	118	38	spectra	spectra	NOUN
ijpds-4638	118	39	.	.	PUNCT
ijpds-4638	119	1	from	from	ADP
ijpds-4638	119	2	overlain	overlain	PROPN
ijpds-4638	119	3	spectra	spectra	NOUN
ijpds-4638	119	4	,	,	PUNCT
ijpds-4638	119	5	it	it	PRON
ijpds-4638	119	6	clearly	clearly	ADV
ijpds-4638	119	7	shows	show	VERB
ijpds-4638	119	8	that	that	SCONJ
ijpds-4638	119	9	no	no	DET
ijpds-4638	119	10	interference	interference	NOUN
ijpds-4638	119	11	or	or	CCONJ
ijpds-4638	119	12	zero	zero	NUM
ijpds-4638	119	13	absorbance	absorbance	NOUN
ijpds-4638	119	14	of	of	ADP
ijpds-4638	119	15	met	meet	VERB
ijpds-4638	119	16	was	be	AUX
ijpds-4638	119	17	found	find	VERB
ijpds-4638	119	18	at	at	ADP
ijpds-4638	119	19	263	263	NUM
ijpds-4638	119	20	nm	nm	ADV
ijpds-4638	119	21	hence	hence	ADV
ijpds-4638	119	22	it	it	PRON
ijpds-4638	119	23	was	be	AUX
ijpds-4638	119	24	selected	select	VERB
ijpds-4638	119	25	λmax	λmax	NOUN
ijpds-4638	119	26	of	of	ADP
ijpds-4638	119	27	cil	cil	PROPN
ijpds-4638	119	28	and	and	CCONJ
ijpds-4638	119	29	229.5	229.5	NUM
ijpds-4638	119	30	nm	nm	NOUN
ijpds-4638	119	31	was	be	AUX
ijpds-4638	119	32	zero	zero	NUM
ijpds-4638	119	33	crossing	crossing	NOUN
ijpds-4638	119	34	of	of	ADP
ijpds-4638	119	35	cil	cil	PROPN
ijpds-4638	119	36	,	,	PUNCT
ijpds-4638	119	37	so	so	SCONJ
ijpds-4638	119	38	it	it	PRON
ijpds-4638	119	39	was	be	AUX
ijpds-4638	119	40	selected	select	VERB
ijpds-4638	119	41	as	as	ADP
ijpds-4638	119	42	λmax	λmax	NOUN
ijpds-4638	119	43	of	of	ADP
ijpds-4638	119	44	met	meet	VERB
ijpds-4638	119	45	.	.	PUNCT
ijpds-4638	120	1	both	both	DET
ijpds-4638	120	2	drugs	drug	NOUN
ijpds-4638	120	3	were	be	AUX
ijpds-4638	120	4	obeying	obey	VERB
ijpds-4638	120	5	beer	beer	NOUN
ijpds-4638	120	6	’s	’s	PART
ijpds-4638	120	7	law	law	NOUN
ijpds-4638	120	8	in	in	ADP
ijpds-4638	120	9	first	first	ADJ
ijpds-4638	120	10	order	order	NOUN
ijpds-4638	120	11	derivative	derivative	ADJ
ijpds-4638	120	12	mode	mode	NOUN
ijpds-4638	120	13	at	at	ADP
ijpds-4638	120	14	the	the	DET
ijpds-4638	120	15	respective	respective	ADJ
ijpds-4638	120	16	wavelength	wavelength	NOUN
ijpds-4638	120	17	.	.	PUNCT
ijpds-4638	121	1	fig	fig	NOUN
ijpds-4638	121	2	4	4	NUM
ijpds-4638	121	3	:	:	PUNCT
ijpds-4638	121	4	uv	uv	NOUN
ijpds-4638	121	5	spectra	spectra	NOUN
ijpds-4638	121	6	of	of	ADP
ijpds-4638	121	7	cilnidipine	cilnidipine	PROPN
ijpds-4638	121	8	and	and	CCONJ
ijpds-4638	121	9	metoprolol	metoprolol	NOUN
ijpds-4638	121	10	succinate	succinate	NOUN
ijpds-4638	121	11	in	in	ADP
ijpds-4638	121	12	ethanol	ethanol	NOUN
ijpds-4638	121	13	validation	validation	NOUN
ijpds-4638	121	14	of	of	ADP
ijpds-4638	121	15	the	the	DET
ijpds-4638	121	16	method	method	NOUN
ijpds-4638	121	17	:	:	PUNCT
ijpds-4638	121	18	selected	select	VERB
ijpds-4638	121	19	critical	critical	ADJ
ijpds-4638	121	20	parameters	parameter	NOUN
ijpds-4638	121	21	should	should	AUX
ijpds-4638	121	22	meet	meet	VERB
ijpds-4638	121	23	the	the	DET
ijpds-4638	121	24	performance	performance	NOUN
ijpds-4638	121	25	characteristics	characteristic	NOUN
ijpds-4638	121	26	of	of	ADP
ijpds-4638	121	27	the	the	DET
ijpds-4638	121	28	analytical	analytical	ADJ
ijpds-4638	121	29	method	method	NOUN
ijpds-4638	121	30	so	so	SCONJ
ijpds-4638	121	31	as	as	SCONJ
ijpds-4638	121	32	to	to	PART
ijpds-4638	121	33	attain	attain	VERB
ijpds-4638	121	34	analytical	analytical	ADJ
ijpds-4638	121	35	target	target	NOUN
ijpds-4638	121	36	profile	profile	NOUN
ijpds-4638	121	37	of	of	ADP
ijpds-4638	121	38	the	the	DET
ijpds-4638	121	39	method	method	NOUN
ijpds-4638	121	40	.	.	PUNCT
ijpds-4638	122	1	an	an	DET
ijpds-4638	122	2	ich	ich	PROPN
ijpds-4638	122	3	guideline	guideline	NOUN
ijpds-4638	122	4	q2	q2	PROPN
ijpds-4638	122	5	r1	r1	PROPN
ijpds-4638	122	6	was	be	AUX
ijpds-4638	122	7	applied	apply	VERB
ijpds-4638	122	8	to	to	PART
ijpds-4638	122	9	study	study	VERB
ijpds-4638	122	10	methods	method	NOUN
ijpds-4638	122	11	performance	performance	NOUN
ijpds-4638	122	12	with	with	ADP
ijpds-4638	122	13	critical	critical	ADJ
ijpds-4638	122	14	parameters	parameter	NOUN
ijpds-4638	122	15	in	in	ADP
ijpds-4638	122	16	order	order	NOUN
ijpds-4638	122	17	to	to	PART
ijpds-4638	122	18	implement	implement	VERB
ijpds-4638	122	19	aqbd	aqbd	NOUN
ijpds-4638	122	20	approach	approach	NOUN
ijpds-4638	122	21	.	.	PUNCT
ijpds-4638	123	1	the	the	DET
ijpds-4638	123	2	method	method	NOUN
ijpds-4638	123	3	was	be	AUX
ijpds-4638	123	4	validated	validate	VERB
ijpds-4638	123	5	as	as	ADP
ijpds-4638	123	6	per	per	ADP
ijpds-4638	123	7	ich	ich	NOUN
ijpds-4638	123	8	guidelines	guideline	NOUN
ijpds-4638	123	9	.	.	PUNCT
ijpds-4638	124	1	system	system	NOUN
ijpds-4638	124	2	suitability	suitability	NOUN
ijpds-4638	124	3	:	:	PUNCT
ijpds-4638	124	4	system	system	NOUN
ijpds-4638	124	5	suitability	suitability	NOUN
ijpds-4638	124	6	is	be	AUX
ijpds-4638	124	7	studied	study	VERB
ijpds-4638	124	8	to	to	PART
ijpds-4638	124	9	demonstrate	demonstrate	VERB
ijpds-4638	124	10	the	the	DET
ijpds-4638	124	11	suitability	suitability	NOUN
ijpds-4638	124	12	of	of	ADP
ijpds-4638	124	13	the	the	DET
ijpds-4638	124	14	developed	develop	VERB
ijpds-4638	124	15	procedure	procedure	NOUN
ijpds-4638	124	16	under	under	ADP
ijpds-4638	124	17	consideration	consideration	NOUN
ijpds-4638	124	18	for	for	ADP
ijpds-4638	124	19	the	the	DET
ijpds-4638	124	20	analytical	analytical	ADJ
ijpds-4638	124	21	method	method	NOUN
ijpds-4638	124	22	.	.	PUNCT
ijpds-4638	125	1	six	six	NUM
ijpds-4638	125	2	replicates	replicate	NOUN
ijpds-4638	125	3	of	of	ADP
ijpds-4638	125	4	working	work	VERB
ijpds-4638	125	5	standard	standard	ADJ
ijpds-4638	125	6	solutions	solution	NOUN
ijpds-4638	125	7	with	with	ADP
ijpds-4638	125	8	conc16	conc16	NOUN
ijpds-4638	125	9	μg	μg	PROPN
ijpds-4638	125	10	/	/	SYM
ijpds-4638	125	11	ml	ml	PROPN
ijpds-4638	125	12	and	and	CCONJ
ijpds-4638	125	13	8	8	NUM
ijpds-4638	125	14	μg	μg	NOUN
ijpds-4638	125	15	/	/	SYM
ijpds-4638	125	16	ml	ml	ADP
ijpds-4638	125	17	each	each	PRON
ijpds-4638	125	18	of	of	ADP
ijpds-4638	125	19	met	meet	VERB
ijpds-4638	125	20	and	and	CCONJ
ijpds-4638	125	21	cil	cil	NOUN
ijpds-4638	125	22	respectively	respectively	ADV
ijpds-4638	125	23	were	be	AUX
ijpds-4638	125	24	prepared	prepare	VERB
ijpds-4638	125	25	separately	separately	ADV
ijpds-4638	125	26	and	and	CCONJ
ijpds-4638	125	27	absorbance	absorbance	NOUN
ijpds-4638	125	28	was	be	AUX
ijpds-4638	125	29	recorded	record	VERB
ijpds-4638	125	30	,	,	PUNCT
ijpds-4638	125	31	sd	sd	NOUN
ijpds-4638	125	32	and	and	CCONJ
ijpds-4638	125	33	%	%	NOUN
ijpds-4638	125	34	rsd	rsd	NOUN
ijpds-4638	125	35	of	of	ADP
ijpds-4638	125	36	the	the	DET
ijpds-4638	125	37	response	response	NOUN
ijpds-4638	125	38	was	be	AUX
ijpds-4638	125	39	calculated	calculate	VERB
ijpds-4638	125	40	.	.	PUNCT
ijpds-4638	126	1	linearity	linearity	NOUN
ijpds-4638	126	2	:	:	PUNCT
ijpds-4638	126	3	the	the	DET
ijpds-4638	126	4	linearity	linearity	NOUN
ijpds-4638	126	5	of	of	ADP
ijpds-4638	126	6	an	an	DET
ijpds-4638	126	7	analytical	analytical	ADJ
ijpds-4638	126	8	method	method	NOUN
ijpds-4638	126	9	is	be	AUX
ijpds-4638	126	10	its	its	PRON
ijpds-4638	126	11	ability	ability	NOUN
ijpds-4638	126	12	to	to	PART
ijpds-4638	126	13	obtain	obtain	VERB
ijpds-4638	126	14	response	response	NOUN
ijpds-4638	126	15	i.e.	i.e.	X
ijpds-4638	126	16	absorbance	absorbance	NOUN
ijpds-4638	126	17	which	which	PRON
ijpds-4638	126	18	is	be	AUX
ijpds-4638	126	19	directly	directly	ADV
ijpds-4638	126	20	proportional	proportional	ADJ
ijpds-4638	126	21	to	to	ADP
ijpds-4638	126	22	the	the	DET
ijpds-4638	126	23	conc	conc	NOUN
ijpds-4638	126	24	of	of	ADP
ijpds-4638	126	25	analyte	analyte	NOUN
ijpds-4638	126	26	.	.	PUNCT
ijpds-4638	127	1	series	series	NOUN
ijpds-4638	127	2	of	of	ADP
ijpds-4638	127	3	working	work	VERB
ijpds-4638	127	4	standard	standard	ADJ
ijpds-4638	127	5	solutions	solution	NOUN
ijpds-4638	127	6	were	be	AUX
ijpds-4638	127	7	prepared	prepare	VERB
ijpds-4638	127	8	in	in	ADP
ijpds-4638	127	9	conc	conc	NOUN
ijpds-4638	127	10	.	.	PUNCT
ijpds-4638	128	1	range	range	NOUN
ijpds-4638	128	2	of	of	ADP
ijpds-4638	128	3	1	1	NUM
ijpds-4638	128	4	-	-	PUNCT
ijpds-4638	128	5	36μg	36μg	NOUN
ijpds-4638	128	6	/	/	SYM
ijpds-4638	128	7	ml	ml	NOUN
ijpds-4638	128	8	for	for	ADP
ijpds-4638	128	9	met	meet	VERB
ijpds-4638	128	10	and	and	CCONJ
ijpds-4638	128	11	1	1	NUM
ijpds-4638	128	12	-	-	SYM
ijpds-4638	128	13	16	16	NUM
ijpds-4638	128	14	μg	μg	NOUN
ijpds-4638	128	15	/	/	SYM
ijpds-4638	128	16	ml	ml	X
ijpds-4638	128	17	for	for	ADP
ijpds-4638	128	18	cil	cil	NOUN
ijpds-4638	128	19	and	and	CCONJ
ijpds-4638	128	20	scanned	scan	VERB
ijpds-4638	128	21	in	in	ADP
ijpds-4638	128	22	400	400	NUM
ijpds-4638	128	23	to	to	PART
ijpds-4638	128	24	200	200	NUM
ijpds-4638	128	25	nm	nm	ADJ
ijpds-4638	128	26	range	range	NOUN
ijpds-4638	128	27	in	in	ADP
ijpds-4638	128	28	spectrum	spectrum	NOUN
ijpds-4638	128	29	mode	mode	NOUN
ijpds-4638	128	30	of	of	ADP
ijpds-4638	128	31	the	the	DET
ijpds-4638	128	32	spectrophotometer	spectrophotometer	NOUN
ijpds-4638	128	33	,	,	PUNCT
ijpds-4638	128	34	absorbance	absorbance	NOUN
ijpds-4638	128	35	of	of	ADP
ijpds-4638	128	36	the	the	DET
ijpds-4638	128	37	standard	standard	ADJ
ijpds-4638	128	38	solutions	solution	NOUN
ijpds-4638	128	39	were	be	AUX
ijpds-4638	128	40	recorded	record	VERB
ijpds-4638	128	41	at	at	ADP
ijpds-4638	128	42	their	their	PRON
ijpds-4638	128	43	respective	respective	ADJ
ijpds-4638	128	44	wavelength	wavelength	NOUN
ijpds-4638	128	45	;	;	PUNCT
ijpds-4638	128	46	i.e.	i.e.	X
ijpds-4638	128	47	221	221	NUM
ijpds-4638	128	48	for	for	ADP
ijpds-4638	128	49	met	meet	VERB
ijpds-4638	128	50	and	and	CCONJ
ijpds-4638	128	51	242	242	NUM
ijpds-4638	128	52	nm	nm	NOUN
ijpds-4638	128	53	for	for	ADP
ijpds-4638	128	54	cil	cil	NOUN
ijpds-4638	128	55	in	in	ADP
ijpds-4638	128	56	spectrum	spectrum	NOUN
ijpds-4638	128	57	order	order	NOUN
ijpds-4638	128	58	.	.	PUNCT
ijpds-4638	129	1	microsoft	microsoft	PROPN
ijpds-4638	129	2	office	office	PROPN
ijpds-4638	129	3	excel	excel	PROPN
ijpds-4638	129	4	software	software	NOUN
ijpds-4638	129	5	tool	tool	NOUN
ijpds-4638	129	6	was	be	AUX
ijpds-4638	129	7	used	use	VERB
ijpds-4638	129	8	to	to	PART
ijpds-4638	129	9	obtain	obtain	VERB
ijpds-4638	129	10	the	the	DET
ijpds-4638	129	11	standard	standard	ADJ
ijpds-4638	129	12	regression	regression	NOUN
ijpds-4638	129	13	curve	curve	NOUN
ijpds-4638	129	14	and	and	CCONJ
ijpds-4638	129	15	its	its	PRON
ijpds-4638	129	16	analysis	analysis	NOUN
ijpds-4638	129	17	as	as	ADP
ijpds-4638	129	18	slope	slope	NOUN
ijpds-4638	129	19	,	,	PUNCT
ijpds-4638	129	20	intercept	intercept	NOUN
ijpds-4638	129	21	,	,	PUNCT
ijpds-4638	129	22	and	and	CCONJ
ijpds-4638	129	23	correlation	correlation	NOUN
ijpds-4638	129	24	coefficient	coefficient	NOUN
ijpds-4638	129	25	.	.	PUNCT
ijpds-4638	130	1	assay	assay	NOUN
ijpds-4638	130	2	of	of	ADP
ijpds-4638	130	3	formulation	formulation	NOUN
ijpds-4638	130	4	:	:	PUNCT
ijpds-4638	130	5	assay	assay	PROPN
ijpds-4638	130	6	was	be	AUX
ijpds-4638	130	7	carried	carry	VERB
ijpds-4638	130	8	out	out	ADP
ijpds-4638	130	9	by	by	ADP
ijpds-4638	130	10	proposed	propose	VERB
ijpds-4638	130	11	methods	method	NOUN
ijpds-4638	130	12	and	and	CCONJ
ijpds-4638	130	13	assay	assay	PROPN
ijpds-4638	130	14	was	be	AUX
ijpds-4638	130	15	validated	validate	VERB
ijpds-4638	130	16	by	by	ADP
ijpds-4638	130	17	statistical	statistical	ADJ
ijpds-4638	130	18	parameters	parameter	NOUN
ijpds-4638	130	19	.	.	PUNCT
ijpds-4638	131	1	estimation	estimation	NOUN
ijpds-4638	131	2	of	of	ADP
ijpds-4638	131	3	formulations	formulation	NOUN
ijpds-4638	131	4	by	by	ADP
ijpds-4638	131	5	absorbance	absorbance	NOUN
ijpds-4638	131	6	correction	correction	NOUN
ijpds-4638	131	7	and	and	CCONJ
ijpds-4638	131	8	amplitude	amplitude	NOUN
ijpds-4638	131	9	modulation	modulation	NOUN
ijpds-4638	131	10	method	method	NOUN
ijpds-4638	131	11	:	:	PUNCT
ijpds-4638	131	12	tablet	tablet	NOUN
ijpds-4638	131	13	powder	powder	NOUN
ijpds-4638	131	14	equivalent	equivalent	ADJ
ijpds-4638	131	15	to	to	ADP
ijpds-4638	131	16	12.5	12.5	NUM
ijpds-4638	131	17	mg	mg	NUM
ijpds-4638	131	18	met	meet	VERB
ijpds-4638	131	19	and	and	CCONJ
ijpds-4638	131	20	2.5	2.5	NUM
ijpds-4638	131	21	mg	mg	NOUN
ijpds-4638	131	22	cil	cil	PROPN
ijpds-4638	131	23	was	be	AUX
ijpds-4638	131	24	weighed	weigh	VERB
ijpds-4638	131	25	and	and	CCONJ
ijpds-4638	131	26	transferred	transfer	VERB
ijpds-4638	131	27	into	into	ADP
ijpds-4638	131	28	25	25	NUM
ijpds-4638	131	29	ml	ml	NOUN
ijpds-4638	131	30	volumetric	volumetric	ADJ
ijpds-4638	131	31	flask	flask	NOUN
ijpds-4638	131	32	.	.	PUNCT
ijpds-4638	132	1	dissolved	dissolve	VERB
ijpds-4638	132	2	into	into	ADP
ijpds-4638	132	3	90	90	NUM
ijpds-4638	132	4	%	%	NOUN
ijpds-4638	132	5	alcohol	alcohol	NOUN
ijpds-4638	132	6	,	,	PUNCT
ijpds-4638	132	7	mixed	mix	VERB
ijpds-4638	132	8	well	well	ADV
ijpds-4638	132	9	for	for	ADP
ijpds-4638	132	10	10	10	NUM
ijpds-4638	132	11	mins	min	NOUN
ijpds-4638	132	12	and	and	CCONJ
ijpds-4638	132	13	volume	volume	NOUN
ijpds-4638	132	14	was	be	AUX
ijpds-4638	132	15	made	make	VERB
ijpds-4638	132	16	to	to	ADP
ijpds-4638	132	17	25	25	NUM
ijpds-4638	132	18	ml	ml	NOUN
ijpds-4638	132	19	with	with	ADP
ijpds-4638	132	20	the	the	DET
ijpds-4638	132	21	solvent	solvent	NOUN
ijpds-4638	132	22	.	.	PUNCT
ijpds-4638	133	1	solution	solution	NOUN
ijpds-4638	133	2	was	be	AUX
ijpds-4638	133	3	filtered	filter	VERB
ijpds-4638	133	4	through	through	ADP
ijpds-4638	133	5	what	what	PRON
ijpds-4638	133	6	man	man	NOUN
ijpds-4638	133	7	filter	filter	NOUN
ijpds-4638	133	8	paper	paper	NOUN
ijpds-4638	133	9	and	and	CCONJ
ijpds-4638	133	10	aliquots	aliquot	NOUN
ijpds-4638	133	11	of	of	ADP
ijpds-4638	133	12	solution	solution	NOUN
ijpds-4638	133	13	were	be	AUX
ijpds-4638	133	14	further	far	ADV
ijpds-4638	133	15	diluted	dilute	VERB
ijpds-4638	133	16	with	with	ADP
ijpds-4638	133	17	the	the	DET
ijpds-4638	133	18	50	50	NUM
ijpds-4638	133	19	%	%	NOUN
ijpds-4638	133	20	alcohol	alcohol	NOUN
ijpds-4638	133	21	to	to	PART
ijpds-4638	133	22	obtain	obtain	VERB
ijpds-4638	133	23	tablet	tablet	NOUN
ijpds-4638	133	24	sample	sample	NOUN
ijpds-4638	133	25	solution	solution	NOUN
ijpds-4638	133	26	.	.	PUNCT
ijpds-4638	134	1	solution	solution	NOUN
ijpds-4638	134	2	was	be	AUX
ijpds-4638	134	3	scanned	scan	VERB
ijpds-4638	134	4	in	in	ADP
ijpds-4638	134	5	the	the	DET
ijpds-4638	134	6	range	range	NOUN
ijpds-4638	134	7	of	of	ADP
ijpds-4638	134	8	400	400	NUM
ijpds-4638	134	9	to	to	PART
ijpds-4638	134	10	200	200	NUM
ijpds-4638	134	11	nm	nm	NOUN
ijpds-4638	134	12	to	to	PART
ijpds-4638	134	13	obtain	obtain	VERB
ijpds-4638	134	14	absorbance	absorbance	NOUN
ijpds-4638	134	15	of	of	ADP
ijpds-4638	134	16	tablet	tablet	ADJ
ijpds-4638	134	17	solution	solution	NOUN
ijpds-4638	134	18	at	at	ADP
ijpds-4638	134	19	221	221	NUM
ijpds-4638	134	20	nm	nm	NOUN
ijpds-4638	134	21	and	and	CCONJ
ijpds-4638	134	22	242	242	NUM
ijpds-4638	134	23	nm	nm	NOUN
ijpds-4638	134	24	in	in	ADP
ijpds-4638	134	25	spectrum	spectrum	NOUN
ijpds-4638	134	26	order	order	NOUN
ijpds-4638	134	27	.	.	PUNCT
ijpds-4638	135	1	also	also	ADV
ijpds-4638	135	2	spectrum	spectrum	VERB
ijpds-4638	135	3	converted	convert	VERB
ijpds-4638	135	4	to	to	ADP
ijpds-4638	135	5	first	first	ADJ
ijpds-4638	135	6	order	order	VERB
ijpds-4638	135	7	derivative	derivative	NOUN
ijpds-4638	135	8	and	and	CCONJ
ijpds-4638	135	9	absorbance	absorbance	NOUN
ijpds-4638	135	10	was	be	AUX
ijpds-4638	135	11	recorded	record	VERB
ijpds-4638	135	12	at	at	ADP
ijpds-4638	135	13	229.5	229.5	NUM
ijpds-4638	135	14	and	and	CCONJ
ijpds-4638	135	15	263	263	NUM
ijpds-4638	135	16	nm	nm	NOUN
ijpds-4638	135	17	.	.	PROPN
ijpds-4638	136	1	obtained	obtain	VERB
ijpds-4638	136	2	absorbance	absorbance	NOUN
ijpds-4638	136	3	were	be	AUX
ijpds-4638	136	4	utilised	utilise	VERB
ijpds-4638	136	5	to	to	PART
ijpds-4638	136	6	estimate	estimate	VERB
ijpds-4638	136	7	unknown	unknown	ADJ
ijpds-4638	136	8	conc	conc	NOUN
ijpds-4638	136	9	of	of	ADP
ijpds-4638	136	10	formulation	formulation	NOUN
ijpds-4638	136	11	;	;	PUNCT
ijpds-4638	136	12	and	and	CCONJ
ijpds-4638	136	13	results	result	NOUN
ijpds-4638	136	14	were	be	AUX
ijpds-4638	136	15	statistically	statistically	ADV
ijpds-4638	136	16	validated	validate	VERB
ijpds-4638	136	17	to	to	PART
ijpds-4638	136	18	obtain	obtain	VERB
ijpds-4638	136	19	%	%	NOUN
ijpds-4638	136	20	of	of	ADP
ijpds-4638	136	21	nominal	nominal	ADJ
ijpds-4638	136	22	conc	conc	NOUN
ijpds-4638	136	23	,	,	PUNCT
ijpds-4638	136	24	standard	standard	ADJ
ijpds-4638	136	25	deviation	deviation	NOUN
ijpds-4638	136	26	and	and	CCONJ
ijpds-4638	136	27	%	%	NOUN
ijpds-4638	136	28	of	of	ADP
ijpds-4638	136	29	rsd	rsd	PROPN
ijpds-4638	136	30	.	.	PUNCT
ijpds-4638	137	1	accuracy	accuracy	NOUN
ijpds-4638	137	2	and	and	CCONJ
ijpds-4638	137	3	precision	precision	NOUN
ijpds-4638	137	4	:	:	PUNCT
ijpds-4638	137	5	the	the	DET
ijpds-4638	137	6	accuracy	accuracy	NOUN
ijpds-4638	137	7	of	of	ADP
ijpds-4638	137	8	an	an	DET
ijpds-4638	137	9	analytical	analytical	ADJ
ijpds-4638	137	10	method	method	NOUN
ijpds-4638	137	11	expresses	express	VERB
ijpds-4638	137	12	the	the	DET
ijpds-4638	137	13	closeness	closeness	NOUN
ijpds-4638	137	14	of	of	ADP
ijpds-4638	137	15	an	an	DET
ijpds-4638	137	16	agreement	agreement	NOUN
ijpds-4638	137	17	between	between	ADP
ijpds-4638	137	18	test	test	NOUN
ijpds-4638	137	19	result	result	NOUN
ijpds-4638	137	20	and	and	CCONJ
ijpds-4638	137	21	true	true	ADJ
ijpds-4638	137	22	result	result	NOUN
ijpds-4638	137	23	.	.	PUNCT
ijpds-4638	138	1	accuracy	accuracy	NOUN
ijpds-4638	138	2	study	study	NOUN
ijpds-4638	138	3	was	be	AUX
ijpds-4638	138	4	performed	perform	VERB
ijpds-4638	138	5	by	by	ADP
ijpds-4638	138	6	recovery	recovery	NOUN
ijpds-4638	138	7	study	study	NOUN
ijpds-4638	138	8	i.e.	i.e.	X
ijpds-4638	138	9	standard	standard	ADJ
ijpds-4638	138	10	addition	addition	NOUN
ijpds-4638	138	11	method	method	NOUN
ijpds-4638	138	12	;	;	PUNCT
ijpds-4638	138	13	diluted	dilute	VERB
ijpds-4638	138	14	standard	standard	ADJ
ijpds-4638	138	15	solutions	solution	NOUN
ijpds-4638	138	16	of	of	ADP
ijpds-4638	138	17	met	meet	VERB
ijpds-4638	138	18	and	and	CCONJ
ijpds-4638	138	19	cil	cil	NOUN
ijpds-4638	138	20	were	be	AUX
ijpds-4638	138	21	prepared	prepared	ADJ
ijpds-4638	138	22	and	and	CCONJ
ijpds-4638	138	23	standard	standard	ADJ
ijpds-4638	138	24	solutions	solution	NOUN
ijpds-4638	138	25	added	add	VERB
ijpds-4638	138	26	in	in	ADP
ijpds-4638	138	27	100	100	NUM
ijpds-4638	138	28	%	%	NOUN
ijpds-4638	138	29	proportionate	proportionate	ADJ
ijpds-4638	138	30	to	to	ADP
ijpds-4638	138	31	the	the	DET
ijpds-4638	138	32	tablet	tablet	NOUN
ijpds-4638	138	33	solution	solution	NOUN
ijpds-4638	138	34	.	.	PUNCT
ijpds-4638	139	1	three	three	NUM
ijpds-4638	139	2	replicates	replicate	NOUN
ijpds-4638	139	3	at	at	ADP
ijpds-4638	139	4	this	this	DET
ijpds-4638	139	5	level	level	NOUN
ijpds-4638	139	6	was	be	AUX
ijpds-4638	139	7	prepared	prepare	VERB
ijpds-4638	139	8	,	,	PUNCT
ijpds-4638	139	9	absorbance	absorbance	NOUN
ijpds-4638	139	10	measured	measure	VERB
ijpds-4638	139	11	and	and	CCONJ
ijpds-4638	139	12	%	%	NOUN
ijpds-4638	139	13	of	of	ADP
ijpds-4638	139	14	conc	conc	NOUN
ijpds-4638	139	15	,	,	PUNCT
ijpds-4638	139	16	sd	sd	NOUN
ijpds-4638	139	17	and	and	CCONJ
ijpds-4638	139	18	rsd	rsd	NOUN
ijpds-4638	139	19	were	be	AUX
ijpds-4638	139	20	calculated	calculate	VERB
ijpds-4638	139	21	.	.	PUNCT
ijpds-4638	140	1	the	the	DET
ijpds-4638	140	2	precision	precision	NOUN
ijpds-4638	140	3	study	study	NOUN
ijpds-4638	140	4	was	be	AUX
ijpds-4638	140	5	carried	carry	VERB
ijpds-4638	140	6	out	out	ADP
ijpds-4638	140	7	by	by	ADP
ijpds-4638	140	8	performing	perform	VERB
ijpds-4638	140	9	assay	assay	NOUN
ijpds-4638	140	10	of	of	ADP
ijpds-4638	140	11	tablet	tablet	NOUN
ijpds-4638	140	12	six	six	NUM
ijpds-4638	140	13	times	time	NOUN
ijpds-4638	140	14	;	;	PUNCT
ijpds-4638	140	15	also	also	ADV
ijpds-4638	140	16	the	the	DET
ijpds-4638	140	17	reproducibility	reproducibility	NOUN
ijpds-4638	140	18	in	in	ADP
ijpds-4638	140	19	result	result	NOUN
ijpds-4638	140	20	was	be	AUX
ijpds-4638	140	21	studied	study	VERB
ijpds-4638	140	22	by	by	ADP
ijpds-4638	140	23	inter	inter	ADJ
ijpds-4638	140	24	day	day	NOUN
ijpds-4638	140	25	and	and	CCONJ
ijpds-4638	140	26	intraday	intraday	NOUN
ijpds-4638	140	27	precision	precision	NOUN
ijpds-4638	140	28	.	.	PUNCT
ijpds-4638	141	1	limit	limit	NOUN
ijpds-4638	141	2	of	of	ADP
ijpds-4638	141	3	detection	detection	NOUN
ijpds-4638	141	4	(	(	PUNCT
ijpds-4638	141	5	lod	lod	PROPN
ijpds-4638	141	6	)	)	PUNCT
ijpds-4638	141	7	and	and	CCONJ
ijpds-4638	141	8	limit	limit	NOUN
ijpds-4638	141	9	of	of	ADP
ijpds-4638	141	10	quantitation	quantitation	NOUN
ijpds-4638	141	11	(	(	PUNCT
ijpds-4638	141	12	loq	loq	PROPN
ijpds-4638	141	13	):	):	PUNCT
ijpds-4638	141	14	the	the	DET
ijpds-4638	141	15	lod	lod	PROPN
ijpds-4638	141	16	and	and	CCONJ
ijpds-4638	141	17	loq	loq	PROPN
ijpds-4638	141	18	of	of	ADP
ijpds-4638	141	19	met	meet	VERB
ijpds-4638	141	20	and	and	CCONJ
ijpds-4638	141	21	cil	cil	NOUN
ijpds-4638	141	22	by	by	ADP
ijpds-4638	141	23	the	the	DET
ijpds-4638	141	24	proposed	propose	VERB
ijpds-4638	141	25	method	method	NOUN
ijpds-4638	141	26	were	be	AUX
ijpds-4638	141	27	determined	determine	VERB
ijpds-4638	141	28	using	use	VERB
ijpds-4638	141	29	calibration	calibration	NOUN
ijpds-4638	141	30	graph	graph	NOUN
ijpds-4638	141	31	method	method	NOUN
ijpds-4638	141	32	and	and	CCONJ
ijpds-4638	141	33	calculated	calculate	VERB
ijpds-4638	141	34	as	as	ADP
ijpds-4638	141	35	3.3σ	3.3σ	NUM
ijpds-4638	141	36	/	/	SYM
ijpds-4638	141	37	s	s	NOUN
ijpds-4638	141	38	and	and	CCONJ
ijpds-4638	141	39	10	10	NUM
ijpds-4638	141	40	σ	σ	NOUN
ijpds-4638	141	41	/	/	SYM
ijpds-4638	141	42	s	s	PROPN
ijpds-4638	141	43	for	for	ADP
ijpds-4638	141	44	lod	lod	PROPN
ijpds-4638	141	45	and	and	CCONJ
ijpds-4638	141	46	loq	loq	PROPN
ijpds-4638	141	47	respectively	respectively	ADV
ijpds-4638	141	48	;	;	PUNCT
ijpds-4638	141	49	σ	σ	PROPN
ijpds-4638	141	50	is	be	AUX
ijpds-4638	141	51	the	the	DET
ijpds-4638	141	52	standard	standard	ADJ
ijpds-4638	141	53	deviation	deviation	NOUN
ijpds-4638	141	54	of	of	ADP
ijpds-4638	141	55	calibration	calibration	NOUN
ijpds-4638	141	56	curve	curve	NOUN
ijpds-4638	141	57	and	and	CCONJ
ijpds-4638	141	58	s	s	NOUN
ijpds-4638	141	59	is	be	AUX
ijpds-4638	141	60	the	the	DET
ijpds-4638	141	61	slope	slope	NOUN
ijpds-4638	141	62	of	of	ADP
ijpds-4638	141	63	regression	regression	NOUN
ijpds-4638	141	64	line	line	NOUN
ijpds-4638	141	65	.	.	PUNCT
ijpds-4638	142	1	robustness	robustness	NOUN
ijpds-4638	142	2	and	and	CCONJ
ijpds-4638	142	3	ruggedness	ruggedness	NOUN
ijpds-4638	142	4	:	:	PUNCT
ijpds-4638	142	5	it	it	PRON
ijpds-4638	142	6	is	be	AUX
ijpds-4638	142	7	measure	measure	NOUN
ijpds-4638	142	8	of	of	ADP
ijpds-4638	142	9	capacity	capacity	NOUN
ijpds-4638	142	10	of	of	ADP
ijpds-4638	142	11	analytical	analytical	ADJ
ijpds-4638	142	12	procedure	procedure	NOUN
ijpds-4638	142	13	to	to	PART
ijpds-4638	142	14	remain	remain	VERB
ijpds-4638	142	15	unaffected	unaffected	ADJ
ijpds-4638	142	16	by	by	ADP
ijpds-4638	142	17	small	small	ADJ
ijpds-4638	142	18	but	but	CCONJ
ijpds-4638	142	19	deliberate	deliberate	ADJ
ijpds-4638	142	20	variations	variation	NOUN
ijpds-4638	142	21	in	in	ADP
ijpds-4638	142	22	method	method	NOUN
ijpds-4638	142	23	parameter	parameter	NOUN
ijpds-4638	142	24	.	.	PUNCT
ijpds-4638	143	1	results	result	NOUN
ijpds-4638	143	2	method	method	VERB
ijpds-4638	143	3	development	development	NOUN
ijpds-4638	143	4	comprises	comprise	VERB
ijpds-4638	143	5	numerous	numerous	ADJ
ijpds-4638	143	6	steps	step	NOUN
ijpds-4638	143	7	,	,	PUNCT
ijpds-4638	143	8	and	and	CCONJ
ijpds-4638	143	9	of	of	ADP
ijpds-4638	143	10	which	which	PRON
ijpds-4638	143	11	solvent	solvent	ADJ
ijpds-4638	143	12	selection	selection	NOUN
ijpds-4638	143	13	,	,	PUNCT
ijpds-4638	143	14	selection	selection	NOUN
ijpds-4638	143	15	of	of	ADP
ijpds-4638	143	16	method	method	NOUN
ijpds-4638	143	17	for	for	ADP
ijpds-4638	143	18	measurement	measurement	NOUN
ijpds-4638	143	19	are	be	AUX
ijpds-4638	143	20	significant	significant	ADJ
ijpds-4638	143	21	one	one	NUM
ijpds-4638	143	22	.	.	PUNCT
ijpds-4638	144	1	uses	use	NOUN
ijpds-4638	144	2	of	of	ADP
ijpds-4638	144	3	aqueous	aqueous	ADJ
ijpds-4638	144	4	solvents	solvent	NOUN
ijpds-4638	144	5	,	,	PUNCT
ijpds-4638	144	6	eco	eco	NOUN
ijpds-4638	144	7	-	-	PUNCT
ijpds-4638	144	8	friendly	friendly	ADJ
ijpds-4638	144	9	solvents	solvent	NOUN
ijpds-4638	144	10	like	like	ADP
ijpds-4638	144	11	hydrotropic	hydrotropic	NOUN
ijpds-4638	144	12	have	have	AUX
ijpds-4638	144	13	got	get	VERB
ijpds-4638	144	14	remarkable	remarkable	ADJ
ijpds-4638	144	15	weightage	weightage	NOUN
ijpds-4638	144	16	due	due	ADP
ijpds-4638	144	17	to	to	ADP
ijpds-4638	144	18	low	low	ADJ
ijpds-4638	144	19	cost	cost	NOUN
ijpds-4638	144	20	,	,	PUNCT
ijpds-4638	144	21	readily	readily	ADV
ijpds-4638	144	22	available	available	ADJ
ijpds-4638	144	23	and	and	CCONJ
ijpds-4638	144	24	environmentally	environmentally	ADV
ijpds-4638	144	25	sound	sound	ADJ
ijpds-4638	144	26	.	.	PUNCT
ijpds-4638	145	1	drugs	drug	NOUN
ijpds-4638	145	2	underlying	underlie	VERB
ijpds-4638	145	3	analysis	analysis	NOUN
ijpds-4638	145	4	must	must	AUX
ijpds-4638	145	5	have	have	VERB
ijpds-4638	145	6	appreciable	appreciable	ADJ
ijpds-4638	145	7	solubility	solubility	NOUN
ijpds-4638	145	8	in	in	ADP
ijpds-4638	145	9	the	the	DET
ijpds-4638	145	10	selected	select	VERB
ijpds-4638	145	11	solvent	solvent	NOUN
ijpds-4638	145	12	.	.	PUNCT
ijpds-4638	146	1	chemical	chemical	ADJ
ijpds-4638	146	2	structure	structure	NOUN
ijpds-4638	146	3	of	of	ADP
ijpds-4638	146	4	the	the	DET
ijpds-4638	146	5	drug	drug	NOUN
ijpds-4638	146	6	and	and	CCONJ
ijpds-4638	146	7	physico	physico	NOUN
ijpds-4638	146	8	-	-	PUNCT
ijpds-4638	146	9	chemical	chemical	NOUN
ijpds-4638	146	10	properties	property	NOUN
ijpds-4638	146	11	available	available	ADJ
ijpds-4638	146	12	in	in	ADP
ijpds-4638	146	13	the	the	DET
ijpds-4638	146	14	literature	literature	NOUN
ijpds-4638	146	15	guides	guide	NOUN
ijpds-4638	146	16	about	about	ADP
ijpds-4638	146	17	use	use	NOUN
ijpds-4638	146	18	of	of	ADP
ijpds-4638	146	19	appropriate	appropriate	ADJ
ijpds-4638	146	20	solvent	solvent	NOUN
ijpds-4638	146	21	in	in	ADP
ijpds-4638	146	22	the	the	DET
ijpds-4638	146	23	method	method	NOUN
ijpds-4638	146	24	.	.	PUNCT
ijpds-4638	147	1	from	from	ADP
ijpds-4638	147	2	uv	uv	PROPN
ijpds-4638	147	3	spectra	spectra	NOUN
ijpds-4638	147	4	two	two	NUM
ijpds-4638	147	5	wavelengths	wavelength	NOUN
ijpds-4638	147	6	were	be	AUX
ijpds-4638	147	7	selected	select	VERB
ijpds-4638	147	8	as	as	ADP
ijpds-4638	147	9	221	221	NUM
ijpds-4638	147	10	nm	nm	PRON
ijpds-4638	147	11	dyade	dyade	NOUN
ijpds-4638	148	1	et	et	PROPN
ijpds-4638	148	2	al	al	PROPN
ijpds-4638	148	3	.	.	PROPN
ijpds-4638	148	4	qbd	qbd	PROPN
ijpds-4638	148	5	and	and	CCONJ
ijpds-4638	148	6	chemometric	chemometric	ADJ
ijpds-4638	148	7	method	method	NOUN
ijpds-4638	148	8	for	for	ADP
ijpds-4638	148	9	estimation	estimation	NOUN
ijpds-4638	148	10	of	of	ADP
ijpds-4638	148	11	metoprolol	metoprolol	NOUN
ijpds-4638	148	12	and	and	CCONJ
ijpds-4638	148	13	cilnidipine	cilnidipine	ADJ
ijpds-4638	148	14	online	online	ADJ
ijpds-4638	148	15	first	first	PROPN
ijpds-4638	148	16	indian	indian	PROPN
ijpds-4638	148	17	j	j	PROPN
ijpds-4638	148	18	pharm	pharm	PROPN
ijpds-4638	148	19	drug	drug	PROPN
ijpds-4638	148	20	studies	study	NOUN
ijpds-4638	148	21	|	|	ADV
ijpds-4638	148	22	5	5	NUM
ijpds-4638	148	23	(	(	PUNCT
ijpds-4638	148	24	λmax	λmax	NOUN
ijpds-4638	148	25	of	of	ADP
ijpds-4638	148	26	met	meet	VERB
ijpds-4638	148	27	)	)	PUNCT
ijpds-4638	148	28	and	and	CCONJ
ijpds-4638	148	29	242	242	NUM
ijpds-4638	148	30	nm	nm	NOUN
ijpds-4638	148	31	(	(	PUNCT
ijpds-4638	148	32	λmax	λmax	NOUN
ijpds-4638	148	33	of	of	ADP
ijpds-4638	148	34	cil	cil	PROPN
ijpds-4638	148	35	)	)	PUNCT
ijpds-4638	148	36	shown	show	VERB
ijpds-4638	148	37	in	in	ADP
ijpds-4638	148	38	fig	fig	NOUN
ijpds-4638	148	39	5	5	NUM
ijpds-4638	148	40	for	for	ADP
ijpds-4638	148	41	calculation	calculation	NOUN
ijpds-4638	148	42	of	of	ADP
ijpds-4638	148	43	both	both	DET
ijpds-4638	148	44	drugs	drug	NOUN
ijpds-4638	148	45	in	in	ADP
ijpds-4638	148	46	combined	combined	ADJ
ijpds-4638	148	47	solution	solution	NOUN
ijpds-4638	148	48	shown	show	VERB
ijpds-4638	148	49	.	.	PUNCT
ijpds-4638	149	1	fig	fig	NOUN
ijpds-4638	149	2	5	5	NUM
ijpds-4638	149	3	:	:	PUNCT
ijpds-4638	149	4	overlaid	overlay	VERB
ijpds-4638	149	5	spectra	spectra	NOUN
ijpds-4638	149	6	of	of	ADP
ijpds-4638	149	7	met	meet	VERB
ijpds-4638	149	8	and	and	CCONJ
ijpds-4638	149	9	cil	cil	ADJ
ijpds-4638	149	10	system	system	NOUN
ijpds-4638	149	11	suitability	suitability	NOUN
ijpds-4638	149	12	:	:	PUNCT
ijpds-4638	149	13	the	the	DET
ijpds-4638	149	14	absorbances	absorbance	NOUN
ijpds-4638	149	15	of	of	ADP
ijpds-4638	149	16	six	six	NUM
ijpds-4638	149	17	replicates	replicate	NOUN
ijpds-4638	149	18	of	of	ADP
ijpds-4638	149	19	standard	standard	ADJ
ijpds-4638	149	20	solutions	solution	NOUN
ijpds-4638	149	21	of	of	ADP
ijpds-4638	149	22	tabulated	tabulate	VERB
ijpds-4638	149	23	respective	respective	ADJ
ijpds-4638	149	24	conc	conc	NOUN
ijpds-4638	149	25	are	be	AUX
ijpds-4638	149	26	reported	report	VERB
ijpds-4638	149	27	in	in	ADP
ijpds-4638	149	28	table	table	NOUN
ijpds-4638	149	29	no	no	DET
ijpds-4638	149	30	1	1	NOUN
ijpds-4638	149	31	.	.	PUNCT
ijpds-4638	150	1	the	the	DET
ijpds-4638	150	2	sd	sd	NOUN
ijpds-4638	150	3	and	and	CCONJ
ijpds-4638	150	4	%	%	NOUN
ijpds-4638	150	5	rsd	rsd	PROPN
ijpds-4638	150	6	was	be	AUX
ijpds-4638	150	7	found	find	VERB
ijpds-4638	150	8	for	for	ADP
ijpds-4638	150	9	met	meet	VERB
ijpds-4638	150	10	and	and	CCONJ
ijpds-4638	150	11	cil	cil	NOUN
ijpds-4638	150	12	and	and	CCONJ
ijpds-4638	150	13	meets	meet	VERB
ijpds-4638	150	14	the	the	DET
ijpds-4638	150	15	system	system	NOUN
ijpds-4638	150	16	suitability	suitability	NOUN
ijpds-4638	150	17	requirements	requirement	NOUN
ijpds-4638	150	18	indicates	indicate	VERB
ijpds-4638	150	19	method	method	NOUN
ijpds-4638	150	20	was	be	AUX
ijpds-4638	150	21	suitable	suitable	ADJ
ijpds-4638	150	22	for	for	ADP
ijpds-4638	150	23	analysis	analysis	NOUN
ijpds-4638	150	24	.	.	PUNCT
ijpds-4638	151	1	table	table	NOUN
ijpds-4638	151	2	no	no	DET
ijpds-4638	151	3	1	1	NUM
ijpds-4638	151	4	:	:	PUNCT
ijpds-4638	151	5	system	system	NOUN
ijpds-4638	151	6	suitability	suitability	NOUN
ijpds-4638	151	7	study	study	NOUN
ijpds-4638	151	8	of	of	ADP
ijpds-4638	151	9	met	meet	VERB
ijpds-4638	151	10	and	and	CCONJ
ijpds-4638	151	11	cil	cil	PROPN
ijpds-4638	151	12	sr	sr	PROPN
ijpds-4638	151	13	no	no	DET
ijpds-4638	151	14	conc	conc	NOUN
ijpds-4638	151	15	in	in	ADP
ijpds-4638	151	16	μg	μg	PROPN
ijpds-4638	151	17	/ml	/ml	PUNCT
ijpds-4638	151	18	absorbance	absorbance	NOUN
ijpds-4638	151	19	of	of	ADP
ijpds-4638	151	20	met	meet	VERB
ijpds-4638	151	21	*	*	PUNCT
ijpds-4638	151	22	conc	conc	VERB
ijpds-4638	151	23	in	in	ADP
ijpds-4638	151	24	μg	μg	PROPN
ijpds-4638	151	25	/ml	/ml	PUNCT
ijpds-4638	151	26	absorbance	absorbance	NOUN
ijpds-4638	151	27	of	of	ADP
ijpds-4638	151	28	cil	cil	PROPN
ijpds-4638	151	29	*	*	PROPN
ijpds-4638	151	30	1	1	NUM
ijpds-4638	151	31	16μg	16μg	NOUN
ijpds-4638	151	32	/	/	SYM
ijpds-4638	151	33	ml	ml	NOUN
ijpds-4638	151	34	0.5157	0.5157	NUM
ijpds-4638	151	35	8	8	NUM
ijpds-4638	151	36	μg	μg	NOUN
ijpds-4638	151	37	/ml	/ml	PUNCT
ijpds-4638	151	38	0.6519	0.6519	NUM
ijpds-4638	151	39	2	2	NUM
ijpds-4638	151	40	sd	sd	ADP
ijpds-4638	151	41	rsd	rsd	NOUN
ijpds-4638	151	42	%	%	NOUN
ijpds-4638	151	43	0.004676	0.004676	NUM
ijpds-4638	151	44	0.9060	0.9060	NUM
ijpds-4638	151	45	sd	sd	ADP
ijpds-4638	151	46	rsd	rsd	PROPN
ijpds-4638	151	47	0.004809	0.004809	NUM
ijpds-4638	151	48	0.73774	0.73774	NUM
ijpds-4638	151	49	*	*	PUNCT
ijpds-4638	152	1	mean	mean	NOUN
ijpds-4638	152	2	of	of	ADP
ijpds-4638	152	3	six	six	NUM
ijpds-4638	152	4	determinations	determination	NOUN
ijpds-4638	152	5	linearity	linearity	NOUN
ijpds-4638	152	6	:	:	PUNCT
ijpds-4638	152	7	the	the	DET
ijpds-4638	152	8	calibration	calibration	NOUN
ijpds-4638	152	9	curve	curve	NOUN
ijpds-4638	152	10	of	of	ADP
ijpds-4638	152	11	both	both	DET
ijpds-4638	152	12	drugs	drug	NOUN
ijpds-4638	152	13	was	be	AUX
ijpds-4638	152	14	found	find	VERB
ijpds-4638	152	15	to	to	PART
ijpds-4638	152	16	be	be	AUX
ijpds-4638	152	17	linear	linear	ADJ
ijpds-4638	152	18	in	in	ADP
ijpds-4638	152	19	the	the	DET
ijpds-4638	152	20	conc	conc	ADJ
ijpds-4638	152	21	range	range	NOUN
ijpds-4638	152	22	of	of	ADP
ijpds-4638	152	23	1	1	NUM
ijpds-4638	152	24	-	-	SYM
ijpds-4638	152	25	36	36	NUM
ijpds-4638	152	26	μg	μg	NOUN
ijpds-4638	152	27	/	/	SYM
ijpds-4638	152	28	ml	ml	PROPN
ijpds-4638	152	29	for	for	ADP
ijpds-4638	152	30	met	meet	VERB
ijpds-4638	152	31	and	and	CCONJ
ijpds-4638	152	32	1	1	NUM
ijpds-4638	152	33	-	-	SYM
ijpds-4638	152	34	16	16	NUM
ijpds-4638	152	35	μg	μg	NOUN
ijpds-4638	152	36	/	/	SYM
ijpds-4638	152	37	ml	ml	X
ijpds-4638	152	38	for	for	ADP
ijpds-4638	152	39	cil	cil	NOUN
ijpds-4638	152	40	in	in	ADP
ijpds-4638	152	41	normal	normal	ADJ
ijpds-4638	152	42	spectrum	spectrum	NOUN
ijpds-4638	152	43	as	as	SCONJ
ijpds-4638	152	44	shown	show	VERB
ijpds-4638	152	45	in	in	ADP
ijpds-4638	152	46	fig	fig	NOUN
ijpds-4638	152	47	6	6	NUM
ijpds-4638	152	48	and	and	CCONJ
ijpds-4638	152	49	in	in	ADP
ijpds-4638	152	50	first	first	ADJ
ijpds-4638	152	51	order	order	NOUN
ijpds-4638	152	52	derivative	derivative	ADJ
ijpds-4638	152	53	mode	mode	NOUN
ijpds-4638	152	54	fig	fig	NOUN
ijpds-4638	152	55	7	7	NUM
ijpds-4638	152	56	.	.	PUNCT
ijpds-4638	153	1	the	the	DET
ijpds-4638	153	2	regression	regression	NOUN
ijpds-4638	153	3	equation	equation	NOUN
ijpds-4638	153	4	of	of	ADP
ijpds-4638	153	5	line	line	NOUN
ijpds-4638	153	6	and	and	CCONJ
ijpds-4638	153	7	its	its	PRON
ijpds-4638	153	8	parameters	parameter	NOUN
ijpds-4638	153	9	slope	slope	VERB
ijpds-4638	153	10	,	,	PUNCT
ijpds-4638	153	11	r2	r2	NOUN
ijpds-4638	153	12	value	value	NOUN
ijpds-4638	153	13	and	and	CCONJ
ijpds-4638	153	14	intercept	intercept	NOUN
ijpds-4638	153	15	are	be	AUX
ijpds-4638	153	16	tabulated	tabulate	VERB
ijpds-4638	153	17	in	in	ADP
ijpds-4638	153	18	table	table	NOUN
ijpds-4638	153	19	no	no	DET
ijpds-4638	153	20	2	2	NUM
ijpds-4638	153	21	,	,	PUNCT
ijpds-4638	153	22	which	which	PRON
ijpds-4638	153	23	proved	prove	VERB
ijpds-4638	153	24	the	the	DET
ijpds-4638	153	25	linear	linear	ADJ
ijpds-4638	153	26	relationship	relationship	NOUN
ijpds-4638	153	27	between	between	ADP
ijpds-4638	153	28	conc	conc	NOUN
ijpds-4638	153	29	and	and	CCONJ
ijpds-4638	153	30	obtained	obtain	VERB
ijpds-4638	153	31	response	response	NOUN
ijpds-4638	153	32	.	.	PUNCT
ijpds-4638	154	1	assay	assay	VERB
ijpds-4638	154	2	:	:	PUNCT
ijpds-4638	154	3	the	the	DET
ijpds-4638	154	4	assay	assay	NOUN
ijpds-4638	154	5	was	be	AUX
ijpds-4638	154	6	carried	carry	VERB
ijpds-4638	154	7	out	out	ADP
ijpds-4638	154	8	by	by	ADP
ijpds-4638	154	9	the	the	DET
ijpds-4638	154	10	proposed	propose	VERB
ijpds-4638	154	11	method	method	NOUN
ijpds-4638	154	12	.	.	PUNCT
ijpds-4638	155	1	the	the	DET
ijpds-4638	155	2	overlaid	overlaid	ADJ
ijpds-4638	155	3	spectra	spectra	NOUN
ijpds-4638	155	4	obtained	obtain	VERB
ijpds-4638	155	5	in	in	ADP
ijpds-4638	155	6	amplitude	amplitude	NOUN
ijpds-4638	155	7	modulation	modulation	NOUN
ijpds-4638	155	8	method	method	NOUN
ijpds-4638	155	9	are	be	AUX
ijpds-4638	155	10	shown	show	VERB
ijpds-4638	155	11	in	in	ADP
ijpds-4638	155	12	fig	fig	NOUN
ijpds-4638	155	13	8	8	NUM
ijpds-4638	155	14	.	.	PUNCT
ijpds-4638	156	1	the	the	DET
ijpds-4638	156	2	assay	assay	NOUN
ijpds-4638	156	3	of	of	ADP
ijpds-4638	156	4	formulation	formulation	NOUN
ijpds-4638	156	5	was	be	AUX
ijpds-4638	156	6	carried	carry	VERB
ijpds-4638	156	7	out	out	ADP
ijpds-4638	156	8	by	by	ADP
ijpds-4638	156	9	proposed	propose	VERB
ijpds-4638	156	10	method	method	NOUN
ijpds-4638	156	11	and	and	CCONJ
ijpds-4638	156	12	calculated	calculate	VERB
ijpds-4638	156	13	%	%	NOUN
ijpds-4638	156	14	of	of	ADP
ijpds-4638	156	15	nominal	nominal	ADJ
ijpds-4638	156	16	conc	conc	NOUN
ijpds-4638	156	17	and	and	CCONJ
ijpds-4638	156	18	rsd	rsd	NOUN
ijpds-4638	156	19	was	be	AUX
ijpds-4638	156	20	found	find	VERB
ijpds-4638	156	21	within	within	ADP
ijpds-4638	156	22	acceptable	acceptable	ADJ
ijpds-4638	156	23	limits	limit	NOUN
ijpds-4638	156	24	are	be	AUX
ijpds-4638	156	25	summarized	summarize	VERB
ijpds-4638	156	26	in	in	ADP
ijpds-4638	156	27	table	table	NOUN
ijpds-4638	156	28	no	no	DET
ijpds-4638	156	29	3	3	X
ijpds-4638	156	30	.	.	PUNCT
ijpds-4638	157	1	the	the	DET
ijpds-4638	157	2	results	result	NOUN
ijpds-4638	157	3	indicated	indicate	VERB
ijpds-4638	157	4	applicability	applicability	NOUN
ijpds-4638	157	5	of	of	ADP
ijpds-4638	157	6	the	the	DET
ijpds-4638	157	7	method	method	NOUN
ijpds-4638	157	8	for	for	ADP
ijpds-4638	157	9	estimation	estimation	NOUN
ijpds-4638	157	10	of	of	ADP
ijpds-4638	157	11	formulation	formulation	NOUN
ijpds-4638	157	12	.	.	PUNCT
ijpds-4638	158	1	fig	fig	NOUN
ijpds-4638	158	2	6	6	NUM
ijpds-4638	158	3	:	:	PUNCT
ijpds-4638	158	4	normal	normal	ADJ
ijpds-4638	158	5	spectrum	spectrum	NOUN
ijpds-4638	158	6	kind	kind	ADJ
ijpds-4638	158	7	calibration	calibration	NOUN
ijpds-4638	158	8	curve	curve	NOUN
ijpds-4638	158	9	of	of	ADP
ijpds-4638	158	10	met	meet	VERB
ijpds-4638	158	11	and	and	CCONJ
ijpds-4638	158	12	cil	cil	ADJ
ijpds-4638	158	13	fig	fig	NOUN
ijpds-4638	158	14	7	7	NUM
ijpds-4638	158	15	:	:	PUNCT
ijpds-4638	158	16	calibration	calibration	NOUN
ijpds-4638	158	17	curve	curve	NOUN
ijpds-4638	158	18	of	of	ADP
ijpds-4638	158	19	met	met	NOUN
ijpds-4638	158	20	and	and	CCONJ
ijpds-4638	158	21	cil	cil	NOUN
ijpds-4638	158	22	in	in	ADP
ijpds-4638	158	23	first	first	ADJ
ijpds-4638	158	24	order	order	NOUN
ijpds-4638	158	25	derivative	derivative	ADJ
ijpds-4638	158	26	accuracy	accuracy	NOUN
ijpds-4638	158	27	and	and	CCONJ
ijpds-4638	158	28	precision	precision	NOUN
ijpds-4638	158	29	:	:	PUNCT
ijpds-4638	158	30	the	the	DET
ijpds-4638	158	31	results	result	NOUN
ijpds-4638	158	32	of	of	ADP
ijpds-4638	158	33	accuracy	accuracy	NOUN
ijpds-4638	158	34	are	be	AUX
ijpds-4638	158	35	summarised	summarise	VERB
ijpds-4638	158	36	in	in	ADP
ijpds-4638	158	37	table	table	NOUN
ijpds-4638	158	38	no	no	DET
ijpds-4638	158	39	4	4	NUM
ijpds-4638	158	40	,	,	PUNCT
ijpds-4638	158	41	the	the	DET
ijpds-4638	158	42	obtained	obtain	VERB
ijpds-4638	158	43	results	result	NOUN
ijpds-4638	158	44	were	be	AUX
ijpds-4638	158	45	within	within	ADP
ijpds-4638	158	46	acceptable	acceptable	ADJ
ijpds-4638	158	47	limit	limit	NOUN
ijpds-4638	158	48	;	;	PUNCT
ijpds-4638	158	49	and	and	CCONJ
ijpds-4638	158	50	methods	method	NOUN
ijpds-4638	158	51	accuracy	accuracy	NOUN
ijpds-4638	158	52	was	be	AUX
ijpds-4638	158	53	justified	justify	VERB
ijpds-4638	158	54	by	by	ADP
ijpds-4638	158	55	calculating	calculate	VERB
ijpds-4638	158	56	%	%	NOUN
ijpds-4638	158	57	drug	drug	NOUN
ijpds-4638	158	58	content	content	NOUN
ijpds-4638	158	59	.	.	PUNCT
ijpds-4638	159	1	the	the	DET
ijpds-4638	159	2	precision	precision	NOUN
ijpds-4638	159	3	study	study	NOUN
ijpds-4638	159	4	was	be	AUX
ijpds-4638	159	5	carried	carry	VERB
ijpds-4638	159	6	out	out	ADP
ijpds-4638	159	7	by	by	ADP
ijpds-4638	159	8	performing	perform	VERB
ijpds-4638	159	9	assay	assay	NOUN
ijpds-4638	159	10	of	of	ADP
ijpds-4638	159	11	solutions	solution	NOUN
ijpds-4638	159	12	;	;	PUNCT
ijpds-4638	159	13	further	far	ADV
ijpds-4638	159	14	the	the	DET
ijpds-4638	159	15	reproducibility	reproducibility	NOUN
ijpds-4638	159	16	in	in	ADP
ijpds-4638	159	17	result	result	NOUN
ijpds-4638	159	18	was	be	AUX
ijpds-4638	159	19	studied	study	VERB
ijpds-4638	159	20	by	by	ADP
ijpds-4638	159	21	interday	interday	NOUN
ijpds-4638	159	22	and	and	CCONJ
ijpds-4638	159	23	intraday	intraday	NOUN
ijpds-4638	159	24	precision	precision	NOUN
ijpds-4638	159	25	.	.	PUNCT
ijpds-4638	160	1	the	the	DET
ijpds-4638	160	2	values	value	NOUN
ijpds-4638	160	3	obtained	obtain	VERB
ijpds-4638	160	4	sd	sd	ADP
ijpds-4638	160	5	and	and	CCONJ
ijpds-4638	160	6	%	%	NOUN
ijpds-4638	160	7	rsd	rsd	PROPN
ijpds-4638	160	8	was	be	AUX
ijpds-4638	160	9	shown	show	VERB
ijpds-4638	160	10	methods	method	NOUN
ijpds-4638	160	11	precision	precision	NOUN
ijpds-4638	160	12	and	and	CCONJ
ijpds-4638	160	13	are	be	AUX
ijpds-4638	160	14	summarised	summarise	VERB
ijpds-4638	160	15	in	in	ADP
ijpds-4638	160	16	table	table	NOUN
ijpds-4638	160	17	no	no	DET
ijpds-4638	160	18	4	4	NUM
ijpds-4638	160	19	.	.	PUNCT
ijpds-4638	160	20	limit	limit	NOUN
ijpds-4638	160	21	of	of	ADP
ijpds-4638	160	22	detection	detection	NOUN
ijpds-4638	160	23	(	(	PUNCT
ijpds-4638	160	24	lod	lod	PROPN
ijpds-4638	160	25	)	)	PUNCT
ijpds-4638	160	26	and	and	CCONJ
ijpds-4638	160	27	limit	limit	NOUN
ijpds-4638	160	28	of	of	ADP
ijpds-4638	160	29	quantitation	quantitation	NOUN
ijpds-4638	160	30	(	(	PUNCT
ijpds-4638	160	31	loq	loq	PROPN
ijpds-4638	160	32	)	)	PUNCT
ijpds-4638	160	33	and	and	CCONJ
ijpds-4638	160	34	robustness	robustness	NOUN
ijpds-4638	160	35	and	and	CCONJ
ijpds-4638	160	36	ruggedness	ruggedness	NOUN
ijpds-4638	160	37	:	:	PUNCT
ijpds-4638	160	38	the	the	DET
ijpds-4638	160	39	lod	lod	PROPN
ijpds-4638	160	40	and	and	CCONJ
ijpds-4638	160	41	loq	loq	PROPN
ijpds-4638	160	42	of	of	ADP
ijpds-4638	160	43	cil	cil	PROPN
ijpds-4638	160	44	and	and	CCONJ
ijpds-4638	160	45	met	meet	VERB
ijpds-4638	160	46	were	be	AUX
ijpds-4638	160	47	found	find	VERB
ijpds-4638	160	48	in	in	ADP
ijpds-4638	160	49	acceptable	acceptable	ADJ
ijpds-4638	160	50	limits	limit	NOUN
ijpds-4638	160	51	by	by	ADP
ijpds-4638	160	52	the	the	DET
ijpds-4638	160	53	proposed	propose	VERB
ijpds-4638	160	54	method	method	NOUN
ijpds-4638	160	55	.	.	PUNCT
ijpds-4638	161	1	robustness	robustness	NOUN
ijpds-4638	161	2	was	be	AUX
ijpds-4638	161	3	studied	study	VERB
ijpds-4638	161	4	and	and	CCONJ
ijpds-4638	161	5	capacity	capacity	NOUN
ijpds-4638	161	6	of	of	ADP
ijpds-4638	161	7	analytical	analytical	ADJ
ijpds-4638	161	8	procedure	procedure	NOUN
ijpds-4638	161	9	to	to	PART
ijpds-4638	161	10	measure	measure	VERB
ijpds-4638	161	11	analyte	analyte	NOUN
ijpds-4638	161	12	was	be	AUX
ijpds-4638	161	13	remain	remain	VERB
ijpds-4638	161	14	unaffected	unaffected	ADJ
ijpds-4638	161	15	by	by	ADP
ijpds-4638	161	16	small	small	ADJ
ijpds-4638	161	17	but	but	CCONJ
ijpds-4638	161	18	deliberate	deliberate	ADJ
ijpds-4638	161	19	variations	variation	NOUN
ijpds-4638	161	20	in	in	ADP
ijpds-4638	161	21	method	method	NOUN
ijpds-4638	161	22	dyade	dyade	VERB
ijpds-4638	162	1	et	et	PROPN
ijpds-4638	162	2	al	al	PROPN
ijpds-4638	162	3	.	.	PROPN
ijpds-4638	162	4	qbd	qbd	PROPN
ijpds-4638	162	5	and	and	CCONJ
ijpds-4638	162	6	chemometric	chemometric	ADJ
ijpds-4638	162	7	method	method	NOUN
ijpds-4638	162	8	for	for	ADP
ijpds-4638	162	9	estimation	estimation	NOUN
ijpds-4638	162	10	of	of	ADP
ijpds-4638	162	11	metoprolol	metoprolol	NOUN
ijpds-4638	162	12	and	and	CCONJ
ijpds-4638	162	13	cilnidipine	cilnidipine	ADJ
ijpds-4638	162	14	online	online	ADJ
ijpds-4638	162	15	first	first	PROPN
ijpds-4638	162	16	indian	indian	PROPN
ijpds-4638	162	17	j	j	PROPN
ijpds-4638	162	18	pharm	pharm	PROPN
ijpds-4638	162	19	drug	drug	PROPN
ijpds-4638	162	20	studies	study	NOUN
ijpds-4638	162	21	|	|	ADV
ijpds-4638	162	22	6	6	NUM
ijpds-4638	162	23	parameter	parameter	NOUN
ijpds-4638	162	24	.	.	PUNCT
ijpds-4638	163	1	the	the	DET
ijpds-4638	163	2	analytical	analytical	ADJ
ijpds-4638	163	3	method	method	NOUN
ijpds-4638	163	4	was	be	AUX
ijpds-4638	163	5	found	find	VERB
ijpds-4638	163	6	rugged	rugged	ADJ
ijpds-4638	163	7	during	during	ADP
ijpds-4638	163	8	development	development	NOUN
ijpds-4638	163	9	;	;	PUNCT
ijpds-4638	163	10	similarity	similarity	NOUN
ijpds-4638	163	11	the	the	DET
ijpds-4638	163	12	result	result	NOUN
ijpds-4638	163	13	was	be	AUX
ijpds-4638	163	14	produced	produce	VERB
ijpds-4638	163	15	by	by	ADP
ijpds-4638	163	16	performing	perform	VERB
ijpds-4638	163	17	the	the	DET
ijpds-4638	163	18	analysis	analysis	NOUN
ijpds-4638	163	19	by	by	ADP
ijpds-4638	163	20	different	different	ADJ
ijpds-4638	163	21	analyst	analyst	NOUN
ijpds-4638	163	22	.	.	PUNCT
ijpds-4638	164	1	table	table	NOUN
ijpds-4638	164	2	no	no	DET
ijpds-4638	164	3	2	2	NUM
ijpds-4638	164	4	:	:	PUNCT
ijpds-4638	164	5	parameters	parameter	NOUN
ijpds-4638	164	6	of	of	ADP
ijpds-4638	164	7	regression	regression	NOUN
ijpds-4638	164	8	equation	equation	NOUN
ijpds-4638	164	9	obtained	obtain	VERB
ijpds-4638	164	10	in	in	ADP
ijpds-4638	164	11	microsoft	microsoft	PROPN
ijpds-4638	164	12	excel	excel	PROPN
ijpds-4638	164	13	parameters	parameter	NOUN
ijpds-4638	164	14	met	meet	VERB
ijpds-4638	164	15	cil	cil	PROPN
ijpds-4638	164	16	met	meet	VERB
ijpds-4638	164	17	cil	cil	PROPN
ijpds-4638	164	18	linearity	linearity	PROPN
ijpds-4638	164	19	study	study	NOUN
ijpds-4638	164	20	in	in	ADP
ijpds-4638	164	21	normal	normal	ADJ
ijpds-4638	164	22	linearity	linearity	NOUN
ijpds-4638	164	23	in	in	ADP
ijpds-4638	164	24	derivative	derivative	ADJ
ijpds-4638	164	25	detection	detection	NOUN
ijpds-4638	164	26	wavelength	wavelength	VERB
ijpds-4638	164	27	221	221	NUM
ijpds-4638	164	28	242	242	NUM
ijpds-4638	164	29	229.5	229.5	NUM
ijpds-4638	164	30	263	263	NUM
ijpds-4638	164	31	beer	beer	NOUN
ijpds-4638	164	32	’s	’s	PART
ijpds-4638	164	33	law	law	NOUN
ijpds-4638	164	34	limit	limit	NOUN
ijpds-4638	164	35	(	(	PUNCT
ijpds-4638	164	36	μg	μg	NOUN
ijpds-4638	164	37	/	/	SYM
ijpds-4638	164	38	ml	ml	NOUN
ijpds-4638	164	39	)	)	PUNCT
ijpds-4638	165	1	1–36	1–36	PROPN
ijpds-4638	165	2	μg	μg	PROPN
ijpds-4638	165	3	/	/	SYM
ijpds-4638	165	4	ml	ml	PROPN
ijpds-4638	165	5	1–16	1–16	PROPN
ijpds-4638	165	6	μg	μg	PROPN
ijpds-4638	165	7	/	/	SYM
ijpds-4638	165	8	ml	ml	PROPN
ijpds-4638	165	9	1–36	1–36	PROPN
ijpds-4638	165	10	μg	μg	NOUN
ijpds-4638	165	11	/	/	SYM
ijpds-4638	165	12	ml	ml	PROPN
ijpds-4638	165	13	1–16	1–16	PROPN
ijpds-4638	165	14	μg	μg	PROPN
ijpds-4638	165	15	/	/	SYM
ijpds-4638	165	16	ml	ml	NOUN
ijpds-4638	165	17	correlation	correlation	NOUN
ijpds-4638	165	18	coefficient	coefficient	NOUN
ijpds-4638	165	19	(	(	PUNCT
ijpds-4638	165	20	r2	r2	PROPN
ijpds-4638	165	21	)	)	PUNCT
ijpds-4638	165	22	0.9984	0.9984	NUM
ijpds-4638	165	23	0.9994	0.9994	NUM
ijpds-4638	165	24	0.9991	0.9991	NUM
ijpds-4638	165	25	0.9972	0.9972	NUM
ijpds-4638	165	26	regression	regression	NOUN
ijpds-4638	165	27	equation	equation	NOUN
ijpds-4638	165	28	(	(	PUNCT
ijpds-4638	165	29	y	y	NOUN
ijpds-4638	165	30	=	=	SYM
ijpds-4638	165	31	mx	mx	PROPN
ijpds-4638	166	1	+	+	CCONJ
ijpds-4638	166	2	c	c	X
ijpds-4638	166	3	)	)	PUNCT
ijpds-4638	166	4	y	y	NOUN
ijpds-4638	167	1	=	=	PUNCT
ijpds-4638	167	2	0.0317x	0.0317x	PROPN
ijpds-4638	168	1	+	+	CCONJ
ijpds-4638	168	2	0.0097	0.0097	NUM
ijpds-4638	168	3	y	y	NOUN
ijpds-4638	168	4	=	=	PUNCT
ijpds-4638	169	1	0.0797x	0.0797x	NOUN
ijpds-4638	170	1	+	+	NUM
ijpds-4638	170	2	0.0145	0.0145	NUM
ijpds-4638	170	3	y=0.0006x	y=0.0006x	NOUN
ijpds-4638	170	4	0.0001	0.0001	NUM
ijpds-4638	170	5	y=0.0015x0.0003	y=0.0015x0.0003	PROPN
ijpds-4638	170	6	table	table	NOUN
ijpds-4638	170	7	no	no	DET
ijpds-4638	170	8	3	3	NUM
ijpds-4638	170	9	:	:	PUNCT
ijpds-4638	170	10	results	result	NOUN
ijpds-4638	170	11	of	of	ADP
ijpds-4638	170	12	assay	assay	NOUN
ijpds-4638	170	13	of	of	ADP
ijpds-4638	170	14	formulation	formulation	NOUN
ijpds-4638	170	15	by	by	ADP
ijpds-4638	170	16	proposed	propose	VERB
ijpds-4638	170	17	method	method	NOUN
ijpds-4638	170	18	formula	formula	NOUN
ijpds-4638	170	19	tion	tion	NOUN
ijpds-4638	170	20	dr	dr	PROPN
ijpds-4638	170	21	ug	ug	PROPN
ijpds-4638	170	22	label	label	NOUN
ijpds-4638	170	23	claim	claim	NOUN
ijpds-4638	170	24	(	(	PUNCT
ijpds-4638	170	25	mg	mg	PROPN
ijpds-4638	170	26	/	/	SYM
ijpds-4638	170	27	ta	ta	X
ijpds-4638	170	28	blet	blet	NOUN
ijpds-4638	170	29	;	;	PUNCT
ijpds-4638	170	30	n=6	n=6	X
ijpds-4638	170	31	)	)	PUNCT
ijpds-4638	170	32	amou	amou	ADJ
ijpds-4638	170	33	nt	nt	ADP
ijpds-4638	170	34	found/	found/	NUM
ijpds-4638	170	35	mg	mg	PROPN
ijpds-4638	170	36	drug	drug	NOUN
ijpds-4638	170	37	cont	cont	PROPN
ijpds-4638	170	38	ent	ent	PROPN
ijpds-4638	170	39	%	%	NOUN
ijpds-4638	170	40	std	std	NOUN
ijpds-4638	170	41	deviat	deviat	NOUN
ijpds-4638	170	42	ion	ion	NOUN
ijpds-4638	170	43	%	%	NOUN
ijpds-4638	170	44	rsd	rsd	PROPN
ijpds-4638	170	45	methodi	methodi	PROPN
ijpds-4638	170	46	me	i	PRON
ijpds-4638	170	47	t	t	VERB
ijpds-4638	170	48	50	50	NUM
ijpds-4638	170	49	47.084	47.084	NUM
ijpds-4638	170	50	94.16	94.16	NUM
ijpds-4638	170	51	7	7	NUM
ijpds-4638	170	52	4.1614	4.1614	NUM
ijpds-4638	170	53	6	6	NUM
ijpds-4638	170	54	4.419	4.419	NUM
ijpds-4638	170	55	2	2	NUM
ijpds-4638	170	56	ci	ci	NOUN
ijpds-4638	170	57	l	l	NOUN
ijpds-4638	170	58	10	10	NUM
ijpds-4638	170	59	9.681	9.681	NUM
ijpds-4638	170	60	96.78	96.78	NUM
ijpds-4638	170	61	7	7	NUM
ijpds-4638	170	62	1.7606	1.7606	NUM
ijpds-4638	170	63	3	3	NUM
ijpds-4638	170	64	1.809	1.809	NUM
ijpds-4638	170	65	67	67	NUM
ijpds-4638	170	66	methodii	methodii	NOUN
ijpds-4638	171	1	me	i	PRON
ijpds-4638	171	2	t	t	VERB
ijpds-4638	171	3	50	50	NUM
ijpds-4638	171	4	51.886	51.886	NUM
ijpds-4638	171	5	103.7	103.7	NUM
ijpds-4638	171	6	73	73	NUM
ijpds-4638	171	7	1.8865	1.8865	NUM
ijpds-4638	171	8	1	1	NUM
ijpds-4638	171	9	1.817	1.817	NUM
ijpds-4638	171	10	91	91	NUM
ijpds-4638	171	11	ci	ci	NOUN
ijpds-4638	171	12	l	l	NOUN
ijpds-4638	171	13	10	10	NUM
ijpds-4638	171	14	9.682	9.682	NUM
ijpds-4638	171	15	96.82	96.82	NUM
ijpds-4638	171	16	5	5	NUM
ijpds-4638	171	17	2.7493	2.7493	NUM
ijpds-4638	171	18	4	4	NUM
ijpds-4638	171	19	2.839	2.839	NUM
ijpds-4638	171	20	49	49	NUM
ijpds-4638	171	21	table	table	NOUN
ijpds-4638	172	1	no	no	DET
ijpds-4638	172	2	4	4	NUM
ijpds-4638	172	3	:	:	PUNCT
ijpds-4638	172	4	results	result	NOUN
ijpds-4638	172	5	of	of	ADP
ijpds-4638	172	6	accuracy	accuracy	NOUN
ijpds-4638	172	7	and	and	CCONJ
ijpds-4638	172	8	precision	precision	NOUN
ijpds-4638	172	9	sr	sr	PROPN
ijpds-4638	172	10	.	.	PUNCT
ijpds-4638	173	1	no	no	INTJ
ijpds-4638	173	2	.	.	PUNCT
ijpds-4638	173	3	parame	parame	PROPN
ijpds-4638	173	4	ter	ter	NOUN
ijpds-4638	173	5	level	level	NOUN
ijpds-4638	173	6	of	of	ADP
ijpds-4638	173	7	study	study	NOUN
ijpds-4638	173	8	dru	dru	NOUN
ijpds-4638	173	9	g	g	PROPN
ijpds-4638	173	10	na	na	INTJ
ijpds-4638	173	11	me	i	PRON
ijpds-4638	174	1	%	%	INTJ
ijpds-4638	174	2	mean	mean	PROPN
ijpds-4638	174	3	s.d	s.d	PROPN
ijpds-4638	174	4	.	.	PROPN
ijpds-4638	174	5	%	%	PROPN
ijpds-4638	174	6	rsd	rsd	PROPN
ijpds-4638	174	7	meth	meth	PROPN
ijpds-4638	175	1	od	od	INTJ
ijpds-4638	176	1	i	i	PRON
ijpds-4638	176	2	precisi	precisi	X
ijpds-4638	176	3	on	on	ADP
ijpds-4638	176	4	intrada	intrada	PROPN
ijpds-4638	176	5	y	y	PROPN
ijpds-4638	176	6	precisi	precisi	PROPN
ijpds-4638	176	7	on	on	ADP
ijpds-4638	176	8	me	i	PRON
ijpds-4638	176	9	t	t	PROPN
ijpds-4638	176	10	94.877	94.877	NUM
ijpds-4638	176	11	%	%	NOUN
ijpds-4638	177	1	0.588	0.588	NUM
ijpds-4638	177	2	94	94	NUM
ijpds-4638	177	3	0.620	0.620	NUM
ijpds-4638	177	4	74	74	NUM
ijpds-4638	177	5	cil	cil	NOUN
ijpds-4638	177	6	97.744	97.744	NUM
ijpds-4638	177	7	%	%	NOUN
ijpds-4638	177	8	1.151	1.151	NUM
ijpds-4638	177	9	16	16	NUM
ijpds-4638	177	10	1.177	1.177	NUM
ijpds-4638	177	11	12	12	NUM
ijpds-4638	177	12	accura	accura	NOUN
ijpds-4638	177	13	cy	cy	PROPN
ijpds-4638	177	14	100	100	NUM
ijpds-4638	177	15	%	%	NOUN
ijpds-4638	177	16	me	i	PRON
ijpds-4638	177	17	t	t	PROPN
ijpds-4638	177	18	96.308	96.308	NUM
ijpds-4638	177	19	%	%	NOUN
ijpds-4638	177	20	2.048	2.048	NUM
ijpds-4638	177	21	59	59	NUM
ijpds-4638	177	22	2.127	2.127	NUM
ijpds-4638	177	23	12	12	NUM
ijpds-4638	177	24	cil	cil	NOUN
ijpds-4638	177	25	94.845	94.845	NUM
ijpds-4638	177	26	%	%	NOUN
ijpds-4638	177	27	1.263	1.263	NUM
ijpds-4638	177	28	21	21	NUM
ijpds-4638	177	29	1.331	1.331	NUM
ijpds-4638	177	30	88	88	NUM
ijpds-4638	177	31	meth	meth	NOUN
ijpds-4638	177	32	od	od	PROPN
ijpds-4638	177	33	ii	ii	PROPN
ijpds-4638	177	34	precisi	precisi	PROPN
ijpds-4638	177	35	on	on	ADP
ijpds-4638	177	36	intrada	intrada	PROPN
ijpds-4638	177	37	y	y	PROPN
ijpds-4638	177	38	precisi	precisi	PROPN
ijpds-4638	177	39	on	on	ADP
ijpds-4638	177	40	me	i	PRON
ijpds-4638	177	41	t	t	PROPN
ijpds-4638	177	42	102.06	102.06	NUM
ijpds-4638	177	43	6	6	NUM
ijpds-4638	177	44	%	%	NOUN
ijpds-4638	177	45	1.665	1.665	NUM
ijpds-4638	177	46	33	33	NUM
ijpds-4638	177	47	1.622	1.622	NUM
ijpds-4638	177	48	08	08	NUM
ijpds-4638	177	49	cil	cil	PROPN
ijpds-4638	177	50	99.476	99.476	NUM
ijpds-4638	177	51	%	%	NOUN
ijpds-4638	177	52	2.260	2.260	NUM
ijpds-4638	177	53	24	24	NUM
ijpds-4638	177	54	2.272	2.272	NUM
ijpds-4638	177	55	15	15	NUM
ijpds-4638	177	56	accura	accura	NOUN
ijpds-4638	177	57	cy	cy	PROPN
ijpds-4638	177	58	100	100	NUM
ijpds-4638	177	59	%	%	NOUN
ijpds-4638	177	60	me	i	PRON
ijpds-4638	177	61	t	t	PROPN
ijpds-4638	177	62	97.646	97.646	NUM
ijpds-4638	177	63	%	%	NOUN
ijpds-4638	177	64	1.176	1.176	NUM
ijpds-4638	177	65	75	75	NUM
ijpds-4638	177	66	1.205	1.205	NUM
ijpds-4638	177	67	11	11	NUM
ijpds-4638	177	68	cil	cil	NOUN
ijpds-4638	177	69	96.667	96.667	NUM
ijpds-4638	177	70	%	%	NOUN
ijpds-4638	177	71	1.159	1.159	NUM
ijpds-4638	177	72	71	71	NUM
ijpds-4638	177	73	1.194	1.194	NUM
ijpds-4638	177	74	52	52	NUM
ijpds-4638	177	75	fig	fig	NOUN
ijpds-4638	177	76	8	8	NUM
ijpds-4638	177	77	:	:	PUNCT
ijpds-4638	177	78	overlaid	overlay	VERB
ijpds-4638	177	79	spectra	spectra	PROPN
ijpds-4638	177	80	obtained	obtain	VERB
ijpds-4638	177	81	in	in	ADP
ijpds-4638	177	82	amplitude	amplitude	NOUN
ijpds-4638	177	83	modulation	modulation	NOUN
ijpds-4638	177	84	method	method	NOUN
ijpds-4638	177	85	dyade	dyade	VERB
ijpds-4638	177	86	et	et	PROPN
ijpds-4638	177	87	al	al	PROPN
ijpds-4638	177	88	.	.	PROPN
ijpds-4638	177	89	qbd	qbd	PROPN
ijpds-4638	177	90	and	and	CCONJ
ijpds-4638	177	91	chemometric	chemometric	ADJ
ijpds-4638	177	92	method	method	NOUN
ijpds-4638	177	93	for	for	ADP
ijpds-4638	177	94	estimation	estimation	NOUN
ijpds-4638	177	95	of	of	ADP
ijpds-4638	177	96	metoprolol	metoprolol	NOUN
ijpds-4638	177	97	and	and	CCONJ
ijpds-4638	177	98	cilnidipine	cilnidipine	ADJ
ijpds-4638	177	99	online	online	ADJ
ijpds-4638	177	100	first	first	PROPN
ijpds-4638	177	101	indian	indian	PROPN
ijpds-4638	177	102	j	j	PROPN
ijpds-4638	177	103	pharm	pharm	PROPN
ijpds-4638	177	104	drug	drug	PROPN
ijpds-4638	177	105	studies	study	NOUN
ijpds-4638	177	106	|	|	ADV
ijpds-4638	177	107	7	7	NUM
ijpds-4638	177	108	discussion	discussion	NOUN
ijpds-4638	177	109	both	both	CCONJ
ijpds-4638	177	110	the	the	DET
ijpds-4638	177	111	drugs	drug	NOUN
ijpds-4638	177	112	were	be	AUX
ijpds-4638	177	113	estimated	estimate	VERB
ijpds-4638	177	114	from	from	ADP
ijpds-4638	177	115	the	the	DET
ijpds-4638	177	116	combined	combine	VERB
ijpds-4638	177	117	formulation	formulation	NOUN
ijpds-4638	177	118	by	by	ADP
ijpds-4638	177	119	absorbance	absorbance	NOUN
ijpds-4638	177	120	correction	correction	NOUN
ijpds-4638	177	121	and	and	CCONJ
ijpds-4638	177	122	amplitude	amplitude	NOUN
ijpds-4638	177	123	modulation	modulation	NOUN
ijpds-4638	177	124	method	method	NOUN
ijpds-4638	177	125	.	.	PUNCT
ijpds-4638	178	1	results	result	NOUN
ijpds-4638	178	2	were	be	AUX
ijpds-4638	178	3	found	find	VERB
ijpds-4638	178	4	within	within	ADP
ijpds-4638	178	5	acceptable	acceptable	ADJ
ijpds-4638	178	6	limits	limit	NOUN
ijpds-4638	178	7	,	,	PUNCT
ijpds-4638	178	8	statistical	statistical	ADJ
ijpds-4638	178	9	data	datum	NOUN
ijpds-4638	178	10	obtained	obtain	VERB
ijpds-4638	178	11	were	be	AUX
ijpds-4638	178	12	shown	show	VERB
ijpds-4638	178	13	rigidity	rigidity	NOUN
ijpds-4638	178	14	of	of	ADP
ijpds-4638	178	15	the	the	DET
ijpds-4638	178	16	method	method	NOUN
ijpds-4638	178	17	.	.	PUNCT
ijpds-4638	179	1	the	the	DET
ijpds-4638	179	2	validated	validate	VERB
ijpds-4638	179	3	method	method	NOUN
ijpds-4638	179	4	was	be	AUX
ijpds-4638	179	5	employed	employ	VERB
ijpds-4638	179	6	alcohol	alcohol	NOUN
ijpds-4638	179	7	as	as	SCONJ
ijpds-4638	179	8	solvent	solvent	NOUN
ijpds-4638	179	9	thus	thus	ADV
ijpds-4638	179	10	become	become	VERB
ijpds-4638	179	11	towards	towards	ADP
ijpds-4638	179	12	eco	eco	NOUN
ijpds-4638	179	13	-	-	PUNCT
ijpds-4638	179	14	friendly	friendly	ADJ
ijpds-4638	179	15	.	.	PUNCT
ijpds-4638	180	1	conclusion	conclusion	NOUN
ijpds-4638	180	2	the	the	DET
ijpds-4638	180	3	proposed	propose	VERB
ijpds-4638	180	4	methods	method	NOUN
ijpds-4638	180	5	are	be	AUX
ijpds-4638	180	6	precise	precise	ADJ
ijpds-4638	180	7	,	,	PUNCT
ijpds-4638	180	8	accurate	accurate	ADJ
ijpds-4638	180	9	,	,	PUNCT
ijpds-4638	180	10	robust	robust	ADJ
ijpds-4638	180	11	and	and	CCONJ
ijpds-4638	180	12	reproducible	reproducible	ADJ
ijpds-4638	180	13	hence	hence	ADV
ijpds-4638	180	14	can	can	AUX
ijpds-4638	180	15	be	be	AUX
ijpds-4638	180	16	routinely	routinely	ADV
ijpds-4638	180	17	used	use	VERB
ijpds-4638	180	18	for	for	ADP
ijpds-4638	180	19	simultaneous	simultaneous	ADJ
ijpds-4638	180	20	estimation	estimation	NOUN
ijpds-4638	180	21	of	of	ADP
ijpds-4638	180	22	cilnidipine	cilnidipine	NOUN
ijpds-4638	180	23	and	and	CCONJ
ijpds-4638	180	24	metoprolol	metoprolol	NOUN
ijpds-4638	180	25	succinate	succinate	NOUN
ijpds-4638	180	26	from	from	ADP
ijpds-4638	180	27	combined	combine	VERB
ijpds-4638	180	28	dosage	dosage	NOUN
ijpds-4638	180	29	form	form	NOUN
ijpds-4638	180	30	.	.	PUNCT
ijpds-4638	181	1	references	reference	NOUN
ijpds-4638	181	2	1	1	NUM
ijpds-4638	181	3	.	.	PUNCT
ijpds-4638	182	1	the	the	DET
ijpds-4638	182	2	merck	merck	PROPN
ijpds-4638	182	3	index	index	PROPN
ijpds-4638	182	4	,	,	PUNCT
ijpds-4638	182	5	an	an	DET
ijpds-4638	182	6	encyclopaedia	encyclopaedia	NOUN
ijpds-4638	182	7	of	of	ADP
ijpds-4638	182	8	chemicals	chemical	NOUN
ijpds-4638	182	9	,	,	PUNCT
ijpds-4638	182	10	drugs	drug	NOUN
ijpds-4638	182	11	and	and	CCONJ
ijpds-4638	182	12	biological	biological	ADJ
ijpds-4638	182	13	,	,	PUNCT
ijpds-4638	182	14	15th	15th	ADJ
ijpds-4638	182	15	edition	edition	NOUN
ijpds-4638	182	16	,	,	PUNCT
ijpds-4638	182	17	the	the	DET
ijpds-4638	182	18	royal	royal	ADJ
ijpds-4638	182	19	society	society	NOUN
ijpds-4638	182	20	of	of	ADP
ijpds-4638	182	21	chemistry	chemistry	PROPN
ijpds-4638	182	22	cambridge	cambridge	PROPN
ijpds-4638	182	23	uk	uk	PROPN
ijpds-4638	182	24	,	,	PUNCT
ijpds-4638	182	25	2013	2013	NUM
ijpds-4638	182	26	,	,	PUNCT
ijpds-4638	182	27	pp	pp	ADJ
ijpds-4638	182	28	.	.	PUNCT
ijpds-4638	182	29	406	406	NUM
ijpds-4638	182	30	,	,	PUNCT
ijpds-4638	182	31	1011	1011	NUM
ijpds-4638	182	32	.	.	PUNCT
ijpds-4638	183	1	2	2	X
ijpds-4638	183	2	.	.	X
ijpds-4638	183	3	alison	alison	PROPN
ijpds-4638	183	4	brayfield	brayfield	PROPN
ijpds-4638	183	5	,	,	PUNCT
ijpds-4638	183	6	martindale	martindale	PROPN
ijpds-4638	183	7	(	(	PUNCT
ijpds-4638	183	8	the	the	DET
ijpds-4638	183	9	complete	complete	ADJ
ijpds-4638	183	10	drug	drug	NOUN
ijpds-4638	183	11	reference	reference	NOUN
ijpds-4638	183	12	)	)	PUNCT
ijpds-4638	183	13	,	,	PUNCT
ijpds-4638	183	14	39th	39th	ADJ
ijpds-4638	183	15	edition	edition	NOUN
ijpds-4638	183	16	,	,	PUNCT
ijpds-4638	183	17	pharmaceutical	pharmaceutical	NOUN
ijpds-4638	183	18	press	press	PROPN
ijpds-4638	183	19	london	london	PROPN
ijpds-4638	183	20	,	,	PUNCT
ijpds-4638	183	21	2017	2017	NUM
ijpds-4638	183	22	,	,	PUNCT
ijpds-4638	183	23	a	a	PRON
ijpds-4638	183	24	:	:	PUNCT
ijpds-4638	183	25	pp	pp	ADJ
ijpds-4638	183	26	.	.	PUNCT
ijpds-4638	183	27	ii	ii	PROPN
ijpds-4638	183	28	,	,	PUNCT
ijpds-4638	183	29	1264	1264	NUM
ijpds-4638	183	30	,	,	PUNCT
ijpds-4638	183	31	1306	1306	NUM
ijpds-4638	183	32	.	.	PUNCT
ijpds-4638	184	1	3	3	X
ijpds-4638	184	2	.	.	X
ijpds-4638	184	3	jadhav	jadhav	PROPN
ijpds-4638	184	4	r	r	PROPN
ijpds-4638	184	5	s	s	PROPN
ijpds-4638	184	6	,	,	PUNCT
ijpds-4638	184	7	ubale	ubale	ADJ
ijpds-4638	184	8	m	m	PROPN
ijpds-4638	184	9	b	b	NOUN
ijpds-4638	184	10	,	,	PUNCT
ijpds-4638	184	11	bharad	bharad	PROPN
ijpds-4638	184	12	j	j	PROPN
ijpds-4638	184	13	v.	v.	ADP
ijpds-4638	184	14	a	a	DET
ijpds-4638	184	15	simple	simple	ADJ
ijpds-4638	184	16	,	,	PUNCT
ijpds-4638	184	17	significant	significant	ADJ
ijpds-4638	184	18	uvspectroscopic	uvspectroscopic	ADJ
ijpds-4638	184	19	analytical	analytical	ADJ
ijpds-4638	184	20	method	method	NOUN
ijpds-4638	184	21	development	development	NOUN
ijpds-4638	184	22	and	and	CCONJ
ijpds-4638	184	23	validation	validation	NOUN
ijpds-4638	184	24	for	for	ADP
ijpds-4638	184	25	estimation	estimation	NOUN
ijpds-4638	184	26	of	of	ADP
ijpds-4638	184	27	formulation	formulation	NOUN
ijpds-4638	184	28	drug	drug	NOUN
ijpds-4638	184	29	product	product	NOUN
ijpds-4638	184	30	-	-	PUNCT
ijpds-4638	184	31	cilnidipine	cilnidipine	NOUN
ijpds-4638	184	32	tablet	tablet	NOUN
ijpds-4638	184	33	.	.	PUNCT
ijpds-4638	185	1	int	int	NOUN
ijpds-4638	185	2	.	.	PUNCT
ijpds-4638	186	1	j.	j.	PROPN
ijpds-4638	186	2	pharm	pharm	PROPN
ijpds-4638	186	3	.	.	PUNCT
ijpds-4638	187	1	biol	biol	PROPN
ijpds-4638	187	2	.	.	PUNCT
ijpds-4638	188	1	sci	sci	PROPN
ijpds-4638	188	2	.	.	PROPN
ijpds-4638	188	3	2018	2018	NUM
ijpds-4638	188	4	;	;	PUNCT
ijpds-4638	188	5	8(3):187	8(3):187	NUM
ijpds-4638	188	6	-	-	SYM
ijpds-4638	188	7	94	94	NUM
ijpds-4638	188	8	.	.	PUNCT
ijpds-4638	189	1	4	4	X
ijpds-4638	189	2	.	.	X
ijpds-4638	189	3	hinge	hinge	NOUN
ijpds-4638	189	4	m	m	NOUN
ijpds-4638	189	5	a	a	PRON
ijpds-4638	189	6	,	,	PUNCT
ijpds-4638	189	7	et	et	PROPN
ijpds-4638	189	8	al	al	PROPN
ijpds-4638	189	9	.	.	PROPN
ijpds-4638	189	10	development	development	PROPN
ijpds-4638	189	11	and	and	CCONJ
ijpds-4638	189	12	validation	validation	NOUN
ijpds-4638	189	13	of	of	ADP
ijpds-4638	189	14	uv	uv	NOUN
ijpds-4638	189	15	spectrophotometric	spectrophotometric	ADJ
ijpds-4638	189	16	method	method	NOUN
ijpds-4638	189	17	for	for	ADP
ijpds-4638	189	18	simultaneous	simultaneous	ADJ
ijpds-4638	189	19	estimation	estimation	NOUN
ijpds-4638	189	20	of	of	ADP
ijpds-4638	189	21	cilnidipine	cilnidipine	NOUN
ijpds-4638	189	22	and	and	CCONJ
ijpds-4638	189	23	metoprolol	metoprolol	NOUN
ijpds-4638	189	24	succinate	succinate	NOUN
ijpds-4638	189	25	in	in	ADP
ijpds-4638	189	26	bulk	bulk	ADJ
ijpds-4638	189	27	drugs	drug	NOUN
ijpds-4638	189	28	and	and	CCONJ
ijpds-4638	189	29	combined	combine	VERB
ijpds-4638	189	30	dosage	dosage	NOUN
ijpds-4638	189	31	form	form	NOUN
ijpds-4638	189	32	.	.	PUNCT
ijpds-4638	190	1	der	der	ADJ
ijpds-4638	190	2	pharmacia	pharmacia	PROPN
ijpds-4638	190	3	lettre	lettre	PROPN
ijpds-4638	190	4	.	.	PUNCT
ijpds-4638	191	1	2015	2015	NUM
ijpds-4638	191	2	;	;	PUNCT
ijpds-4638	191	3	7(7	7(7	NUM
ijpds-4638	191	4	):	):	PUNCT
ijpds-4638	191	5	299	299	NUM
ijpds-4638	191	6	-	-	SYM
ijpds-4638	191	7	306	306	NUM
ijpds-4638	191	8	.	.	PUNCT
ijpds-4638	192	1	5	5	NUM
ijpds-4638	192	2	.	.	PUNCT
ijpds-4638	192	3	kadia	kadia	PROPN
ijpds-4638	192	4	t	t	PROPN
ijpds-4638	192	5	k	k	PROPN
ijpds-4638	192	6	,	,	PUNCT
ijpds-4638	192	7	shah	shah	PROPN
ijpds-4638	192	8	d	d	PROPN
ijpds-4638	192	9	b	b	PROPN
ijpds-4638	192	10	,	,	PUNCT
ijpds-4638	192	11	dilip	dilip	PROPN
ijpds-4638	192	12	g	g	PROPN
ijpds-4638	192	13	m.	m.	NOUN
ijpds-4638	192	14	development	development	NOUN
ijpds-4638	192	15	and	and	CCONJ
ijpds-4638	192	16	validation	validation	NOUN
ijpds-4638	192	17	of	of	ADP
ijpds-4638	192	18	q	q	ADJ
ijpds-4638	192	19	-	-	PUNCT
ijpds-4638	192	20	absorbance	absorbance	NOUN
ijpds-4638	192	21	ratio	ratio	NOUN
ijpds-4638	192	22	spectrophotometric	spectrophotometric	VERB
ijpds-4638	192	23	method	method	NOUN
ijpds-4638	192	24	for	for	ADP
ijpds-4638	192	25	simultaneous	simultaneous	ADJ
ijpds-4638	192	26	estimation	estimation	NOUN
ijpds-4638	192	27	of	of	ADP
ijpds-4638	192	28	cilnidipine	cilnidipine	NOUN
ijpds-4638	192	29	and	and	CCONJ
ijpds-4638	192	30	metoprolol	metoprolol	NOUN
ijpds-4638	192	31	succinate	succinate	NOUN
ijpds-4638	192	32	in	in	ADP
ijpds-4638	192	33	bulk	bulk	NOUN
ijpds-4638	192	34	and	and	CCONJ
ijpds-4638	192	35	combined	combined	ADJ
ijpds-4638	192	36	dosage	dosage	NOUN
ijpds-4638	192	37	form	form	NOUN
ijpds-4638	192	38	.	.	PUNCT
ijpds-4638	193	1	int	int	NOUN
ijpds-4638	193	2	.	.	PUNCT
ijpds-4638	194	1	j.	j.	PROPN
ijpds-4638	194	2	pharm	pharm	PROPN
ijpds-4638	194	3	.	.	PUNCT
ijpds-4638	195	1	pharm	pharm	PROPN
ijpds-4638	195	2	.	.	PUNCT
ijpds-4638	196	1	sci	sci	PROPN
ijpds-4638	196	2	.	.	PUNCT
ijpds-4638	197	1	2014;6(6):401407	2014;6(6):401407	NUM
ijpds-4638	197	2	.	.	NOUN
ijpds-4638	197	3	6	6	NUM
ijpds-4638	197	4	.	.	X
ijpds-4638	197	5	sankar	sankar	NOUN
ijpds-4638	197	6	p	p	PROPN
ijpds-4638	197	7	r	r	PROPN
ijpds-4638	197	8	,	,	PUNCT
ijpds-4638	197	9	swathi	swathi	NOUN
ijpds-4638	197	10	v	v	NOUN
ijpds-4638	197	11	,	,	PUNCT
ijpds-4638	197	12	babu	babu	PROPN
ijpds-4638	197	13	p	p	PROPN
ijpds-4638	197	14	s.	s.	PROPN
ijpds-4638	197	15	development	development	PROPN
ijpds-4638	197	16	and	and	CCONJ
ijpds-4638	197	17	validation	validation	NOUN
ijpds-4638	197	18	of	of	ADP
ijpds-4638	197	19	novel	novel	NOUN
ijpds-4638	197	20	uv	uv	NOUN
ijpds-4638	197	21	and	and	CCONJ
ijpds-4638	197	22	rp	rp	NOUN
ijpds-4638	197	23	-	-	PUNCT
ijpds-4638	197	24	hplc	hplc	NOUN
ijpds-4638	197	25	methods	method	NOUN
ijpds-4638	197	26	for	for	ADP
ijpds-4638	197	27	determination	determination	NOUN
ijpds-4638	197	28	of	of	ADP
ijpds-4638	197	29	cilnidipine	cilnidipine	NOUN
ijpds-4638	197	30	(	(	PUNCT
ijpds-4638	197	31	a	a	DET
ijpds-4638	197	32	new	new	ADJ
ijpds-4638	197	33	generation	generation	NOUN
ijpds-4638	197	34	ca	can	AUX
ijpds-4638	197	35	channel	channel	NOUN
ijpds-4638	197	36	blocker	blocker	NOUN
ijpds-4638	197	37	)	)	PUNCT
ijpds-4638	197	38	in	in	ADP
ijpds-4638	197	39	pharmaceutical	pharmaceutical	ADJ
ijpds-4638	197	40	dosage	dosage	NOUN
ijpds-4638	197	41	form	form	NOUN
ijpds-4638	197	42	.	.	PUNCT
ijpds-4638	198	1	international	international	ADJ
ijpds-4638	198	2	journal	journal	PROPN
ijpds-4638	198	3	of	of	ADP
ijpds-4638	198	4	pharmaceutical	pharmaceutical	NOUN
ijpds-4638	198	5	sciences	science	NOUN
ijpds-4638	198	6	and	and	CCONJ
ijpds-4638	198	7	research	research	NOUN
ijpds-4638	198	8	.	.	PUNCT
ijpds-4638	199	1	2019	2019	NUM
ijpds-4638	199	2	;	;	PUNCT
ijpds-4638	199	3	10(4	10(4	NUM
ijpds-4638	199	4	):	):	PUNCT
ijpds-4638	199	5	1886	1886	NUM
ijpds-4638	199	6	-	-	SYM
ijpds-4638	199	7	1894	1894	NUM
ijpds-4638	199	8	.	.	PUNCT
ijpds-4638	200	1	7	7	X
ijpds-4638	200	2	.	.	X
ijpds-4638	200	3	tiwari	tiwari	PROPN
ijpds-4638	200	4	b	b	NUM
ijpds-4638	200	5	,	,	PUNCT
ijpds-4638	200	6	shirsat	shirsat	NOUN
ijpds-4638	200	7	m	m	VERB
ijpds-4638	200	8	k	k	NOUN
ijpds-4638	200	9	,	,	PUNCT
ijpds-4638	200	10	kulkarni	kulkarni	PROPN
ijpds-4638	200	11	a.	a.	PROPN
ijpds-4638	200	12	development	development	PROPN
ijpds-4638	200	13	and	and	CCONJ
ijpds-4638	200	14	validation	validation	NOUN
ijpds-4638	200	15	of	of	ADP
ijpds-4638	200	16	stability	stability	NOUN
ijpds-4638	200	17	indicating	indicate	VERB
ijpds-4638	200	18	rp	rp	NOUN
ijpds-4638	200	19	-	-	PUNCT
ijpds-4638	200	20	hplc	hplc	NOUN
ijpds-4638	200	21	method	method	NOUN
ijpds-4638	200	22	for	for	ADP
ijpds-4638	200	23	estimation	estimation	NOUN
ijpds-4638	200	24	of	of	ADP
ijpds-4638	200	25	cilnidipine	cilnidipine	PROPN
ijpds-4638	200	26	.	.	PUNCT
ijpds-4638	201	1	journal	journal	PROPN
ijpds-4638	201	2	of	of	ADP
ijpds-4638	201	3	drug	drug	NOUN
ijpds-4638	201	4	delivery	delivery	NOUN
ijpds-4638	201	5	and	and	CCONJ
ijpds-4638	201	6	therapeutics	therapeutic	NOUN
ijpds-4638	201	7	.	.	PUNCT
ijpds-4638	202	1	2020;10(1	2020;10(1	NUM
ijpds-4638	202	2	):	):	PUNCT
ijpds-4638	202	3	97	97	NUM
ijpds-4638	202	4	-	-	SYM
ijpds-4638	202	5	100	100	NUM
ijpds-4638	202	6	.	.	PUNCT
ijpds-4638	203	1	8	8	X
ijpds-4638	203	2	.	.	PUNCT
ijpds-4638	204	1	marques	marques	PROPN
ijpds-4638	204	2	s	s	PART
ijpds-4638	204	3	m	m	PROPN
ijpds-4638	204	4	,	,	PUNCT
ijpds-4638	204	5	shirodkar	shirodkar	PROPN
ijpds-4638	204	6	r	r	PROPN
ijpds-4638	204	7	k	k	PROPN
ijpds-4638	204	8	,	,	PUNCT
ijpds-4638	204	9	kumar	kumar	PROPN
ijpds-4638	204	10	analytical	analytical	ADJ
ijpds-4638	204	11	‘	'	PUNCT
ijpds-4638	204	12	quality	quality	NOUN
ijpds-4638	204	13	-	-	PUNCT
ijpds-4638	204	14	bydesign’paradigm	bydesign’paradigm	NOUN
ijpds-4638	204	15	in	in	ADP
ijpds-4638	204	16	development	development	NOUN
ijpds-4638	204	17	of	of	ADP
ijpds-4638	204	18	a	a	DET
ijpds-4638	204	19	rp	rp	NOUN
ijpds-4638	204	20	-	-	PUNCT
ijpds-4638	204	21	hplc	hplc	NOUN
ijpds-4638	204	22	method	method	NOUN
ijpds-4638	204	23	for	for	ADP
ijpds-4638	204	24	the	the	DET
ijpds-4638	204	25	estimation	estimation	NOUN
ijpds-4638	204	26	of	of	ADP
ijpds-4638	204	27	cilnidipine	cilnidipine	NOUN
ijpds-4638	204	28	in	in	ADP
ijpds-4638	204	29	nanoformulations	nanoformulation	NOUN
ijpds-4638	204	30	:	:	PUNCT
ijpds-4638	204	31	forced	force	VERB
ijpds-4638	204	32	degradation	degradation	NOUN
ijpds-4638	204	33	studies	study	NOUN
ijpds-4638	204	34	and	and	CCONJ
ijpds-4638	204	35	mathematical	mathematical	ADJ
ijpds-4638	204	36	modelling	modelling	NOUN
ijpds-4638	204	37	of	of	ADP
ijpds-4638	204	38	in	in	ADP
ijpds-4638	204	39	-	-	PUNCT
ijpds-4638	204	40	vitro	vitro	X
ijpds-4638	204	41	release	release	NOUN
ijpds-4638	204	42	studies	study	NOUN
ijpds-4638	204	43	.	.	PUNCT
ijpds-4638	204	44	microchemical	microchemical	ADJ
ijpds-4638	204	45	journal	journal	NOUN
ijpds-4638	204	46	.	.	PUNCT
ijpds-4638	205	1	2023	2023	NUM
ijpds-4638	205	2	;	;	PUNCT
ijpds-4638	205	3	193	193	NUM
ijpds-4638	205	4	:	:	PUNCT
ijpds-4638	205	5	doi.org/10.1016/j.microc.2023.109124	doi.org/10.1016/j.microc.2023.109124	NUM
ijpds-4638	205	6	.	.	PUNCT
ijpds-4638	206	1	9	9	X
ijpds-4638	206	2	.	.	X
ijpds-4638	206	3	shah	shah	PROPN
ijpds-4638	206	4	p	p	PROPN
ijpds-4638	206	5	,	,	PUNCT
ijpds-4638	206	6	dhaduk	dhaduk	PROPN
ijpds-4638	206	7	b.	b.	PROPN
ijpds-4638	206	8	rp	rp	NOUN
ijpds-4638	206	9	-	-	PUNCT
ijpds-4638	206	10	hplc	hplc	NOUN
ijpds-4638	206	11	in	in	ADP
ijpds-4638	206	12	-	-	PUNCT
ijpds-4638	206	13	vitro	vitro	X
ijpds-4638	206	14	dissolution	dissolution	NOUN
ijpds-4638	206	15	method	method	NOUN
ijpds-4638	206	16	development	development	NOUN
ijpds-4638	206	17	and	and	CCONJ
ijpds-4638	206	18	validation	validation	NOUN
ijpds-4638	206	19	for	for	ADP
ijpds-4638	206	20	determination	determination	NOUN
ijpds-4638	206	21	of	of	ADP
ijpds-4638	206	22	olmesartan	olmesartan	PROPN
ijpds-4638	206	23	medoxomil	medoxomil	PROPN
ijpds-4638	206	24	,	,	PUNCT
ijpds-4638	206	25	chlorthalidone	chlorthalidone	NOUN
ijpds-4638	206	26	and	and	CCONJ
ijpds-4638	206	27	cilnidipine	cilnidipine	ADJ
ijpds-4638	206	28	drug	drug	NOUN
ijpds-4638	206	29	combinations	combination	NOUN
ijpds-4638	206	30	.	.	PUNCT
ijpds-4638	207	1	current	current	ADJ
ijpds-4638	207	2	pharmaceutical	pharmaceutical	ADJ
ijpds-4638	207	3	analysis	analysis	NOUN
ijpds-4638	207	4	.	.	PUNCT
ijpds-4638	208	1	2022	2022	NUM
ijpds-4638	208	2	;	;	PUNCT
ijpds-4638	208	3	18(6	18(6	NUM
ijpds-4638	208	4	):	):	PUNCT
ijpds-4638	208	5	629	629	NUM
ijpds-4638	208	6	-	-	SYM
ijpds-4638	208	7	641	641	NUM
ijpds-4638	208	8	.	.	PUNCT
ijpds-4638	208	9	10	10	NUM
ijpds-4638	208	10	sawaikar	sawaikar	ADJ
ijpds-4638	208	11	kapupara	kapupara	PROPN
ijpds-4638	208	12	p.	p.	PROPN
ijpds-4638	208	13	development	development	PROPN
ijpds-4638	208	14	and	and	CCONJ
ijpds-4638	208	15	validation	validation	NOUN
ijpds-4638	208	16	of	of	ADP
ijpds-4638	208	17	a	a	DET
ijpds-4638	208	18	stability	stability	NOUN
ijpds-4638	208	19	indicating	indicate	VERB
ijpds-4638	208	20	rp	rp	NOUN
ijpds-4638	208	21	-	-	PUNCT
ijpds-4638	208	22	hplc	hplc	NOUN
ijpds-4638	208	23	method	method	NOUN
ijpds-4638	208	24	for	for	ADP
ijpds-4638	208	25	the	the	DET
ijpds-4638	208	26	estimation	estimation	NOUN
ijpds-4638	208	27	of	of	ADP
ijpds-4638	208	28	chlorthalidone	chlorthalidone	NOUN
ijpds-4638	208	29	and	and	CCONJ
ijpds-4638	208	30	cilnidipine	cilnidipine	NOUN
ijpds-4638	208	31	in	in	ADP
ijpds-4638	208	32	combined	combine	VERB
ijpds-4638	208	33	pharmaceutical	pharmaceutical	ADJ
ijpds-4638	208	34	dosage	dosage	NOUN
ijpds-4638	208	35	form	form	NOUN
ijpds-4638	208	36	.	.	PUNCT
ijpds-4638	209	1	research	research	NOUN
ijpds-4638	209	2	journal	journal	PROPN
ijpds-4638	209	3	of	of	ADP
ijpds-4638	209	4	pharmacy	pharmacy	NOUN
ijpds-4638	209	5	and	and	CCONJ
ijpds-4638	209	6	technology	technology	NOUN
ijpds-4638	209	7	.	.	PUNCT
ijpds-4638	210	1	2020	2020	NUM
ijpds-4638	210	2	;	;	PUNCT
ijpds-4638	210	3	13(5):23762380	13(5):23762380	NUM
ijpds-4638	210	4	.	.	NOUN
ijpds-4638	210	5	11	11	NUM
ijpds-4638	210	6	dagariya	dagariya	NOUN
ijpds-4638	210	7	r	r	PROPN
ijpds-4638	210	8	k	k	PROPN
ijpds-4638	210	9	,	,	PUNCT
ijpds-4638	210	10	jat	jat	PROPN
ijpds-4638	210	11	r	r	PROPN
ijpds-4638	210	12	k.	k.	PROPN
ijpds-4638	210	13	method	method	PROPN
ijpds-4638	210	14	development	development	NOUN
ijpds-4638	210	15	and	and	CCONJ
ijpds-4638	210	16	validation	validation	NOUN
ijpds-4638	210	17	of	of	ADP
ijpds-4638	210	18	irbesartan	irbesartan	PROPN
ijpds-4638	210	19	chlorthalidone	chlorthalidone	NOUN
ijpds-4638	210	20	and	and	CCONJ
ijpds-4638	210	21	cilnidipine	cilnidipine	NOUN
ijpds-4638	210	22	in	in	ADP
ijpds-4638	210	23	their	their	PRON
ijpds-4638	210	24	combined	combine	VERB
ijpds-4638	210	25	tablet	tablet	NOUN
ijpds-4638	210	26	dosage	dosage	NOUN
ijpds-4638	210	27	form	form	NOUN
ijpds-4638	210	28	by	by	ADP
ijpds-4638	210	29	high	high	ADJ
ijpds-4638	210	30	performance	performance	NOUN
ijpds-4638	210	31	liquid	liquid	NOUN
ijpds-4638	210	32	chromatography	chromatography	NOUN
ijpds-4638	210	33	.	.	PUNCT
ijpds-4638	211	1	journal	journal	PROPN
ijpds-4638	211	2	of	of	ADP
ijpds-4638	211	3	drug	drug	NOUN
ijpds-4638	211	4	delivery	delivery	NOUN
ijpds-4638	211	5	and	and	CCONJ
ijpds-4638	211	6	therapeutics	therapeutic	NOUN
ijpds-4638	211	7	.	.	PUNCT
ijpds-4638	212	1	2017	2017	NUM
ijpds-4638	212	2	;	;	PUNCT
ijpds-4638	212	3	7(4	7(4	NUM
ijpds-4638	212	4	):	):	PUNCT
ijpds-4638	212	5	88	88	NUM
ijpds-4638	212	6	-	-	SYM
ijpds-4638	212	7	96	96	NUM
ijpds-4638	212	8	.	.	NOUN
ijpds-4638	213	1	12	12	NUM
ijpds-4638	213	2	hinge	hinge	NOUN
ijpds-4638	213	3	m	m	VERB
ijpds-4638	213	4	a	a	INTJ
ijpds-4638	213	5	,	,	PUNCT
ijpds-4638	213	6	et	et	PROPN
ijpds-4638	213	7	al	al	PROPN
ijpds-4638	213	8	.	.	PROPN
ijpds-4638	213	9	analytical	analytical	ADJ
ijpds-4638	213	10	method	method	PROPN
ijpds-4638	213	11	development	development	NOUN
ijpds-4638	213	12	and	and	CCONJ
ijpds-4638	213	13	validation	validation	NOUN
ijpds-4638	213	14	for	for	ADP
ijpds-4638	213	15	simultaneous	simultaneous	ADJ
ijpds-4638	213	16	estimation	estimation	NOUN
ijpds-4638	213	17	of	of	ADP
ijpds-4638	213	18	cilnidipine	cilnidipine	NOUN
ijpds-4638	213	19	and	and	CCONJ
ijpds-4638	213	20	metoprolol	metoprolol	NOUN
ijpds-4638	213	21	succinate	succinate	NOUN
ijpds-4638	213	22	by	by	ADP
ijpds-4638	213	23	rp	rp	NOUN
ijpds-4638	213	24	-	-	PUNCT
ijpds-4638	213	25	hplc	hplc	NOUN
ijpds-4638	213	26	.	.	PUNCT
ijpds-4638	214	1	der	der	ADJ
ijpds-4638	214	2	pharmacia	pharmacia	PROPN
ijpds-4638	214	3	lett	lett	PROPN
ijpds-4638	214	4	.	.	PUNCT
ijpds-4638	215	1	2015;7(5):333	2015;7(5):333	NUM
ijpds-4638	215	2	-	-	SYM
ijpds-4638	215	3	40	40	NUM
ijpds-4638	215	4	.	.	PUNCT
ijpds-4638	215	5	13	13	NUM
ijpds-4638	215	6	horyn	horyn	PROPN
ijpds-4638	215	7	m	m	PROPN
ijpds-4638	215	8	,	,	PUNCT
ijpds-4638	215	9	piponsni	piponsni	PROPN
ijpds-4638	215	10	m	m	PROPN
ijpds-4638	215	11	,	,	PUNCT
ijpds-4638	215	12	melnyn	melnyn	PROPN
ijpds-4638	215	13	o	o	NOUN
ijpds-4638	215	14	,	,	PUNCT
ijpds-4638	215	15	et.al	et.al	PROPN
ijpds-4638	215	16	.	.	PUNCT
ijpds-4638	216	1	development	development	NOUN
ijpds-4638	216	2	of	of	ADP
ijpds-4638	216	3	the	the	DET
ijpds-4638	216	4	spectrophotometric	spectrophotometric	ADJ
ijpds-4638	216	5	method	method	NOUN
ijpds-4638	216	6	for	for	ADP
ijpds-4638	216	7	the	the	DET
ijpds-4638	216	8	determination	determination	NOUN
ijpds-4638	216	9	of	of	ADP
ijpds-4638	216	10	metoprolol	metoprolol	NOUN
ijpds-4638	216	11	in	in	ADP
ijpds-4638	216	12	tablets	tablet	NOUN
ijpds-4638	216	13	by	by	ADP
ijpds-4638	216	14	using	use	VERB
ijpds-4638	216	15	bromothymol	bromothymol	PROPN
ijpds-4638	216	16	blue	blue	NOUN
ijpds-4638	216	17	.	.	PUNCT
ijpds-4638	217	1	methods	method	NOUN
ijpds-4638	217	2	and	and	CCONJ
ijpds-4638	217	3	objects	object	NOUN
ijpds-4638	217	4	of	of	ADP
ijpds-4638	217	5	chemical	chemical	ADJ
ijpds-4638	217	6	analysis	analysis	NOUN
ijpds-4638	217	7	.	.	PUNCT
ijpds-4638	218	1	2023	2023	NUM
ijpds-4638	218	2	;	;	PUNCT
ijpds-4638	218	3	18(2):63	18(2):63	NUM
ijpds-4638	218	4	-	-	SYM
ijpds-4638	218	5	69	69	NUM
ijpds-4638	218	6	.	.	PUNCT
ijpds-4638	219	1	14	14	NUM
ijpds-4638	219	2	pagar	pagar	NOUN
ijpds-4638	219	3	s	s	NOUN
ijpds-4638	219	4	a	a	PRON
ijpds-4638	219	5	,	,	PUNCT
ijpds-4638	219	6	shinkar	shinkar	PROPN
ijpds-4638	219	7	d	d	PROPN
ijpds-4638	219	8	m	m	PROPN
ijpds-4638	219	9	,	,	PUNCT
ijpds-4638	219	10	saudagar	saudagar	NOUN
ijpds-4638	219	11	r	r	PROPN
ijpds-4638	219	12	b.	b.	PROPN
ijpds-4638	219	13	development	development	NOUN
ijpds-4638	219	14	and	and	CCONJ
ijpds-4638	219	15	validation	validation	NOUN
ijpds-4638	219	16	of	of	ADP
ijpds-4638	219	17	spectrophotometric	spectrophotometric	ADJ
ijpds-4638	219	18	method	method	NOUN
ijpds-4638	219	19	for	for	ADP
ijpds-4638	219	20	determination	determination	NOUN
ijpds-4638	219	21	of	of	ADP
ijpds-4638	219	22	metoprolol	metoprolol	PROPN
ijpds-4638	219	23	succinate	succinate	NOUN
ijpds-4638	219	24	.	.	PUNCT
ijpds-4638	220	1	int	int	PROPN
ijpds-4638	220	2	j	j	PROPN
ijpds-4638	220	3	pharm	pharm	PROPN
ijpds-4638	220	4	biol	biol	PROPN
ijpds-4638	220	5	sci	sci	PROPN
ijpds-4638	220	6	.	.	PROPN
ijpds-4638	220	7	2013	2013	NUM
ijpds-4638	220	8	;	;	PUNCT
ijpds-4638	220	9	3(4	3(4	NUM
ijpds-4638	220	10	):	):	PUNCT
ijpds-4638	220	11	224	224	NUM
ijpds-4638	220	12	-	-	SYM
ijpds-4638	220	13	228	228	NUM
ijpds-4638	220	14	.	.	NOUN
ijpds-4638	220	15	15	15	NUM
ijpds-4638	220	16	verma	verma	PROPN
ijpds-4638	220	17	n	n	CCONJ
ijpds-4638	220	18	,	,	PUNCT
ijpds-4638	220	19	ghosh	ghosh	PROPN
ijpds-4638	220	20	a	a	PROPN
ijpds-4638	221	1	k	k	NOUN
ijpds-4638	221	2	,	,	PUNCT
ijpds-4638	221	3	chattopadhyay	chattopadhyay	PROPN
ijpds-4638	222	1	p.	p.	PROPN
ijpds-4638	222	2	uv	uv	NOUN
ijpds-4638	222	3	-	-	PUNCT
ijpds-4638	222	4	spectrophotometric	spectrophotometric	VERB
ijpds-4638	222	5	determination	determination	NOUN
ijpds-4638	222	6	of	of	ADP
ijpds-4638	222	7	metoprolol	metoprolol	PROPN
ijpds-4638	222	8	succinate	succinate	NOUN
ijpds-4638	222	9	.	.	PUNCT
ijpds-4638	223	1	research	research	PROPN
ijpds-4638	223	2	journal	journal	PROPN
ijpds-4638	223	3	of	of	ADP
ijpds-4638	223	4	pharmacy	pharmacy	NOUN
ijpds-4638	223	5	and	and	CCONJ
ijpds-4638	223	6	technology	technology	NOUN
ijpds-4638	223	7	.	.	PUNCT
ijpds-4638	224	1	2011	2011	NUM
ijpds-4638	224	2	;	;	PUNCT
ijpds-4638	224	3	4(2):271	4(2):271	NUM
ijpds-4638	224	4	-	-	SYM
ijpds-4638	224	5	2	2	NUM
ijpds-4638	224	6	.	.	NUM
ijpds-4638	224	7	16	16	NUM
ijpds-4638	224	8	kulkarni	kulkarni	PROPN
ijpds-4638	224	9	m	m	PROPN
ijpds-4638	224	10	n	n	NOUN
ijpds-4638	224	11	,	,	PUNCT
ijpds-4638	224	12	kshirsagar	kshirsagar	NOUN
ijpds-4638	224	13	r	r	NOUN
ijpds-4638	224	14	v	v	NOUN
ijpds-4638	224	15	,	,	PUNCT
ijpds-4638	224	16	sakarkar	sakarkar	NOUN
ijpds-4638	224	17	d	d	PROPN
ijpds-4638	224	18	m.	m.	NOUN
ijpds-4638	224	19	development	development	NOUN
ijpds-4638	224	20	and	and	CCONJ
ijpds-4638	224	21	validation	validation	NOUN
ijpds-4638	224	22	of	of	ADP
ijpds-4638	224	23	spectrophotometric	spectrophotometric	ADJ
ijpds-4638	224	24	method	method	NOUN
ijpds-4638	224	25	for	for	ADP
ijpds-4638	224	26	determination	determination	NOUN
ijpds-4638	224	27	of	of	ADP
ijpds-4638	224	28	metoprolol	metoprolol	PROPN
ijpds-4638	224	29	succinate	succinate	NOUN
ijpds-4638	224	30	.	.	PUNCT
ijpds-4638	225	1	international	international	ADJ
ijpds-4638	225	2	journal	journal	NOUN
ijpds-4638	225	3	of	of	ADP
ijpds-4638	225	4	chemtech	chemtech	NOUN
ijpds-4638	225	5	research	research	NOUN
ijpds-4638	225	6	.	.	PUNCT
ijpds-4638	226	1	2009;1(4	2009;1(4	NUM
ijpds-4638	226	2	):	):	PUNCT
ijpds-4638	226	3	1273	1273	NUM
ijpds-4638	226	4	-	-	SYM
ijpds-4638	226	5	1277	1277	NUM
ijpds-4638	226	6	.	.	PUNCT
ijpds-4638	227	1	17	17	NUM
ijpds-4638	227	2	vyas	vyas	PROPN
ijpds-4638	227	3	k	k	PROPN
ijpds-4638	227	4	h	h	PROPN
ijpds-4638	227	5	,	,	PUNCT
ijpds-4638	227	6	soniwala	soniwala	NOUN
ijpds-4638	227	7	m	m	PROPN
ijpds-4638	227	8	,	,	PUNCT
ijpds-4638	227	9	vyas	vyas	PROPN
ijpds-4638	227	10	a	a	PROPN
ijpds-4638	227	11	,	,	PUNCT
ijpds-4638	227	12	et	et	PROPN
ijpds-4638	227	13	al	al	PROPN
ijpds-4638	227	14	.	.	PUNCT
ijpds-4638	227	15	development	development	NOUN
ijpds-4638	227	16	of	of	ADP
ijpds-4638	227	17	a	a	DET
ijpds-4638	227	18	uv	uv	NOUN
ijpds-4638	227	19	visible	visible	ADJ
ijpds-4638	227	20	spectrophotometric	spectrophotometric	ADJ
ijpds-4638	227	21	method	method	NOUN
ijpds-4638	227	22	for	for	ADP
ijpds-4638	227	23	simultaneous	simultaneous	ADJ
ijpds-4638	227	24	estimation	estimation	NOUN
ijpds-4638	227	25	of	of	ADP
ijpds-4638	227	26	ranolazine	ranolazine	NOUN
ijpds-4638	227	27	and	and	CCONJ
ijpds-4638	227	28	metoprolol	metoprolol	PROPN
ijpds-4638	227	29	.	.	PUNCT
ijpds-4638	228	1	journal	journal	PROPN
ijpds-4638	228	2	of	of	ADP
ijpds-4638	228	3	drug	drug	NOUN
ijpds-4638	228	4	delivery	delivery	NOUN
ijpds-4638	228	5	and	and	CCONJ
ijpds-4638	228	6	therapeutics	therapeutic	NOUN
ijpds-4638	228	7	.	.	PUNCT
ijpds-4638	229	1	2022	2022	NUM
ijpds-4638	229	2	;	;	PUNCT
ijpds-4638	230	1	12(3	12(3	NUM
ijpds-4638	230	2	-	-	SYM
ijpds-4638	230	3	s	s	NOUN
ijpds-4638	230	4	):	):	PUNCT
ijpds-4638	230	5	64	64	NUM
ijpds-4638	230	6	-	-	SYM
ijpds-4638	230	7	72	72	NUM
ijpds-4638	230	8	.	.	PUNCT
ijpds-4638	230	9	18	18	NUM
ijpds-4638	230	10	alekhya	alekhya	PROPN
ijpds-4638	230	11	b	b	NUM
ijpds-4638	230	12	,	,	PUNCT
ijpds-4638	230	13	sindhusha	sindhusha	PROPN
ijpds-4638	230	14	m	m	PRON
ijpds-4638	230	15	,	,	PUNCT
ijpds-4638	230	16	soraj	soraj	ADJ
ijpds-4638	230	17	k	k	PROPN
ijpds-4638	230	18	,	,	PUNCT
ijpds-4638	230	19	et	et	PROPN
ijpds-4638	230	20	al	al	PROPN
ijpds-4638	230	21	.	.	PUNCT
ijpds-4638	231	1	a	a	DET
ijpds-4638	231	2	new	new	ADJ
ijpds-4638	231	3	validated	validated	ADJ
ijpds-4638	231	4	third	third	ADJ
ijpds-4638	231	5	order	order	NOUN
ijpds-4638	231	6	derivative	derivative	ADJ
ijpds-4638	231	7	spectroscopic	spectroscopic	NOUN
ijpds-4638	231	8	method	method	NOUN
ijpds-4638	231	9	for	for	ADP
ijpds-4638	231	10	simultaneous	simultaneous	ADJ
ijpds-4638	231	11	estimation	estimation	NOUN
ijpds-4638	231	12	of	of	ADP
ijpds-4638	231	13	metoprolol	metoprolol	PROPN
ijpds-4638	231	14	succinate	succinate	NOUN
ijpds-4638	231	15	and	and	CCONJ
ijpds-4638	231	16	ramipril	ramipril	NOUN
ijpds-4638	231	17	in	in	ADP
ijpds-4638	231	18	tablet	tablet	ADJ
ijpds-4638	231	19	dosage	dosage	NOUN
ijpds-4638	231	20	form	form	NOUN
ijpds-4638	231	21	.	.	PUNCT
ijpds-4638	232	1	international	international	ADJ
ijpds-4638	232	2	journal	journal	PROPN
ijpds-4638	232	3	of	of	ADP
ijpds-4638	232	4	pharmacy	pharmacy	NOUN
ijpds-4638	232	5	and	and	CCONJ
ijpds-4638	232	6	pharmaceutical	pharmaceutical	NOUN
ijpds-4638	232	7	sciences	science	NOUN
ijpds-4638	232	8	.	.	PUNCT
ijpds-4638	233	1	2020;12(5	2020;12(5	NUM
ijpds-4638	233	2	)	)	PUNCT
ijpds-4638	233	3	.	.	PUNCT
ijpds-4638	234	1	54	54	NUM
ijpds-4638	234	2	-	-	SYM
ijpds-4638	234	3	59	59	NUM
ijpds-4638	234	4	.	.	PUNCT
ijpds-4638	234	5	19	19	NUM
ijpds-4638	234	6	dhole	dhole	NOUN
ijpds-4638	234	7	s	s	PART
ijpds-4638	234	8	m	m	NOUN
ijpds-4638	234	9	,	,	PUNCT
ijpds-4638	234	10	chaple	chaple	ADJ
ijpds-4638	234	11	d	d	X
ijpds-4638	234	12	r	r	PROPN
ijpds-4638	234	13	,	,	PUNCT
ijpds-4638	234	14	harde	harde	NOUN
ijpds-4638	234	15	m	m	VERB
ijpds-4638	234	16	t.	t.	PROPN
ijpds-4638	234	17	validated	validate	VERB
ijpds-4638	234	18	uv	uv	NOUN
ijpds-4638	234	19	spectrophotometric	spectrophotometric	ADJ
ijpds-4638	234	20	method	method	NOUN
ijpds-4638	234	21	for	for	ADP
ijpds-4638	234	22	simultaneous	simultaneous	ADJ
ijpds-4638	234	23	estimation	estimation	NOUN
ijpds-4638	234	24	of	of	ADP
ijpds-4638	234	25	metoprolol	metoprolol	PROPN
ijpds-4638	234	26	succinate	succinate	NOUN
ijpds-4638	234	27	and	and	CCONJ
ijpds-4638	234	28	amlodipine	amlodipine	NOUN
ijpds-4638	234	29	besylate	besylate	ADJ
ijpds-4638	234	30	in	in	ADP
ijpds-4638	234	31	their	their	PRON
ijpds-4638	234	32	combined	combine	VERB
ijpds-4638	234	33	tablet	tablet	NOUN
ijpds-4638	234	34	dosage	dosage	NOUN
ijpds-4638	234	35	form	form	NOUN
ijpds-4638	234	36	.	.	PUNCT
ijpds-4638	235	1	int	int	NOUN
ijpds-4638	235	2	.	.	PUNCT
ijpds-4638	236	1	j.	j.	PROPN
ijpds-4638	236	2	ana	ana	PROPN
ijpds-4638	236	3	.	.	PROPN
ijpds-4638	237	1	bio	bio	PROPN
ijpds-4638	237	2	.	.	PROPN
ijpds-4638	237	3	chem	chem	PROPN
ijpds-4638	237	4	.	.	PUNCT
ijpds-4638	238	1	2013	2013	NUM
ijpds-4638	238	2	;	;	PUNCT
ijpds-4638	238	3	3(3):82	3(3):82	NUM
ijpds-4638	238	4	-	-	SYM
ijpds-4638	238	5	85	85	NUM
ijpds-4638	238	6	.	.	NOUN
ijpds-4638	238	7	20	20	NUM
ijpds-4638	238	8	vora	vora	PROPN
ijpds-4638	238	9	b	b	PROPN
ijpds-4638	238	10	n	n	CCONJ
ijpds-4638	238	11	,	,	PUNCT
ijpds-4638	238	12	parmar	parmar	PROPN
ijpds-4638	238	13	r	r	NOUN
ijpds-4638	238	14	r	r	PROPN
ijpds-4638	238	15	,	,	PUNCT
ijpds-4638	238	16	nayak	nayak	NOUN
ijpds-4638	238	17	p	p	PROPN
ijpds-4638	238	18	p	p	PROPN
ijpds-4638	238	19	,	,	PUNCT
ijpds-4638	238	20	et	et	PROPN
ijpds-4638	238	21	al	al	PROPN
ijpds-4638	238	22	.	.	PROPN
ijpds-4638	238	23	development	development	PROPN
ijpds-4638	238	24	and	and	CCONJ
ijpds-4638	238	25	validation	validation	NOUN
ijpds-4638	238	26	of	of	ADP
ijpds-4638	238	27	the	the	DET
ijpds-4638	238	28	simultaneous	simultaneous	ADJ
ijpds-4638	238	29	uv	uv	NOUN
ijpds-4638	238	30	spectrophotometric	spectrophotometric	ADJ
ijpds-4638	238	31	method	method	NOUN
ijpds-4638	238	32	for	for	ADP
ijpds-4638	238	33	estimation	estimation	NOUN
ijpds-4638	238	34	of	of	ADP
ijpds-4638	238	35	metoprolol	metoprolol	PROPN
ijpds-4638	238	36	succinate	succinate	NOUN
ijpds-4638	238	37	and	and	CCONJ
ijpds-4638	238	38	olmesartan	olmesartan	PROPN
ijpds-4638	238	39	medoxomil	medoxomil	PROPN
ijpds-4638	238	40	in	in	ADP
ijpds-4638	238	41	the	the	DET
ijpds-4638	238	42	tablet	tablet	ADJ
ijpds-4638	238	43	dosage	dosage	NOUN
ijpds-4638	238	44	form	form	NOUN
ijpds-4638	238	45	.	.	PUNCT
ijpds-4638	239	1	pharmaceutical	pharmaceutical	ADJ
ijpds-4638	239	2	methods	method	NOUN
ijpds-4638	239	3	.	.	PUNCT
ijpds-4638	240	1	2012	2012	NUM
ijpds-4638	240	2	;	;	PUNCT
ijpds-4638	240	3	3(1	3(1	NUM
ijpds-4638	240	4	):	):	PUNCT
ijpds-4638	240	5	44	44	NUM
ijpds-4638	240	6	-	-	SYM
ijpds-4638	240	7	47	47	NUM
ijpds-4638	240	8	.	.	PUNCT
ijpds-4638	241	1	21	21	NUM
ijpds-4638	241	2	patel	patel	NOUN
ijpds-4638	241	3	d	d	PROPN
ijpds-4638	241	4	d	d	PROPN
ijpds-4638	241	5	,	,	PUNCT
ijpds-4638	241	6	patel	patel	PROPN
ijpds-4638	241	7	m	m	PROPN
ijpds-4638	241	8	m.	m.	PROPN
ijpds-4638	241	9	simultaneous	simultaneous	ADJ
ijpds-4638	241	10	estimation	estimation	NOUN
ijpds-4638	241	11	of	of	ADP
ijpds-4638	241	12	metoprolol	metoprolol	PROPN
ijpds-4638	241	13	succinate	succinate	NOUN
ijpds-4638	241	14	and	and	CCONJ
ijpds-4638	241	15	olmesartan	olmesartan	PROPN
ijpds-4638	241	16	medoxomil	medoxomil	PROPN
ijpds-4638	241	17	in	in	ADP
ijpds-4638	241	18	pharmaceutical	pharmaceutical	ADJ
ijpds-4638	241	19	dosage	dosage	NOUN
ijpds-4638	241	20	form	form	NOUN
ijpds-4638	241	21	by	by	ADP
ijpds-4638	241	22	uv	uv	NOUN
ijpds-4638	241	23	spectroscopy	spectroscopy	NOUN
ijpds-4638	241	24	.	.	PUNCT
ijpds-4638	242	1	international	international	ADJ
ijpds-4638	242	2	journal	journal	PROPN
ijpds-4638	242	3	of	of	ADP
ijpds-4638	242	4	research	research	NOUN
ijpds-4638	242	5	in	in	ADP
ijpds-4638	242	6	pharmaceutical	pharmaceutical	NOUN
ijpds-4638	242	7	and	and	CCONJ
ijpds-4638	242	8	biomedical	biomedical	ADJ
ijpds-4638	242	9	sciences	science	NOUN
ijpds-4638	242	10	.	.	PUNCT
ijpds-4638	243	1	2012;3(2	2012;3(2	NUM
ijpds-4638	243	2	):	):	PUNCT
ijpds-4638	243	3	935	935	NUM
ijpds-4638	243	4	-	-	SYM
ijpds-4638	243	5	939	939	NUM
ijpds-4638	243	6	.	.	PUNCT
ijpds-4638	244	1	22	22	NUM
ijpds-4638	244	2	modi	modi	PROPN
ijpds-4638	244	3	m	m	PROPN
ijpds-4638	244	4	,	,	PUNCT
ijpds-4638	244	5	shah	shah	PROPN
ijpds-4638	244	6	r	r	NOUN
ijpds-4638	244	7	,	,	PUNCT
ijpds-4638	244	8	mashru	mashru	PROPN
ijpds-4638	244	9	r	r	PROPN
ijpds-4638	244	10	c.	c.	PROPN
ijpds-4638	244	11	development	development	NOUN
ijpds-4638	244	12	and	and	CCONJ
ijpds-4638	244	13	validation	validation	NOUN
ijpds-4638	244	14	of	of	ADP
ijpds-4638	244	15	spectrophotometric	spectrophotometric	ADJ
ijpds-4638	244	16	methods	method	NOUN
ijpds-4638	244	17	for	for	ADP
ijpds-4638	244	18	simultaneous	simultaneous	ADJ
ijpds-4638	244	19	estimation	estimation	NOUN
ijpds-4638	244	20	of	of	ADP
ijpds-4638	244	21	metoprolol	metoprolol	PROPN
ijpds-4638	244	22	succinate	succinate	NOUN
ijpds-4638	244	23	and	and	CCONJ
ijpds-4638	244	24	telmisartan	telmisartan	NOUN
ijpds-4638	244	25	in	in	ADP
ijpds-4638	244	26	combined	combine	VERB
ijpds-4638	244	27	pharmaceutical	pharmaceutical	ADJ
ijpds-4638	244	28	formulation	formulation	NOUN
ijpds-4638	244	29	.	.	PUNCT
ijpds-4638	245	1	international	international	ADJ
ijpds-4638	245	2	journal	journal	PROPN
ijpds-4638	245	3	of	of	ADP
ijpds-4638	245	4	pharmaceutical	pharmaceutical	NOUN
ijpds-4638	245	5	sciences	science	NOUN
ijpds-4638	245	6	and	and	CCONJ
ijpds-4638	245	7	research	research	NOUN
ijpds-4638	245	8	.	.	PUNCT
ijpds-4638	246	1	2012	2012	NUM
ijpds-4638	246	2	;	;	PUNCT
ijpds-4638	246	3	3(5	3(5	NUM
ijpds-4638	246	4	):	):	PUNCT
ijpds-4638	246	5	1348	1348	NUM
ijpds-4638	246	6	-	-	SYM
ijpds-4638	246	7	1354	1354	NUM
ijpds-4638	246	8	.	.	PUNCT
ijpds-4638	247	1	23	23	NUM
ijpds-4638	248	1	kumar	kumar	PROPN
ijpds-4638	248	2	j	j	PROPN
ijpds-4638	248	3	s	s	PROPN
ijpds-4638	248	4	,	,	PUNCT
ijpds-4638	248	5	nilesh	nilesh	PROPN
ijpds-4638	248	6	j	j	PROPN
ijpds-4638	248	7	,	,	PUNCT
ijpds-4638	248	8	piyush	piyush	PROPN
ijpds-4638	248	9	s	s	PROPN
ijpds-4638	248	10	,	,	PUNCT
ijpds-4638	248	11	et	et	PROPN
ijpds-4638	248	12	al	al	PROPN
ijpds-4638	248	13	.	.	PROPN
ijpds-4638	248	14	bioanalytical	bioanalytical	PROPN
ijpds-4638	248	15	method	method	PROPN
ijpds-4638	248	16	development	development	NOUN
ijpds-4638	248	17	and	and	CCONJ
ijpds-4638	248	18	validation	validation	NOUN
ijpds-4638	248	19	for	for	ADP
ijpds-4638	248	20	metoprolol	metoprolol	NOUN
ijpds-4638	248	21	succinate	succinate	NOUN
ijpds-4638	248	22	and	and	CCONJ
ijpds-4638	248	23	telmisartan	telmisartan	NOUN
ijpds-4638	248	24	using	use	VERB
ijpds-4638	248	25	uv	uv	NOUN
ijpds-4638	248	26	spectro	spectro	NOUN
ijpds-4638	248	27	-	-	PUNCT
ijpds-4638	248	28	photometry	photometry	NOUN
ijpds-4638	248	29	and	and	CCONJ
ijpds-4638	248	30	rp	rp	NOUN
ijpds-4638	248	31	-	-	PUNCT
ijpds-4638	248	32	hplc	hplc	NOUN
ijpds-4638	248	33	.	.	PUNCT
ijpds-4638	249	1	journal	journal	PROPN
ijpds-4638	249	2	of	of	ADP
ijpds-4638	249	3	pharmaceutical	pharmaceutical	NOUN
ijpds-4638	249	4	research	research	NOUN
ijpds-4638	249	5	.	.	PUNCT
ijpds-4638	250	1	2014	2014	NUM
ijpds-4638	250	2	;	;	PUNCT
ijpds-4638	251	1	13(2	13(2	NUM
ijpds-4638	251	2	):	):	PUNCT
ijpds-4638	251	3	50	50	NUM
ijpds-4638	251	4	-	-	SYM
ijpds-4638	251	5	56	56	NUM
ijpds-4638	251	6	.	.	NOUN
ijpds-4638	251	7	24	24	NUM
ijpds-4638	251	8	soni	soni	PROPN
ijpds-4638	251	9	s	s	PROPN
ijpds-4638	251	10	,	,	PUNCT
ijpds-4638	251	11	ram	ram	NOUN
ijpds-4638	251	12	v	v	NOUN
ijpds-4638	251	13	,	,	PUNCT
ijpds-4638	251	14	verma	verma	PROPN
ijpds-4638	251	15	d	d	PROPN
ijpds-4638	251	16	,	,	PUNCT
ijpds-4638	251	17	verma	verma	PROPN
ijpds-4638	251	18	a.	a.	PROPN
ijpds-4638	251	19	analytical	analytical	PROPN
ijpds-4638	251	20	method	method	PROPN
ijpds-4638	251	21	development	development	NOUN
ijpds-4638	251	22	and	and	CCONJ
ijpds-4638	251	23	validation	validation	NOUN
ijpds-4638	251	24	of	of	ADP
ijpds-4638	251	25	metoprolol	metoprolol	NOUN
ijpds-4638	251	26	succinate	succinate	NOUN
ijpds-4638	251	27	by	by	ADP
ijpds-4638	251	28	high	high	ADJ
ijpds-4638	251	29	dyade	dyade	PROPN
ijpds-4638	251	30	et	et	PROPN
ijpds-4638	252	1	al	al	PROPN
ijpds-4638	252	2	.	.	PROPN
ijpds-4638	252	3	qbd	qbd	PROPN
ijpds-4638	252	4	and	and	CCONJ
ijpds-4638	252	5	chemometric	chemometric	ADJ
ijpds-4638	252	6	method	method	NOUN
ijpds-4638	252	7	for	for	ADP
ijpds-4638	252	8	estimation	estimation	NOUN
ijpds-4638	252	9	of	of	ADP
ijpds-4638	252	10	metoprolol	metoprolol	NOUN
ijpds-4638	252	11	and	and	CCONJ
ijpds-4638	252	12	cilnidipine	cilnidipine	ADJ
ijpds-4638	252	13	online	online	ADJ
ijpds-4638	252	14	first	first	PROPN
ijpds-4638	252	15	indian	indian	PROPN
ijpds-4638	252	16	j	j	PROPN
ijpds-4638	252	17	pharm	pharm	PROPN
ijpds-4638	252	18	drug	drug	PROPN
ijpds-4638	252	19	studies	study	NOUN
ijpds-4638	252	20	|	|	ADV
ijpds-4638	252	21	8	8	NUM
ijpds-4638	252	22	performance	performance	NOUN
ijpds-4638	252	23	liquid	liquid	ADJ
ijpds-4638	252	24	chromatography	chromatography	NOUN
ijpds-4638	252	25	and	and	CCONJ
ijpds-4638	252	26	ultraviolet	ultraviolet	ADJ
ijpds-4638	252	27	spectroscopy	spectroscopy	NOUN
ijpds-4638	252	28	technique	technique	NOUN
ijpds-4638	252	29	.	.	PUNCT
ijpds-4638	253	1	research	research	NOUN
ijpds-4638	253	2	journal	journal	PROPN
ijpds-4638	253	3	of	of	ADP
ijpds-4638	253	4	pharmacy	pharmacy	NOUN
ijpds-4638	253	5	and	and	CCONJ
ijpds-4638	253	6	technology	technology	NOUN
ijpds-4638	253	7	.	.	PUNCT
ijpds-4638	254	1	2021;14(2):931	2021;14(2):931	NUM
ijpds-4638	254	2	-	-	SYM
ijpds-4638	254	3	937	937	NUM
ijpds-4638	254	4	.	.	PUNCT
ijpds-4638	255	1	25	25	NUM
ijpds-4638	255	2	singh	singh	PROPN
ijpds-4638	255	3	a	a	X
ijpds-4638	255	4	,	,	PUNCT
ijpds-4638	255	5	rajput	rajput	PROPN
ijpds-4638	255	6	a	a	X
ijpds-4638	255	7	,	,	PUNCT
ijpds-4638	255	8	kureshi	kureshi	PROPN
ijpds-4638	255	9	g	g	PROPN
ijpds-4638	255	10	,	,	PUNCT
ijpds-4638	255	11	carpenter	carpenter	NOUN
ijpds-4638	255	12	g	g	NOUN
ijpds-4638	255	13	,	,	PUNCT
ijpds-4638	255	14	et	et	PROPN
ijpds-4638	255	15	al	al	PROPN
ijpds-4638	255	16	.	.	PUNCT
ijpds-4638	256	1	an	an	DET
ijpds-4638	256	2	rp	rp	NOUN
ijpds-4638	256	3	-	-	PUNCT
ijpds-4638	256	4	hplc	hplc	NOUN
ijpds-4638	256	5	method	method	NOUN
ijpds-4638	256	6	performance	performance	NOUN
ijpds-4638	256	7	and	and	CCONJ
ijpds-4638	256	8	validation	validation	NOUN
ijpds-4638	256	9	for	for	ADP
ijpds-4638	256	10	azelnidipine	azelnidipine	NOUN
ijpds-4638	256	11	measurment	measurment	NOUN
ijpds-4638	256	12	and	and	CCONJ
ijpds-4638	256	13	metoprolol	metoprolol	NOUN
ijpds-4638	256	14	succinate	succinate	NOUN
ijpds-4638	256	15	within	within	ADP
ijpds-4638	256	16	a	a	DET
ijpds-4638	256	17	synthetic	synthetic	ADJ
ijpds-4638	256	18	mixture	mixture	NOUN
ijpds-4638	256	19	.	.	PUNCT
ijpds-4638	257	1	pharmacophore	pharmacophore	NOUN
ijpds-4638	257	2	.	.	PUNCT
ijpds-4638	258	1	2023;14(3):1	2023;14(3):1	NUM
ijpds-4638	258	2	-	-	SYM
ijpds-4638	258	3	6	6	NUM
ijpds-4638	258	4	.	.	NOUN
ijpds-4638	258	5	26	26	NUM
ijpds-4638	258	6	kalshetti	kalshetti	PROPN
ijpds-4638	258	7	m	m	PROPN
ijpds-4638	258	8	s	s	PROPN
ijpds-4638	258	9	,	,	PUNCT
ijpds-4638	258	10	kankure	kankure	PROPN
ijpds-4638	258	11	s	s	PROPN
ijpds-4638	258	12	s.	s.	PROPN
ijpds-4638	258	13	development	development	PROPN
ijpds-4638	258	14	and	and	CCONJ
ijpds-4638	258	15	validation	validation	NOUN
ijpds-4638	258	16	of	of	ADP
ijpds-4638	258	17	rphplc	rphplc	NOUN
ijpds-4638	258	18	method	method	NOUN
ijpds-4638	258	19	for	for	ADP
ijpds-4638	258	20	simultaneous	simultaneous	ADJ
ijpds-4638	258	21	es	es	NOUN
ijpds-4638	258	22	-	-	PUNCT
ijpds-4638	258	23	timation	timation	NOUN
ijpds-4638	258	24	of	of	ADP
ijpds-4638	258	25	metoprolol	metoprolol	PROPN
ijpds-4638	258	26	,	,	PUNCT
ijpds-4638	258	27	telmisartan	telmisartan	NOUN
ijpds-4638	258	28	and	and	CCONJ
ijpds-4638	258	29	clinidipine	clinidipine	NOUN
ijpds-4638	258	30	in	in	ADP
ijpds-4638	258	31	tablet	tablet	NOUN
ijpds-4638	258	32	.	.	PUNCT
ijpds-4638	259	1	int	int	PROPN
ijpds-4638	259	2	j	j	PROPN
ijpds-4638	259	3	pharm	pharm	PROPN
ijpds-4638	259	4	sci	sci	PROPN
ijpds-4638	259	5	&	&	CCONJ
ijpds-4638	259	6	res	re	NOUN
ijpds-4638	259	7	2021	2021	NUM
ijpds-4638	259	8	;	;	PUNCT
ijpds-4638	259	9	12(3	12(3	NUM
ijpds-4638	259	10	):	):	PUNCT
ijpds-4638	259	11	1651	1651	NUM
ijpds-4638	259	12	-	-	SYM
ijpds-4638	259	13	57	57	NUM
ijpds-4638	259	14	.	.	PUNCT
ijpds-4638	259	15	27	27	NUM
ijpds-4638	259	16	akanksha	akanksha	VERB
ijpds-4638	259	17	s	s	PROPN
ijpds-4638	259	18	,	,	PUNCT
ijpds-4638	259	19	manish	manish	PROPN
ijpds-4638	259	20	r	r	PROPN
ijpds-4638	259	21	,	,	PUNCT
ijpds-4638	259	22	ganesh	ganesh	NOUN
ijpds-4638	259	23	b	b	PROPN
ijpds-4638	259	24	,	,	PUNCT
ijpds-4638	259	25	varsha	varsha	PROPN
ijpds-4638	259	26	r	r	PROPN
ijpds-4638	259	27	,	,	PUNCT
ijpds-4638	259	28	et	et	PROPN
ijpds-4638	259	29	al	al	PROPN
ijpds-4638	259	30	.	.	PUNCT
ijpds-4638	260	1	simultaneous	simultaneous	ADJ
ijpds-4638	260	2	estimation	estimation	NOUN
ijpds-4638	260	3	of	of	ADP
ijpds-4638	260	4	metoprolol	metoprolol	PROPN
ijpds-4638	260	5	succinate	succinate	NOUN
ijpds-4638	260	6	,	,	PUNCT
ijpds-4638	260	7	telmisartan	telmisartan	NOUN
ijpds-4638	260	8	and	and	CCONJ
ijpds-4638	260	9	cilnidipine	cilnidipine	NOUN
ijpds-4638	260	10	in	in	ADP
ijpds-4638	260	11	bulk	bulk	ADJ
ijpds-4638	260	12	pharmaceutical	pharmaceutical	NOUN
ijpds-4638	260	13	dosage	dosage	NOUN
ijpds-4638	260	14	form	form	NOUN
ijpds-4638	260	15	.	.	PUNCT
ijpds-4638	261	1	international	international	ADJ
ijpds-4638	261	2	journal	journal	PROPN
ijpds-4638	261	3	of	of	ADP
ijpds-4638	261	4	chemical	chemical	PROPN
ijpds-4638	261	5	&	&	CCONJ
ijpds-4638	261	6	pharmaceutical	pharmaceutical	NOUN
ijpds-4638	261	7	analysis	analysis	NOUN
ijpds-4638	261	8	.	.	PUNCT
ijpds-4638	261	9	2021	2021	NUM
ijpds-4638	261	10	;	;	PUNCT
ijpds-4638	261	11	8(4	8(4	NUM
ijpds-4638	261	12	)	)	PUNCT
ijpds-4638	261	13	;	;	PUNCT
ijpds-4638	261	14	1	1	NUM
ijpds-4638	261	15	-	-	SYM
ijpds-4638	261	16	11	11	NUM
ijpds-4638	261	17	.	.	PUNCT
ijpds-4638	262	1	28	28	NUM
ijpds-4638	262	2	chaudhari	chaudhari	PROPN
ijpds-4638	262	3	s	s	PART
ijpds-4638	262	4	m	m	PROPN
ijpds-4638	262	5	,	,	PUNCT
ijpds-4638	262	6	karan	karan	PROPN
ijpds-4638	262	7	m	m	PROPN
ijpds-4638	262	8	p	p	PROPN
ijpds-4638	262	9	,	,	PUNCT
ijpds-4638	262	10	luhar	luhar	PROPN
ijpds-4638	262	11	s	s	PROPN
ijpds-4638	262	12	v	v	NOUN
ijpds-4638	262	13	,	,	PUNCT
ijpds-4638	262	14	et	et	PROPN
ijpds-4638	262	15	al	al	PROPN
ijpds-4638	262	16	.	.	PUNCT
ijpds-4638	263	1	rp	rp	NOUN
ijpds-4638	263	2	-	-	PUNCT
ijpds-4638	263	3	hplc	hplc	NOUN
ijpds-4638	263	4	method	method	NOUN
ijpds-4638	263	5	development	development	NOUN
ijpds-4638	263	6	and	and	CCONJ
ijpds-4638	263	7	validation	validation	NOUN
ijpds-4638	263	8	for	for	ADP
ijpds-4638	263	9	simultaneous	simultaneous	ADJ
ijpds-4638	263	10	estimation	estimation	NOUN
ijpds-4638	263	11	of	of	ADP
ijpds-4638	263	12	atorvastatin	atorvastatin	PROPN
ijpds-4638	263	13	,	,	PUNCT
ijpds-4638	263	14	aspirin	aspirin	NOUN
ijpds-4638	263	15	,	,	PUNCT
ijpds-4638	263	16	ramipril	ramipril	NOUN
ijpds-4638	263	17	and	and	CCONJ
ijpds-4638	263	18	metoprolol	metoprolol	PROPN
ijpds-4638	263	19	succinate	succinate	NOUN
ijpds-4638	263	20	in	in	ADP
ijpds-4638	263	21	tablet	tablet	ADJ
ijpds-4638	263	22	dosage	dosage	NOUN
ijpds-4638	263	23	form	form	NOUN
ijpds-4638	263	24	.	.	PUNCT
ijpds-4638	264	1	pharma	pharma	PROPN
ijpds-4638	264	2	science	science	NOUN
ijpds-4638	264	3	monitor	monitor	VERB
ijpds-4638	264	4	an	an	DET
ijpds-4638	264	5	international	international	ADJ
ijpds-4638	264	6	journal	journal	NOUN
ijpds-4638	264	7	of	of	ADP
ijpds-4638	264	8	pharmaceutical	pharmaceutical	NOUN
ijpds-4638	264	9	science	science	NOUN
ijpds-4638	264	10	.	.	PUNCT
ijpds-4638	265	1	2018	2018	NUM
ijpds-4638	265	2	;	;	PUNCT
ijpds-4638	265	3	9(2):205	9(2):205	NUM
ijpds-4638	265	4	-	-	SYM
ijpds-4638	265	5	17	17	NUM
ijpds-4638	265	6	.	.	PUNCT
ijpds-4638	265	7	29	29	NUM
ijpds-4638	265	8	jain	jain	PROPN
ijpds-4638	265	9	n	n	CCONJ
ijpds-4638	265	10	,	,	PUNCT
ijpds-4638	265	11	jain	jain	PROPN
ijpds-4638	265	12	d	d	PROPN
ijpds-4638	265	13	k	k	PROPN
ijpds-4638	265	14	,	,	PUNCT
ijpds-4638	265	15	jain	jain	PROPN
ijpds-4638	265	16	r	r	PROPN
ijpds-4638	265	17	,	,	PUNCT
ijpds-4638	265	18	et	et	PROPN
ijpds-4638	265	19	al	al	PROPN
ijpds-4638	265	20	.	.	PUNCT
ijpds-4638	265	21	simultaneous	simultaneous	ADJ
ijpds-4638	265	22	estimation	estimation	NOUN
ijpds-4638	265	23	of	of	ADP
ijpds-4638	265	24	metoprolol	metoprolol	PROPN
ijpds-4638	265	25	succinate	succinate	NOUN
ijpds-4638	265	26	and	and	CCONJ
ijpds-4638	265	27	lacidipine	lacidipine	NOUN
ijpds-4638	265	28	in	in	ADP
ijpds-4638	265	29	binary	binary	ADJ
ijpds-4638	265	30	combination	combination	NOUN
ijpds-4638	265	31	using	use	VERB
ijpds-4638	265	32	high	high	ADJ
ijpds-4638	265	33	performance	performance	NOUN
ijpds-4638	265	34	liquid	liquid	ADJ
ijpds-4638	265	35	chromatographic	chromatographic	ADJ
ijpds-4638	265	36	method	method	NOUN
ijpds-4638	265	37	.	.	PUNCT
ijpds-4638	266	1	jordan	jordan	PROPN
ijpds-4638	266	2	journal	journal	PROPN
ijpds-4638	266	3	of	of	ADP
ijpds-4638	266	4	pharmaceutical	pharmaceutical	NOUN
ijpds-4638	266	5	sciences	science	NOUN
ijpds-4638	266	6	.	.	PUNCT
ijpds-4638	266	7	2016	2016	NUM
ijpds-4638	266	8	;	;	PUNCT
ijpds-4638	266	9	9(3):193	9(3):193	NUM
ijpds-4638	266	10	-	-	SYM
ijpds-4638	266	11	202	202	NUM
ijpds-4638	266	12	.	.	NOUN
ijpds-4638	266	13	30	30	NUM
ijpds-4638	266	14	patel	patel	PROPN
ijpds-4638	266	15	m	m	NOUN
ijpds-4638	266	16	m	m	PROPN
ijpds-4638	266	17	,	,	PUNCT
ijpds-4638	266	18	patel	patel	PROPN
ijpds-4638	266	19	d	d	PROPN
ijpds-4638	266	20	d.	d.	PROPN
ijpds-4638	266	21	simultaneous	simultaneous	PROPN
ijpds-4638	266	22	estimation	estimation	NOUN
ijpds-4638	266	23	of	of	ADP
ijpds-4638	266	24	metoprolol	metoprolol	PROPN
ijpds-4638	266	25	succinate	succinate	NOUN
ijpds-4638	266	26	and	and	CCONJ
ijpds-4638	266	27	olmesartan	olmesartan	PROPN
ijpds-4638	266	28	medoxomil	medoxomil	PROPN
ijpds-4638	266	29	in	in	ADP
ijpds-4638	266	30	pharmaceutical	pharmaceutical	ADJ
ijpds-4638	266	31	dosage	dosage	NOUN
ijpds-4638	266	32	form	form	NOUN
ijpds-4638	266	33	by	by	ADP
ijpds-4638	266	34	rp	rp	NOUN
ijpds-4638	266	35	-	-	PUNCT
ijpds-4638	266	36	hplc	hplc	NOUN
ijpds-4638	266	37	.	.	PUNCT
ijpds-4638	267	1	j	j	PROPN
ijpds-4638	267	2	chromatogr	chromatogr	PROPN
ijpds-4638	267	3	sep	sep	PROPN
ijpds-4638	267	4	tech	tech	NOUN
ijpds-4638	267	5	.	.	PUNCT
ijpds-4638	268	1	2012	2012	NUM
ijpds-4638	268	2	;	;	PUNCT
ijpds-4638	268	3	3(151):1	3(151):1	NUM
ijpds-4638	268	4	-	-	SYM
ijpds-4638	268	5	3	3	NUM
ijpds-4638	268	6	.	.	NUM
ijpds-4638	268	7	31	31	NUM
ijpds-4638	268	8	saravanan	saravanan	PROPN
ijpds-4638	268	9	g	g	PROPN
ijpds-4638	268	10	,	,	PUNCT
ijpds-4638	268	11	praveen	praveen	PROPN
ijpds-4638	268	12	p	p	PROPN
ijpds-4638	268	13	n	n	CCONJ
ijpds-4638	268	14	,	,	PUNCT
ijpds-4638	268	15	janeyulu	janeyulu	VERB
ijpds-4638	268	16	i	i	PRON
ijpds-4638	268	17	s	s	PROPN
ijpds-4638	268	18	,	,	PUNCT
ijpds-4638	268	19	et	et	NOUN
ijpds-4638	268	20	.	.	PUNCT
ijpds-4638	269	1	al	al	PROPN
ijpds-4638	269	2	.	.	PROPN
ijpds-4638	269	3	development	development	PROPN
ijpds-4638	269	4	and	and	CCONJ
ijpds-4638	269	5	validation	validation	NOUN
ijpds-4638	269	6	of	of	ADP
ijpds-4638	269	7	stability	stability	NOUN
ijpds-4638	269	8	indicating	indicate	VERB
ijpds-4638	269	9	rp	rp	NOUN
ijpds-4638	269	10	-	-	PUNCT
ijpds-4638	269	11	hplc	hplc	NOUN
ijpds-4638	269	12	method	method	NOUN
ijpds-4638	269	13	for	for	ADP
ijpds-4638	269	14	the	the	DET
ijpds-4638	269	15	simultaneous	simultaneous	ADJ
ijpds-4638	269	16	estimation	estimation	NOUN
ijpds-4638	269	17	of	of	ADP
ijpds-4638	269	18	metoprolol	metoprolol	PROPN
ijpds-4638	269	19	succinate	succinate	NOUN
ijpds-4638	269	20	and	and	CCONJ
ijpds-4638	269	21	cilnidipine	cilnidipine	NOUN
ijpds-4638	269	22	in	in	ADP
ijpds-4638	269	23	bulk	bulk	NOUN
ijpds-4638	269	24	and	and	CCONJ
ijpds-4638	269	25	pharmaceutical	pharmaceutical	ADJ
ijpds-4638	269	26	dosage	dosage	NOUN
ijpds-4638	269	27	form	form	NOUN
ijpds-4638	269	28	.	.	PUNCT
ijpds-4638	270	1	int	int	NOUN
ijpds-4638	270	2	.	.	PUNCT
ijpds-4638	271	1	j.	j.	PROPN
ijpds-4638	271	2	pharm	pharm	PROPN
ijpds-4638	271	3	.	.	PUNCT
ijpds-4638	272	1	pharm	pharm	PROPN
ijpds-4638	272	2	.	.	PUNCT
ijpds-4638	273	1	sci	sci	PROPN
ijpds-4638	273	2	.	.	PUNCT
ijpds-4638	274	1	2015;7(1):150	2015;7(1):150	NUM
ijpds-4638	274	2	-	-	SYM
ijpds-4638	274	3	4	4	NUM
ijpds-4638	274	4	.	.	X
ijpds-4638	274	5	32	32	NUM
ijpds-4638	274	6	kumar	kumar	PROPN
ijpds-4638	274	7	t	t	PROPN
ijpds-4638	274	8	h	h	PROPN
ijpds-4638	274	9	,	,	PUNCT
ijpds-4638	274	10	ravindar	ravindar	PROPN
ijpds-4638	274	11	b	b	NUM
ijpds-4638	274	12	,	,	PUNCT
ijpds-4638	274	13	rasheed	rasheed	PROPN
ijpds-4638	274	14	s	s	PROPN
ijpds-4638	274	15	h	h	NOUN
ijpds-4638	274	16	,	,	PUNCT
ijpds-4638	274	17	et	et	NOUN
ijpds-4638	274	18	.	.	PUNCT
ijpds-4638	274	19	al.stability	al.stability	NOUN
ijpds-4638	274	20	-	-	PUNCT
ijpds-4638	274	21	indicating	indicate	VERB
ijpds-4638	274	22	rp	rp	NOUN
ijpds-4638	274	23	-	-	PUNCT
ijpds-4638	274	24	hplc	hplc	NOUN
ijpds-4638	274	25	method	method	NOUN
ijpds-4638	274	26	for	for	ADP
ijpds-4638	274	27	the	the	DET
ijpds-4638	274	28	estimation	estimation	NOUN
ijpds-4638	274	29	of	of	ADP
ijpds-4638	274	30	metoprolol	metoprolol	PROPN
ijpds-4638	274	31	succinate	succinate	NOUN
ijpds-4638	274	32	and	and	CCONJ
ijpds-4638	274	33	hydrochlorothiazide	hydrochlorothiazide	PROPN
ijpds-4638	274	34	in	in	ADP
ijpds-4638	274	35	tablet	tablet	ADJ
ijpds-4638	274	36	dosage	dosage	NOUN
ijpds-4638	274	37	form	form	NOUN
ijpds-4638	274	38	.	.	PUNCT
ijpds-4638	275	1	international	international	ADJ
ijpds-4638	275	2	journal	journal	PROPN
ijpds-4638	275	3	of	of	ADP
ijpds-4638	275	4	pharmaceutical	pharmaceutical	NOUN
ijpds-4638	275	5	technology	technology	NOUN
ijpds-4638	275	6	letters	letter	NOUN
ijpds-4638	275	7	.	.	PUNCT
ijpds-4638	276	1	2023;1(1):17	2023;1(1):17	NUM
ijpds-4638	276	2	-	-	SYM
ijpds-4638	276	3	26	26	NUM
ijpds-4638	276	4	.	.	PUNCT
ijpds-4638	277	1	33	33	NUM
ijpds-4638	277	2	patel	patel	PROPN
ijpds-4638	277	3	k	k	NOUN
ijpds-4638	277	4	,	,	PUNCT
ijpds-4638	277	5	macwan	macwan	PROPN
ijpds-4638	277	6	p	p	PROPN
ijpds-4638	277	7	,	,	PUNCT
ijpds-4638	277	8	prajapati	prajapati	PROPN
ijpds-4638	277	9	a	a	PRON
ijpds-4638	277	10	,	,	PUNCT
ijpds-4638	277	11	et	et	X
ijpds-4638	277	12	.	.	PUNCT
ijpds-4638	278	1	al	al	AUX
ijpds-4638	278	2	.	.	PROPN
ijpds-4638	278	3	box‒behnken	box‒behnken	VERB
ijpds-4638	278	4	designassisted	designassiste	VERB
ijpds-4638	278	5	development	development	NOUN
ijpds-4638	278	6	of	of	ADP
ijpds-4638	278	7	an	an	DET
ijpds-4638	278	8	eco	eco	NOUN
ijpds-4638	278	9	-	-	PUNCT
ijpds-4638	278	10	friendly	friendly	ADJ
ijpds-4638	278	11	thin	thin	ADJ
ijpds-4638	278	12	-	-	PUNCT
ijpds-4638	278	13	layer	layer	NOUN
ijpds-4638	278	14	chromatography‒densitometry	chromatography‒densitometry	NOUN
ijpds-4638	278	15	method	method	NOUN
ijpds-4638	278	16	for	for	ADP
ijpds-4638	278	17	the	the	DET
ijpds-4638	278	18	quantification	quantification	NOUN
ijpds-4638	278	19	of	of	ADP
ijpds-4638	278	20	amlodipine	amlodipine	NOUN
ijpds-4638	278	21	besylate	besylate	NOUN
ijpds-4638	278	22	,	,	PUNCT
ijpds-4638	278	23	metoprolol	metoprolol	NOUN
ijpds-4638	278	24	succinate	succinate	NOUN
ijpds-4638	278	25	,	,	PUNCT
ijpds-4638	278	26	and	and	CCONJ
ijpds-4638	278	27	telmisartan	telmisartan	NOUN
ijpds-4638	278	28	in	in	ADP
ijpds-4638	278	29	synthetic	synthetic	ADJ
ijpds-4638	278	30	mixture	mixture	NOUN
ijpds-4638	278	31	using	use	VERB
ijpds-4638	278	32	agree	agree	ADJ
ijpds-4638	278	33	tool	tool	NOUN
ijpds-4638	278	34	.	.	PUNCT
ijpds-4638	279	1	jpc	jpc	PROPN
ijpds-4638	279	2	–	–	PUNCT
ijpds-4638	279	3	journal	journal	NOUN
ijpds-4638	279	4	of	of	ADP
ijpds-4638	279	5	planar	planar	ADJ
ijpds-4638	279	6	chromatography	chromatography	NOUN
ijpds-4638	279	7	–	–	PUNCT
ijpds-4638	279	8	modern	modern	ADJ
ijpds-4638	279	9	tlc	tlc	NOUN
ijpds-4638	279	10	.	.	PUNCT
ijpds-4638	280	1	2023;36	2023;36	X
ijpds-4638	280	2	:	:	PUNCT
ijpds-4638	280	3	265	265	NUM
ijpds-4638	280	4	-	-	SYM
ijpds-4638	280	5	277	277	NUM
ijpds-4638	280	6	.	.	PUNCT
ijpds-4638	281	1	34	34	NUM
ijpds-4638	281	2	patil	patil	PROPN
ijpds-4638	281	3	v	v	ADP
ijpds-4638	281	4	p.	p.	PROPN
ijpds-4638	281	5	simulteneous	simulteneous	ADJ
ijpds-4638	281	6	hptlc	hptlc	NOUN
ijpds-4638	281	7	analysis	analysis	NOUN
ijpds-4638	281	8	of	of	ADP
ijpds-4638	281	9	hydrochlorthiazide	hydrochlorthiazide	NOUN
ijpds-4638	281	10	and	and	CCONJ
ijpds-4638	281	11	metoprolol	metoprolol	PROPN
ijpds-4638	281	12	succinate	succinate	NOUN
ijpds-4638	281	13	in	in	ADP
ijpds-4638	281	14	tablet	tablet	NOUN
ijpds-4638	281	15	and	and	CCONJ
ijpds-4638	281	16	bulk	bulk	ADJ
ijpds-4638	281	17	dosage	dosage	NOUN
ijpds-4638	281	18	form	form	NOUN
ijpds-4638	281	19	.	.	PUNCT
ijpds-4638	282	1	world	world	PROPN
ijpds-4638	282	2	research	research	PROPN
ijpds-4638	282	3	journal	journal	NOUN
ijpds-4638	282	4	of	of	ADP
ijpds-4638	282	5	organic	organic	ADJ
ijpds-4638	282	6	chemistry	chemistry	NOUN
ijpds-4638	282	7	.	.	PUNCT
ijpds-4638	283	1	2012	2012	NUM
ijpds-4638	283	2	;	;	PUNCT
ijpds-4638	284	1	1(1):1	1(1):1	PROPN
ijpds-4638	284	2	-	-	SYM
ijpds-4638	284	3	5	5	NUM
ijpds-4638	284	4	.	.	NOUN
ijpds-4638	284	5	35	35	NUM
ijpds-4638	284	6	indian	indian	ADJ
ijpds-4638	284	7	pharmacopoeia	pharmacopoeia	NOUN
ijpds-4638	284	8	,	,	PUNCT
ijpds-4638	284	9	govt	govt	NOUN
ijpds-4638	284	10	of	of	ADP
ijpds-4638	284	11	india	india	PROPN
ijpds-4638	284	12	,	,	PUNCT
ijpds-4638	284	13	ministry	ministry	PROPN
ijpds-4638	284	14	of	of	ADP
ijpds-4638	284	15	health	health	PROPN
ijpds-4638	284	16	and	and	CCONJ
ijpds-4638	284	17	family	family	NOUN
ijpds-4638	284	18	welfare	welfare	NOUN
ijpds-4638	284	19	,	,	PUNCT
ijpds-4638	284	20	8th	8th	ADJ
ijpds-4638	284	21	edition	edition	NOUN
ijpds-4638	284	22	,	,	PUNCT
ijpds-4638	284	23	the	the	DET
ijpds-4638	284	24	indian	indian	PROPN
ijpds-4638	284	25	pharmacopoeia	pharmacopoeia	PROPN
ijpds-4638	284	26	commission	commission	PROPN
ijpds-4638	284	27	ghaziabad	ghaziabad	PROPN
ijpds-4638	284	28	,	,	PUNCT
ijpds-4638	284	29	2018	2018	NUM
ijpds-4638	284	30	,	,	PUNCT
ijpds-4638	284	31	iii	iii	PROPN
ijpds-4638	284	32	:	:	PUNCT
ijpds-4638	284	33	pp	pp	ADJ
ijpds-4638	284	34	.	.	PUNCT
ijpds-4638	284	35	1616	1616	NUM
ijpds-4638	284	36	,	,	PUNCT
ijpds-4638	284	37	2583	2583	NUM
ijpds-4638	284	38	.	.	PUNCT
ijpds-4638	285	1	36	36	NUM
ijpds-4638	285	2	british	british	ADJ
ijpds-4638	285	3	pharmacopoeia	pharmacopoeia	NOUN
ijpds-4638	285	4	,	,	PUNCT
ijpds-4638	285	5	medicines	medicine	NOUN
ijpds-4638	285	6	and	and	CCONJ
ijpds-4638	285	7	healthcare	healthcare	NOUN
ijpds-4638	285	8	products	product	NOUN
ijpds-4638	285	9	regulatory	regulatory	ADJ
ijpds-4638	285	10	agency	agency	NOUN
ijpds-4638	285	11	london	london	PROPN
ijpds-4638	285	12	,	,	PUNCT
ijpds-4638	285	13	2019	2019	NUM
ijpds-4638	285	14	,	,	PUNCT
ijpds-4638	285	15	ii	ii	NOUN
ijpds-4638	285	16	:	:	PUNCT
ijpds-4638	285	17	1361	1361	NUM
ijpds-4638	285	18	,	,	PUNCT
ijpds-4638	285	19	1762	1762	NUM
ijpds-4638	285	20	.	.	PUNCT
ijpds-4638	286	1	37	37	NUM
ijpds-4638	286	2	ich	ich	NOUN
ijpds-4638	286	3	expert	expert	NOUN
ijpds-4638	286	4	working	working	NOUN
ijpds-4638	286	5	group	group	NOUN
ijpds-4638	286	6	.	.	PUNCT
ijpds-4638	287	1	ich	ich	PROPN
ijpds-4638	287	2	harmonized	harmonize	VERB
ijpds-4638	287	3	tripartite	tripartite	ADJ
ijpds-4638	287	4	guideline	guideline	NOUN
ijpds-4638	287	5	-	-	PUNCT
ijpds-4638	287	6	pharmaceutical	pharmaceutical	NOUN
ijpds-4638	287	7	development	development	NOUN
ijpds-4638	287	8	q	q	PROPN
ijpds-4638	287	9	8	8	NUM
ijpds-4638	287	10	r2	r2	NOUN
ijpds-4638	287	11	.	.	PUNCT
ijpds-4638	288	1	in	in	ADP
ijpds-4638	288	2	current	current	ADJ
ijpds-4638	288	3	step	step	NOUN
ijpds-4638	288	4	4	4	NUM
ijpds-4638	288	5	version	version	NOUN
ijpds-4638	288	6	.	.	PUNCT
ijpds-4638	289	1	2009	2009	NUM
ijpds-4638	289	2	;	;	PUNCT
ijpds-4638	290	1	p.	p.	NOUN
ijpds-4638	290	2	1	1	NUM
ijpds-4638	290	3	-	-	SYM
ijpds-4638	290	4	28	28	NUM
ijpds-4638	290	5	.	.	PUNCT
ijpds-4638	291	1	38	38	NUM
ijpds-4638	291	2	ich	ich	NOUN
ijpds-4638	291	3	expert	expert	NOUN
ijpds-4638	291	4	working	working	NOUN
ijpds-4638	291	5	group	group	NOUN
ijpds-4638	291	6	.	.	PUNCT
ijpds-4638	292	1	ich	ich	PROPN
ijpds-4638	292	2	harmonized	harmonize	VERB
ijpds-4638	292	3	tripartite	tripartite	ADJ
ijpds-4638	292	4	guideline	guideline	NOUN
ijpds-4638	292	5	-	-	PUNCT
ijpds-4638	292	6	quality	quality	NOUN
ijpds-4638	292	7	risk	risk	NOUN
ijpds-4638	292	8	management	management	NOUN
ijpds-4638	292	9	q	q	NOUN
ijpds-4638	292	10	9	9	NUM
ijpds-4638	292	11	.	.	PUNCT
ijpds-4638	293	1	in	in	ADP
ijpds-4638	293	2	current	current	ADJ
ijpds-4638	293	3	step	step	NOUN
ijpds-4638	293	4	4	4	NUM
ijpds-4638	293	5	version	version	NOUN
ijpds-4638	293	6	..	..	PUNCT
ijpds-4638	293	7	2005	2005	NUM
ijpds-4638	293	8	;	;	PUNCT
ijpds-4638	293	9	p.	p.	NOUN
ijpds-4638	293	10	1	1	NUM
ijpds-4638	293	11	-	-	SYM
ijpds-4638	293	12	23	23	NUM
ijpds-4638	293	13	.	.	X
ijpds-4638	293	14	39	39	NUM
ijpds-4638	293	15	ich	ich	NOUN
ijpds-4638	293	16	expert	expert	NOUN
ijpds-4638	293	17	working	working	NOUN
ijpds-4638	293	18	group	group	NOUN
ijpds-4638	293	19	.	.	PUNCT
ijpds-4638	294	1	ich	ich	PROPN
ijpds-4638	294	2	harmonized	harmonize	VERB
ijpds-4638	294	3	tripartite	tripartite	ADJ
ijpds-4638	294	4	guideline	guideline	NOUN
ijpds-4638	294	5	-	-	PUNCT
ijpds-4638	294	6	pharmaceutical	pharmaceutical	ADJ
ijpds-4638	294	7	quality	quality	NOUN
ijpds-4638	294	8	system	system	NOUN
ijpds-4638	294	9	q	q	PROPN
ijpds-4638	294	10	10	10	NUM
ijpds-4638	294	11	.	.	PUNCT
ijpds-4638	295	1	in	in	ADP
ijpds-4638	295	2	current	current	ADJ
ijpds-4638	295	3	step	step	NOUN
ijpds-4638	295	4	4	4	NUM
ijpds-4638	295	5	version	version	NOUN
ijpds-4638	295	6	.	.	PUNCT
ijpds-4638	295	7	2008	2008	NUM
ijpds-4638	295	8	;	;	PUNCT
ijpds-4638	295	9	p.	p.	NOUN
ijpds-4638	295	10	1	1	NUM
ijpds-4638	295	11	-	-	SYM
ijpds-4638	295	12	21	21	NUM
ijpds-4638	295	13	.	.	NUM
ijpds-4638	295	14	40	40	NUM
ijpds-4638	295	15	ich	ich	NOUN
ijpds-4638	295	16	expert	expert	NOUN
ijpds-4638	295	17	working	working	NOUN
ijpds-4638	295	18	group	group	NOUN
ijpds-4638	295	19	.	.	PUNCT
ijpds-4638	296	1	ich	ich	PROPN
ijpds-4638	296	2	harmonized	harmonize	VERB
ijpds-4638	296	3	tripartite	tripartite	ADJ
ijpds-4638	296	4	guideline	guideline	NOUN
ijpds-4638	296	5	-	-	PUNCT
ijpds-4638	296	6	validation	validation	NOUN
ijpds-4638	296	7	of	of	ADP
ijpds-4638	296	8	analytical	analytical	ADJ
ijpds-4638	296	9	procedures	procedure	NOUN
ijpds-4638	296	10	:	:	PUNCT
ijpds-4638	296	11	text	text	NOUN
ijpds-4638	296	12	and	and	CCONJ
ijpds-4638	296	13	methodology	methodology	NOUN
ijpds-4638	296	14	q	q	PROPN
ijpds-4638	296	15	2	2	NUM
ijpds-4638	296	16	r1	r1	NOUN
ijpds-4638	296	17	.	.	PUNCT
ijpds-4638	297	1	in	in	ADP
ijpds-4638	297	2	current	current	ADJ
ijpds-4638	297	3	step	step	NOUN
ijpds-4638	297	4	4	4	NUM
ijpds-4638	297	5	version.2005	version.2005	ADJ
ijpds-4638	297	6	;	;	PUNCT
ijpds-4638	297	7	p.	p.	NOUN
ijpds-4638	297	8	1	1	NUM
ijpds-4638	297	9	-	-	SYM
ijpds-4638	297	10	17	17	NUM
ijpds-4638	297	11	41	41	NUM
ijpds-4638	297	12	schweitzer	schweitzer	PROPN
ijpds-4638	297	13	m	m	PROPN
ijpds-4638	297	14	,	,	PUNCT
ijpds-4638	297	15	pohl	pohl	PROPN
ijpds-4638	297	16	m	m	PROPN
ijpds-4638	297	17	,	,	PUNCT
ijpds-4638	297	18	hanna	hanna	NOUN
ijpds-4638	297	19	-	-	PUNCT
ijpds-4638	297	20	brown	brown	NOUN
ijpds-4638	297	21	m	m	PROPN
ijpds-4638	297	22	,	,	PUNCT
ijpds-4638	297	23	et	et	PROPN
ijpds-4638	297	24	al	al	PROPN
ijpds-4638	297	25	.	.	PUNCT
ijpds-4638	297	26	implications	implication	NOUN
ijpds-4638	297	27	and	and	CCONJ
ijpds-4638	297	28	opportunities	opportunity	NOUN
ijpds-4638	297	29	of	of	ADP
ijpds-4638	297	30	applying	apply	VERB
ijpds-4638	297	31	qbd	qbd	NOUN
ijpds-4638	297	32	principles	principle	NOUN
ijpds-4638	297	33	to	to	ADP
ijpds-4638	297	34	analytical	analytical	ADJ
ijpds-4638	297	35	measurements	measurement	NOUN
ijpds-4638	297	36	.	.	PUNCT
ijpds-4638	298	1	pharm	pharm	NOUN
ijpds-4638	298	2	technology	technology	PROPN
ijpds-4638	298	3	.	.	PUNCT
ijpds-4638	299	1	2010	2010	NUM
ijpds-4638	299	2	;	;	PUNCT
ijpds-4638	299	3	34	34	NUM
ijpds-4638	299	4	:	:	SYM
ijpds-4638	299	5	12	12	NUM
ijpds-4638	299	6	-	-	SYM
ijpds-4638	299	7	29	29	NUM
ijpds-4638	299	8	.	.	PUNCT
ijpds-4638	300	1	42	42	NUM
ijpds-4638	300	2	vogt	vogt	PROPN
ijpds-4638	300	3	f	f	PROPN
ijpds-4638	300	4	g	g	PROPN
ijpds-4638	300	5	,	,	PUNCT
ijpds-4638	300	6	kord	kord	PROPN
ijpds-4638	300	7	a	a	DET
ijpds-4638	300	8	s.	s.	PROPN
ijpds-4638	300	9	development	development	PROPN
ijpds-4638	300	10	of	of	ADP
ijpds-4638	300	11	quality	quality	NOUN
ijpds-4638	300	12	-	-	PUNCT
ijpds-4638	300	13	by	by	ADP
ijpds-4638	300	14	-	-	PUNCT
ijpds-4638	300	15	design	design	NOUN
ijpds-4638	300	16	analytical	analytical	ADJ
ijpds-4638	300	17	methods	method	NOUN
ijpds-4638	300	18	.	.	PUNCT
ijpds-4638	301	1	j	j	PROPN
ijpds-4638	301	2	of	of	ADP
ijpds-4638	301	3	pharm	pharm	PROPN
ijpds-4638	301	4	science	science	NOUN
ijpds-4638	301	5	.	.	PUNCT
ijpds-4638	302	1	2011	2011	NUM
ijpds-4638	302	2	;	;	PUNCT
ijpds-4638	303	1	100:797	100:797	NOUN
ijpds-4638	303	2	-	-	PUNCT
ijpds-4638	303	3	812	812	NUM
ijpds-4638	303	4	.	.	PUNCT
ijpds-4638	304	1	43	43	NUM
ijpds-4638	304	2	bhatt	bhatt	PROPN
ijpds-4638	304	3	d	d	PROPN
ijpds-4638	304	4	a	a	PROPN
ijpds-4638	304	5	,	,	PUNCT
ijpds-4638	304	6	rane	rane	PROPN
ijpds-4638	304	7	s	s	PROPN
ijpds-4638	304	8	i.	i.	PROPN
ijpds-4638	304	9	qbd	qbd	PROPN
ijpds-4638	304	10	approach	approach	NOUN
ijpds-4638	304	11	to	to	ADP
ijpds-4638	304	12	analytical	analytical	ADJ
ijpds-4638	304	13	rp	rp	NOUN
ijpds-4638	304	14	-	-	PUNCT
ijpds-4638	304	15	hplc	hplc	NOUN
ijpds-4638	304	16	method	method	NOUN
ijpds-4638	304	17	development	development	NOUN
ijpds-4638	304	18	and	and	CCONJ
ijpds-4638	304	19	its	its	PRON
ijpds-4638	304	20	validation	validation	NOUN
ijpds-4638	304	21	,	,	PUNCT
ijpds-4638	304	22	int	int	PROPN
ijpds-4638	304	23	j	j	PROPN
ijpds-4638	304	24	of	of	ADP
ijpds-4638	304	25	pharma	pharma	PROPN
ijpds-4638	304	26	science	science	NOUN
ijpds-4638	304	27	.	.	PUNCT
ijpds-4638	305	1	2011	2011	NUM
ijpds-4638	305	2	;	;	PUNCT
ijpds-4638	305	3	(	(	PUNCT
ijpds-4638	305	4	3):179	3):179	NUM
ijpds-4638	305	5	-	-	SYM
ijpds-4638	305	6	187	187	NUM
ijpds-4638	305	7	.	.	PUNCT
ijpds-4638	306	1	how	how	SCONJ
ijpds-4638	306	2	to	to	PART
ijpds-4638	306	3	cite	cite	VERB
ijpds-4638	306	4	this	this	DET
ijpds-4638	306	5	article	article	NOUN
ijpds-4638	306	6	:	:	PUNCT
ijpds-4638	306	7	dyade	dyade	PROPN
ijpds-4638	306	8	gk	gk	PROPN
ijpds-4638	306	9	,	,	PUNCT
ijpds-4638	306	10	jadhav	jadhav	PROPN
ijpds-4638	306	11	rb	rb	PROPN
ijpds-4638	306	12	,	,	PUNCT
ijpds-4638	306	13	repal	repal	NOUN
ijpds-4638	306	14	s	s	PROPN
ijpds-4638	306	15	,	,	PUNCT
ijpds-4638	306	16	uparwad	uparwad	NOUN
ijpds-4638	306	17	s	s	PART
ijpds-4638	306	18	,	,	PUNCT
ijpds-4638	306	19	suryawanshi	suryawanshi	NOUN
ijpds-4638	306	20	p	p	PRON
ijpds-4638	306	21	,	,	PUNCT
ijpds-4638	306	22	taware	taware	ADJ
ijpds-4638	306	23	a	a	NOUN
ijpds-4638	306	24	,	,	PUNCT
ijpds-4638	306	25	khapne	khapne	PROPN
ijpds-4638	306	26	s	s	PROPN
ijpds-4638	306	27	,	,	PUNCT
ijpds-4638	306	28	kokare	kokare	PROPN
ijpds-4638	306	29	s	s	PROPN
ijpds-4638	306	30	,	,	PUNCT
ijpds-4638	306	31	dnyaneshwar	dnyaneshwar	ADJ
ijpds-4638	306	32	a.	a.	NOUN
ijpds-4638	306	33	qbd	qbd	NOUN
ijpds-4638	306	34	approach	approach	NOUN
ijpds-4638	306	35	and	and	CCONJ
ijpds-4638	306	36	chemo	chemo	VERB
ijpds-4638	306	37	metric	metric	ADJ
ijpds-4638	306	38	method	method	NOUN
ijpds-4638	306	39	development	development	NOUN
ijpds-4638	306	40	for	for	ADP
ijpds-4638	306	41	the	the	DET
ijpds-4638	306	42	estimation	estimation	NOUN
ijpds-4638	306	43	of	of	ADP
ijpds-4638	306	44	metoprolol	metoprolol	PROPN
ijpds-4638	306	45	succinate	succinate	NOUN
ijpds-4638	306	46	and	and	CCONJ
ijpds-4638	306	47	cilnidipine	cilnidipine	NOUN
ijpds-4638	306	48	in	in	ADP
ijpds-4638	306	49	combined	combine	VERB
ijpds-4638	306	50	solid	solid	ADJ
ijpds-4638	306	51	dosage	dosage	NOUN
ijpds-4638	306	52	form	form	NOUN
ijpds-4638	306	53	.	.	PUNCT
ijpds-4638	307	1	indian	indian	PROPN
ijpds-4638	307	2	j	j	PROPN
ijpds-4638	307	3	pharm	pharm	PROPN
ijpds-4638	307	4	drug	drug	PROPN
ijpds-4638	307	5	studies	study	NOUN
ijpds-4638	307	6	.	.	PUNCT
ijpds-4638	307	7	2024	2024	NUM
ijpds-4638	307	8	;	;	PUNCT
ijpds-4638	307	9	online	online	ADJ
ijpds-4638	307	10	first	first	ADJ
ijpds-4638	307	11	.	.	PUNCT
ijpds-4638	308	1	funding	funding	NOUN
ijpds-4638	308	2	:	:	PUNCT
ijpds-4638	308	3	none	none	NOUN
ijpds-4638	308	4	;	;	PUNCT
ijpds-4638	308	5	conflicts	conflict	NOUN
ijpds-4638	308	6	of	of	ADP
ijpds-4638	308	7	interest	interest	NOUN
ijpds-4638	308	8	:	:	PUNCT
ijpds-4638	308	9	none	none	NOUN
ijpds-4638	308	10	stated	state	VERB
ijpds-4638	308	11	keywords	keyword	NOUN
ijpds-4638	308	12	:	:	PUNCT
ijpds-4638	308	13	metoprolol	metoprolol	NOUN
ijpds-4638	308	14	succinate	succinate	NOUN
ijpds-4638	308	15	,	,	PUNCT
ijpds-4638	308	16	cilnidipine	cilnidipine	NOUN
ijpds-4638	308	17	,	,	PUNCT
ijpds-4638	308	18	qbd	qbd	PROPN
ijpds-4638	308	19	,	,	PUNCT
ijpds-4638	308	20	ich	ich	NOUN
ijpds-4638	308	21	,	,	PUNCT
ijpds-4638	308	22	absorbance	absorbance	NOUN
ijpds-4638	308	23	correction	correction	NOUN
ijpds-4638	308	24	method	method	NOUN
ijpds-4638	308	25	,	,	PUNCT
ijpds-4638	308	26	amplitude	amplitude	NOUN
ijpds-4638	308	27	modulation	modulation	NOUN
ijpds-4638	308	28	method	method	NOUN